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Abstract 
The aims of this work were first to synthesize and fully characterize compounds that may 
function as bleomycin analogues and, second, to test their anticancer activity in vitro. Three 
novel tetradentate O,N,N,O Schiff base ligands, H3L
1, H2L
3 and H2L
3 were synthesized by 
condensation of three different 1,3-diaminoalkane bridging units with two equivalents of 
(2,4-dihydroxy–phenyl)-(phenyl)methanone. These ligands contain two neutral imine 
nitrogen donors and two anionic phenolate oxygen donors for the coordination of metal ions. 
The choice of ligand was guided by the fact that Cu(II) bleomycin analogues with ligands 
employing O,N,N,O donor atom sets are able to cleave double-stranded DNA via oxygen 
radical formation. Using these ligands, six novel metal complexes of copper(II), nickel(II) 
and zinc(II) were synthesized and fully characterised. Two novel ligand crystal structures and 
six novel metal complex crystal structures are reported in this work. 
 
The X-ray structures of the two structurally characterized nickel(II) complexes [Ni(L2)] and 
[Ni(L 3)] adopted the same nominally square planar coordination geometry, with the metal ion 
bound by the pairs of imine nitrogen and ortho-phenolic oxygen atoms of the ligand’s 
tetradentate donor atom set. The Ni–  and Ni–O distances averaged 1.892(3) Å and 
1.845(2) Å, respectively. However, when reacted with Cu(II) and Zn(II), the ligands favored 
the formation of multinuclear complexes as a result of metal ion bridging by ionized oxygen 
donor atoms (either the phenolic oxygen atoms or an alkoxide oxygen atom of the 2-hydroxy 
substituted alkane bridge in the case of H3L
1) of the polyfunctional ligands. For the di- and 
trinuclear copper(II) complexes, the mean Cu–N and Cu–O distances averaged 1.953(3) Å 
and 2.082(3) Å, respectively. For the dinuclear zinc(II) complex, the mean Zn–N a d Zn–O 
distances averaged 2.074(3) Å and 2.042(3) Å, respectively. 
 
Electron spin resonance (ESR) measurements on the paramagnetic trinuclear copper(II) 
complexes confirmed that the trinuclear solid state structures remain intact in fluid solution 
(DMF) and that two of the three copper(II) ions are antiferromagnetically coupled, leaving 
the third as an S = ½ center with a hyperfine coupling constant to the I = 3/2 Cu nucleus of 
14.80 G. Super-hyperfine coupling (15.13 G) to two N atoms was also evident, consistent 
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with one of the terminal copper(II) centers (O,N,N,O donor atom set) being the site of the 
unpaired spin density in the molecule. 
 
Density functional theory (DFT) simulations were used to determine the electronic structures 
of the diamagnetic mononuclear nickel(II) complexes. The simulations reproduced the 
structures of [Ni(L2)] and [Ni(L3)] accurately with similarity coefficients for the two 
complexes of 0.982 and 0.990, respectively. The simulated electronic spectra (TD-DFT) of 
the nickel(II) complexes showed reasonably good agreement with the experimental spectra 
and were useful for the assignment of the low-lying MLCT state (near 400 nm) for the 
complexes as well as the higher-lying -* transitions between 300–350 nm. 
 
All of the metal complexes and one ligand were sent to MINTEK1 (Project AuTEK) for anti-
cancer screening. The copper(II) complexes (bleomycin analogues capable of generating 
hydroxyl radicals in vivo) showed significant cytotoxicity against the human cancer cell lines 
A549, DU145, HT-29, and U21. The trinuclear complexes were the most cytotoxic with 
mean IC50 values of 6(2) and 7(1) M for [Cu3(L2)2Cl2(DMF)2] and [Cu3(L3)2(H2O)2]Cl2, 
respectively. The nickel(II) complexes [Ni(L2)] and [Ni(L3)] were comparatively inactive 
with mean IC50 values of >50 and 35(16) M, respectively, consistent with the fact that they 
do not readily generate reactive oxygen species in a cellular environment. 
  
                                                          
1
 200 Malibongwe Drive, Strijdom Park, Randburg 
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Cancer is a global health problem as it does not discriminate who it affects, is deadly if left 
untreated, and thus commands a regimen of treatment methods from health care 
professionals. Some tumour cells have an innate resistance to the drugs used to treat them and 
so secondary cancers can become resistant after primary treatment. This project focuses on 
reproducing bleomycin activity with regard to DNA cleavage via radical production. Various 
analogues of a known copper compound, (5-amino-5-methyl-3,7-diazanonanedioate) 
copper(II), have been synthesised in this project by imine formation. This complex was 












Figure 1.1: Structure of (5-amino-5-methyl-3,7-diazanonanedioate) copper(II).[1] 
 
In the present work, structural analogues of the ligand in Figure 1.1 will be chelated to 
copper(II), nickel(II) and zinc(II). The complexes therefore have the same N2O2 tetradentate 
coordination sphere as (5-amino-5-methyl-3,7-diazanonanedioate) copper(II). These chelates 
would be aimed towards uses in cancer treatment and would therefore be screened as such. 
Illustrated below in Figure 1.2 are the ligands to be synthesised. The ligands consist of 2,4-
dihydroxybenzophenone linked by a synthetically variable di(azomethine) bridge. 
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Figure 1.2: Ligands proposed for synthesis and chelation to Cu(II), Ni(II) and Zn(II).  
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1.2 Chemistry of Copper 
 
Figure 1.3: Copper metal in its raw state.[2] 
 
The date of copper’s discovery is not clearly known, but its extraction from its commonly 
found ores was already well developed by 3400 B.C. by the early Egyptians.[3] Copper 
(Figure 1.3) has many ores of which an example is malachite (CuCO3.Cu(OH)2) that has a 
brilliant green colour and was used as a pigment by the Renaissance artists in the fabrics of 
paintings.[3] Copper has an atomic number of 29, atomic mass of 65.55 g mol-1, it has a 
melting point of 1083 °C[3-5] and it boils at 2310 °C[3]. The copper atom has one electron in its 
4s shell, outside its filled 3d shell giving an electronic configuration of [Ar] 3d10 4s1. 
Copper’s most common oxidation states are (I) and (II).[4] Copper(I) adopts square planar or 
tetrahedral geometries more commonly; whereas copper(II) will favour a distorted octahedral 
geometry with two longer trans bonds.[4] These distortions can be attributed to the d9 
configuration of copper(II).[4] Copper(II) is classified as an intermediate acid[6] meaning it 
will favour coordination by intermediate bases, such as NO2
-. Copper is classified as a noble 
metal and can sometimes be found in its pure state which has a fine rose-pink sheen, however 
once molten the colour is green.[3, 5] The pure metal is soft, malleable and ductile with a very 
high electrical and heat conductivity.[3, 5] This coupled with its reasonable cost allows for its 
wide use in electrics.[5] Copper is miscible with gold and other metals and is used in alloys, 
such as its most commonly known mixture with zinc; brass.[4] In biology, copper is used in 
the oxygen transport molecule haemocyanin in molluscs and arthropods[6] as well as in the 
terminal oxidase enzyme system in the mitochondrial respiratory chain of all living cells.  
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 1.3 Chemistry of Nickel 
 
Figure 1.4: Metallic nickel in its raw state.[7] 
 
Nickel (Figure 1.4) was first isolated accidentally in 1751 by Axel Fredrik Cronstedt who 
believed it to be copper. Nickel has an atomic number 28, atomic mass of 58.69 g mol-1, it 
has a melting point of 1455 °C and boils at 2732 °C.[5] The nickel atom has two electrons in 
its 4s shell making its electronic configuration [Ar] 3d8 4s2. Nickel’s most common oxidation 
state is nickel(II); however less common are the nickel(III) and nickel(IV) states. Nickel(II) 
has a wide variety of geometries, namely octahedral, trigonal bipyramidal, square pyramidal, 




2) will be uniquely high in energy making the eight electrons occupy the four 
lower d orbitals leaving the one highest in energy vacant.[4] Nickel(II) is also an intermediate 
acid[6] meaning it will favour coordination by intermediate bases, such as SO3
2-. Nickel ores 
that are found naturally all consist of metal mixtures.[5] It is less magnetic than iron and loses 
its magnetism at 340 °C.[5] Nickel is used in many alloys, one of the more important being 
stainless steel. Due to its corrosion resistance it is often applied in a thin layer via 
electroplating as a protective barrier, for example in the automotive industry bumpers may be 
nickel plated.[4-5] It is also used as a catalyst in a Raney nickel hydrogenation reaction using 
hydrogen to reduce organic compounds.[5] Nickel is used by several enzymes and a cofactor 
in biology.[8] For example, nickel(II) is incorporated in Factor F430 which is a cofactor of 
methyl coenzyme M reductase.[9] This Factor is involved in the last step of methanogenesis.[9] 
However, nickel(II) can be very toxic in living systems if taken in high doses.[10-11] Unlike 
copper(II), nickel(II) does not produce hydroxyl radicals, capable of cleaving DNA. 
Comparison of the copper(II) and nickel(II) compounds could therefore aid elucidation of the 
mode of action of the potential chemotherapeutic agents. 
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1.4 Chemistry of Zinc 
 
Figure 1.5: Metallic zinc in its raw state. 
 
Zinc (Figure 1.5) was first isolated in 1746 by Marggraf upon heating its oxide with carbon, 
which acts as a reducing agent.[3] It has an atomic number of 30, atomic mass of  
65.41 g mol-1, it melts at 419 °C[3, 5] and boils at 907 °C[3]. The zinc atom has the electronic 
configuration of [Ar] 3d10 4s2. The most common oxidation state is zinc(II). Like copper(II) 
and nickel(II), zinc(II) is an intermediate Lewis acid[6] meaning it will favour coordination by 
intermediate bases, such as SCN-. Since copper(II), nickel(II) and zinc(II) are all Lewis acids 
of comparable strength with similar ionic radii (0.072 nm, 0.069 nm, 0.074 nm, respectively), 
it should be possible to chelate all three to the same ligands. Zinc complexes tend to be four 
to six coordinate species and the main geometry is tetrahedral.[3, 6] Zinc ores are quite 
plentiful; the ore that supplies the most zinc is called sphalerite and is a sulphide. Zinc is 
easily extracted from its ores.[3-5] It is a white metal that, if polished, has a lustre that is 
tarnished and dulled by air exposure.[3-5] Zinc metal is relatively hard and very brittle, 
especially at 200 °C where it can be ground to powder.[5] The main use of zinc is in the 
making of alloys, the most commonly known being brass, and in galvanising steel.[5] Zinc 
acts as a very strong reducing agent and when combined with hydrochloric acid is commonly 
used by chemists as a reducing system.[3] In biological systems the Zn2+ ion is commonly 
utilised due to its slightly softer accepting nature in comparison to Mg2+, which means it is a 
stronger Lewis acid for biological molecules.[6] As zinc will not readily undergo redox 
reactions it simplifies its chemistry in these biological systems.[6] Furthermore, its labile 
nature with respect to chelating and releasing ligands is a desirable feature in biology and in 
synthetic chemistry.[6] Zinc occurs in two important enzymes; carbonic anhydrase, that 
functions in the hydration-dehydration cycle of carbon dioxide and carboxypeptidases that 
catalytically hydrolyse peptide bonds in proteins.[6] 
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1.5 Applications of Metal Schiff Base Complexes 
Schiff bases are used as ligands for a wide variety of metal ions as the complexes they form 
can perform a variety of functions, ranging from nitric oxide sensors[12] to 
pharmaceuticals[13]. The ligands themselves can be used for photochromic and 
thermochromic purposes in the solid state.[14] A few Schiff base metal complexes have been 
selected for a brief overview of the wide application of these complexes. 
  
Yao et al. [15] synthesised and characterised four copper(II) Schiff base complexes in an 
attempt to study their solvatochroism. They found that only one complex, [N,N’-bis(4-
methyoxy salicylidene)-1,2-diaminoethane]copper(II), displayed colour isomerism. It 
produced three coloured solids; brown from methanol in the presence of water, blue from 
methanol with water absent and green from ethanol and DMSO. They reported a range of 
violet to blue colouring of the solutions of the green solid when dissolved in different 
solvents. Yao et al. [15] stated that as the σ donor capacity of the solvent increased the solvent 
would coordinate to the metal centre via substitution of a water molecule, and this would in 
turn change the energy of the transitions leading to the solvatochromic effect. The structure is 
shown below in Figure 1.6.  
 
 
Figure 1.6: Structure of (N,N'-bis(4-methoxysalicylidene)ethane-1,2-diamine)copper(II), 
a potential sensor for organic solvents.[15] 
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Research into the oxidation of hydrocarbons, such as toluene and cyclohexane by means of a 
metal complex catalyst is of some importance as the products of these reactions are of 
industrial significance.[16] Cyclohexanol, for example, is the oxidised product of cyclohexane 
and is used in the manufacture of adipic acid, which is one of the materials used for pesticides 
and rubber chemicals, among many other things.[16] Roy et al. [16] successfully synthesised 
and studied tetranuclear copper(II) Schiff base complexes (Figure 1.7) for use as catalysts in 
these types of oxidation reactions. They found that in a slightly acidic medium under ambient 
conditions with hydrogen peroxide as the oxidant, cyclohexane and toluene were oxidised to 
cyclohexanol and cyclohexanone, and benzyl alcohol and benzaldehyde, respectively. They 
also reported that by varying the proportions of nitric acid and oxidant with respect to the 
catalyst and reaction times, one can optimize the yield of these reactions with respect to both 
reaction products; alcohol and aldehyde or ketone. It was suggested that the nitric acid would 
accommodate the pentacoordinated copper centre in the catalyst by protonation of the ligand, 
which allows for increased unsaturation of the copper atom.[16]  
 
 
Figure 1.7: Structure of the copper(II) Schiff base duplicated from Roy et al.[16] A 
catalyst for the oxidation of organic compounds. 
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Nitric oxide is a compound of interest as it is a signal molecule (endothelial-derived relaxing 
factor which promotes smooth muscle relaxation) for animals and in order to study its 
biological uses there is a need for selective and sensitive measurement of it. [12] Most of the 
specific molecular materials used in surface-modified electrodes are metal complexes. Mao et 
al. [12] developed metal complexes of salen, (ethylenebis(salicylideneminate)) using iron, 
cobalt, copper and manganese, which they then constructed into an electropolymerized film 
in order to study its application in electrochemical nitric oxide sensors. The structure of salen 
is shown in Figure 1.8. 
 
 
Figure 1.8: Structure of the ligand ethylenebis(salicylideneminate). 
 
In previous studies with the same aim, nickel(II) was used as the metal for complexation by 
salen, porphyrin and phthalocyanine ligands.[12] Mao et al. [12] found that these complexes 
produced similar results, which suggested that the metal centre was not the key factor in 
producing the electrochemical catalytic activity. It was suggested that the nitric oxide 
oxidation was possibly due to electron conjugation.  
 
Table 1.1: Response of nitric oxide to the different polymeric films studied by Mao et 
al.
[12] 
Film used Linear range of detection Detection limit (nM) 
Co(salen) 19.8 nm – 2.80 µM 12 
Fe(salen) 19.6 nm – 1.13 µM 10 
Cu(salen) 23.4 nm – 2.10 µM 19.8 
Mn(salen) 39.6 nm – 1.50 µM 20 
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1.6 Metal-Based Anti-Microbial and Anti-Cancer Agents 
Some of the earliest documentations of copper chemistry show its use as an anti-microbial 
agent.[17] Between 2600 and 2200 B.C. copper was used in the sterilisation of drinking water 
and chest wounds. Then around 1500 B.C. it was documented that copper compounds were 
being prescribed to treat ailments such as burn wounds, itching and neck growths.[17] In 1867 
the first publication of copper’s role in the immune system was published when copper 
workers were found to be immune to the cholera outbreaks in Paris.[17] Then in 1895 Kobert 
published inorganic copper preparations that were proven to be effective in the treatment of 
eczema, tubercular infections, lupus, and syphilis.[17] In Germany in 1912, facial epitheliomas 
were successfully treated using a combination of copper chloride and lecithin.[17] In 1913 at 
the University of Liverpool and in 1930 in France, injections of colloidal copper were proven 
to help treat solid tumours. Bayer synthesised an organic copper complex used for the 
treatment of tuberculosis which led to copper treatments of tuberculosis persisting into the 
1940s.[17] The anti-microbial effects of copper have been incorporated into everyday surfaces 
in an attempt to decrease the spread of microbes, especially in hospitals and clinics. Copper 
alloys have thus been used to make things such as doorknobs and tray tables.  
 
Cancer is defined as abnormal cell growth.[18-19] The proliferation can lead to masses of 
tissue, which are then called malignant tumours. [19] There are three main pathways to treating 
people with cancer; chemotherapy, radiation therapy and surgery. Radiation therapy involves 
utilising radiation from radioactive substances to target these fast dividing cells causing 
destruction of the tissue or tumour. This technique is based on the fact that these fast dividing 
cells are more susceptible to radiation damage than healthy cells.[19] Alternatively, 
chemotherapy can be used to treat cancer. Chemotherapy is the treatment of cancer using 
drugs, (sometimes alone but more commonly in combinations) that target cancer cells. These 
drugs either stop cancer cell division or slow it down.[19] Chemotherapy is sometimes used in 
conjunction with radiation therapy. 
 
Anti-cancer drugs are generally designed to target rapidly proliferating cells.[20] This includes 
cancer cells, but also non-cancerous but rapidly dividing cells, such as hair follicles. This lack 
of specificity leads to the unpleasant side-effects of chemotherapy. This is shown, for 
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example, by the targeting of DNA polymerase by the drugs Vernolepin and Helenalin.[18, 20] 
DNA polymerase is an enzyme that cells use to replicate their DNA in order to proliferate. 
The drug’s mode of action is via an irreversible conjugate addition of the α-β-unsaturated 
carbonyls in the drugs (Figure 1.9) and the thiol present on the enzyme itself. This 
abnormality in the enzyme means it loses functionality and the DNA cannot replicate. 
 
 
Figure 1.9: Structures of DNA polymerase targeting anti-cancer drugs. The highlighted 
areas indicate where the enzyme will bind. 
 
Cisplatin is one of the most well known and widely used metal-based anti-cancer drugs, due 
to its high success. It was first FDA approved for clinical use in 1978.[21] It works by binding 
DNA through its bases, preferentially through guanine.[22] This forms an intermediate of 
[PtCl(guanine-DNA)(NH3)2]
+, meaning another chlorine atom can be displaced by another 
guanine to form a crosslink. The crosslink prevents mitosis from occurring and will trigger 
DNA to attempt a repair. The repair will prove unsuccessful, which leads the cell to initiate 
apoptosis; programmed cell death. The main problem with this drug is that if the cancer 
returned it would be cisplatin-resistant. Cisplatin does, however, have its side-effects, namely 
kidney damage, nerve damage, nausea and vomiting, electrolyte imbalances, and loss of 
hearing. 
 
Sugars are of the utmost importance in many biological activities, for example, signal 
transduction and as targets of bacterial or viral infection of cells.[23] This is why efforts have 
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been made to understand and imitate these processes.[23] Striegler and Gichinga[23] 
synthesised a sugar discriminating, binuclear Schiff base copper(II) complex. They suggested 
that the ligand itself was the determining factor for the sugar recognition as it would 
determine the complex’s geometry. They therefore synthesised one asymmetrical and two 
symmetrical complexes in order to study the effects of changing the ligand structure. In so 
doing they proved that although structurally similar and with identical sugar binding sites, the 
slightest structural changes had large effects on the complex’s interactions with the sugar.  
 
It has been found that certain guanine-rich DNA sequences are potential targets for 
chemotherapeutics in cancerous cells. These guanine-rich sequences utilise hydrogen bonding 
to form tetrads (four in-plane guanine bases hydrogen-bonded), which in turn lead to 
quadruplex DNA structures (stacks of tetrads).[24-31] These guanine-rich structures can be 
stabilised by electrostatic interactions with alkali metal cations.[24-25] Using a complex to 
stabilise these quadruplex structures, specifically in human telomeric DNA (DNA consisting 
of TTAGGG sequence repeats that end in guanine-rich single-strand overhangs) leads to 
inhibition of an enzyme called telomerase which is responsible for preventing shorting of 
telomeric DNA.[24-31] This enzyme is over-expressed by cancer cells and therefore is an 
essential factor in immortalising cancer cells.[24-31] In research done by Arola-Arnal et al. [24] 
a series of salphen and salen complexes of nickel(II), copper(II), zinc(II) and vanadium(IV) 
were synthesised and their interactions with human telomeric DNA was studied.  
 
Arola-Arnal et al. [24] used their studies to elucidate important features in metal chelates for 
interaction with quadraplex DNA to enable further research to be done to create potential 
anti-cancer agents. It was found that the planar complexes of nickel(II) and copper(II) were 
efficient stabilisers of the quadruplex structures. They also discovered that when the metal 
atom was bound to the ligand it reduced electron density in the rings which allows for better 
π-π stacking interactions (Figure 1.10). The zinc(II) complex lacked interaction due to its  
non-planar region and pentacoordination.  
 
Page | 12  
 
 
Figure 1.10: Stacking of the nickel(II) salphen complexes, showing an centroid-to-
centroid spacing of 3.567 Å.[24] 
 
These select examples show the wide application of Schiff base ligands when coordinated to 
copper(II), nickel(II) , zinc (II) and other metals. 
 
The above examples also show that although there are effective chemotherapeutics available, 
they all have their disadvantages. It is thus critical that there is constant research into the 
development of new, more effective drugs. 
 
1.7 Bleomycin and Its Analogues 
Bleomycin is of interest as its mode of action is reproducible using smaller and easier to 
produce compounds. The compounds synthesised in this project were based on a well known 
bleomycin analogue[1] (Figure 1.1), to mimic the mode of action and thus find application in 
cancer treatment.  
 
Bleomycin was first isolated in 1966 by Umezawa et al. [32] from Streptomyces verticillus. It 
was deemed a glycopeptide anti-biotic that had anti-cancer properties.[33] It has since been 
used in combination with drugs, such as cisplatin, for the treatment of mostly testicular 
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cancer, but also for types of lymphomas. [32, 34] Hashimoto et al. [35] have proposed that there 
are three components to bleomycin; the DNA recognition component (the bis(thiazole) 
moiety), the binding site which activates the bleomycin by chelating a metal and finally, a 




Figure 1.11: Structure of bleomycin from Streptomyces verticillus and its components. 
 
Bleomycin is not an active species on its own. It requires chelation of a reduced transition 
metal ion in order to be activated and this is only achieved in the presence of oxygen and a 
reductant of some sort.[32, 34-35] Once activated, bleomycin can bind DNA in two alternative 
ways; via intercalation or by binding the minor groove.[36] The bleomycin structure chelates 
metal ions and the complex cleaves DNA by producing reactive oxygen species such as 
superoxide and hydroxide free radicals.[37] It is believed to function as an anti-cancer 
treatment that works by inducing both double- and single- stranded DNA breaks[35]. 
Furthermore, the metal centres are thought to play a very important role in the activation of 
the phosphate group present in the backbone of the DNA molecule in order for it to be 
attacked by the nucleophilic radicals, created by activation of a water molecule via the metal 
centre.[38] Bleomycin can degrade species in two ways; via a radical pathway or through 
formation of hydroxyl radicals.[32] 
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A proposed cleavage mechanism is suggested by Chen and Stubbe.[32] It suggests that in the 
presence of oxygen and a suitable reductant, bleomycin will chelate iron(II) to form an 
Fe(II)-O2-Bleomycin species. (Bleomycin first forms an Fe(II)-bleomycin complex which 
will activate the oxygen).[39] The iron is oxidised from Fe(II) to Fe(III), whilst the oxygen in 
the compound undergoes a reduction, yielding a negatively charged bleomycin-Fe(III) 
species.[35] Further reaction occurs to afford the activated bleomycin-Fe(III)-OOH species. 
This compound can then either; cleave the protein, damage lipids, cleave DNA/RNA or 




Figure 1.12: Activation of bleomycin (BLM) in the presence of oxygen and iron. 
 
During DNA cleavage, the activated compound will remove the 4′-hydrogen from the 
deoxyribose of a pyrimidine[40] that is 3′ to a guanine thus forming a 4′-radical intermediate. 
Bleomycin recognises guanosine-cytosine rich fragments in DNA for its cleavage action by 
intercalating its bis(thiazole) component.[33] Two pathways are possible for the 4′-radical, 
depending on oxygen concentration. At lower concentrations of oxygen, the radical can be 
oxidised to a carbocation which will then form an oxidised, abasic site by the addition of two 
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equivalents of water. The abasic site refers to the loss of a nucleotide base. This also removes 
the pyrimidine from its deoxyribose segment attached to the DNA backbone. This is 
illustrated in Figure 1.13. 
 
 
Figure 1.13: Cleavage by bleomycin (BLM) in low oxygen concentrations. 
 
Alternatively, in the presence of higher oxygen concentrations, the radical could be converted 
to a peroxy radical in a reaction involving oxygen. This peroxy radical is then reduced to a 
hydroperoxide, which reacts further to ultimately afford cleaved DNA in the form of three 
end products; a pyrimidine propenal, the 5′- phosphate end of DNA and the 3′-
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phosphoglycolate end of DNA.[41] They also propose that a single bleomycin molecule is 
responsible for double stranded DNA cleavage. This is illustrated in Figure 1.14. 
 
 
Figure 1.14: DNA cleavage by bleomycin (BLM) in high oxygen concentrations. 
 
In 1986 Hashimoto et al. [35] synthesised novel hemin-intercalators that cleaved DNA using 
bleomycin as their model. The design of their ligands incorporated a DNA-recognition and 
intercalation portion and a hemin group. Hemin is considered to be an oxygen activating 
molecule, which would follow the above mechanism for bleomycin induced DNA cleavage. 
These hemin-ligands were chelated to iron(II) for the purposes of their studies. They found 
two of their complexes were strong DNA cleavers, the structures are shown in Figure 1.15.  
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Figure 1.15: Structures of hemin-intercalators studied by Hashimoto et al.[35] with the 
highlighted DNA recognition portion. 
 
The intercalator portion of the compound is 2-amino-6-methyldipyrido[1,2-a:3′,2′-d] 
imidazole and was found to be of utmost importance in DNA recognition and intercalation in 
order to allow for effective DNA-cleavage. This moiety is suitable for DNA intercalation as it 
is planar and aromatic. It is thus able to intercalate between the planar aromatic base pairs of 
DNA. The intercalated moiety is stabilised by favourable π-π interactions with the aromatic 
base pairs. The other factor for strong DNA-cleavage was found to be any functional group in 
the hemin molecule that acts as an intramolecular ligand for iron(II). The DNA cleavage 
studies performed by Hashimoto et al.[35] revealed that their hemin-intercalators were 
cleaving DNA in a pattern almost identical to that of bleomycin. The cleavage by these 
hemin-intercalators was performed preferentially at guanine-cytosine and guanine-thymine 
sequences which afforded a 5′-phosphoryl group and three groups on the 3′-end; one being a 
hydroxyl group. Some of the hemin-intercalators studied by Hashimoto et al. [35] were found 
to have anti-tumour activity similar to that of bleomycin. 
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Pamatong et al.[1] reported a bleomycin analogue of copper which was shown to produce 
hydroxyl radicals and induce DNA cleavage. Their research was directed towards creating a 
complex that could perform non-random, double-stranded DNA cleavage as this is known to 
induce cell apoptosis as it is much harder for the cell to repair than a single strand DNA 
break. They designed their complexes with two priorities in mind, a metal centre that can be 
reactivated and DNA recognition segments. These features allow the complex to carry out its 
function; nick the DNA, bind at the nicked site, activate oxygen and finally, induce strand 
scission in order to yield linear DNA fragments.[1] The two complexes synthesised in their 
study are shown below in Figure 1.16.  
 
 
Figure 1.16: Structures of (5-amino-5-methyl-3,7-diazanonanedioate)copper(II) (a) and 
((2S,8R)-5-amino-2,8-dibenzyl-5-methyl-3,7-diazanonanedioate)copper(II) (b). Both 
complexes are capable of inducing double-stranded DNA cleavage. 
 
The amino acids glycine and phenylalanine were used in the synthesis of the ligands for their 
hydrophobic nature as this creates the possibility for hydrophobic interactions with DNA 
bases. The ammonium group allows for favourable electrostatic interaction with the 
negatively charged phosphate backbone of the DNA helix. This interaction also allows for the 
amino acid segments to be positioned into the hydrophobic interior of the DNA itself. In their 
studies of these complexes, Pamatong et al. found that both complexes cleave DNA.[1] 
However, they found that the phenylalanine complex cleaves DNA more efficiently than the 
glycine complex. They attribute this difference in activity to the phenylalanine side chain, 
proposing that the charge and aromaticity allows for improved DNA binding, which leads to 
more efficient cleavage. Their studies also went so far as to prove that hydroxyl radicals were 
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the active species in DNA cleavage by studying the effects of the compounds in the presence 
of hydroxyl radical quenchers.  
 
In further studies done by Pamatong et al., [42] copper(II) was chosen as the metal centre due 
to its redox activity and its well known ability to generate activated oxygen species which 
lead to cleavage of DNA through hydrolysis of its phosphodiesters. In this study it was again 
shown that the bleomycin analogues, shown above in Figure 1.16, cleave DNA by the 
production of hydroxyl radicals and not through any other activated oxygen species or metal-
oxo intermediates. Their results are shown in Figure 1.17.  
 
 
Figure 1.17: Monitoring hydroxyl radical production by rhodamine B decay in 
phosphate buffer. The reaction conditions for each are as follows: ● aerobic activation 
with both H2O2 and sodium ascorbate, ▲ aerobic activation with only sodium 
ascorbate, ● anaerobic activation with both H2O2 and sodium ascorbate ▲ anaerobic 
activation with only sodium ascorbate, + quenching of ascorbate activation by ethanol. 
Reproduced from reference [42]. 
 
Figure 1.17 shows three different hydroxyl radical quenchers were used along with the 
synthesised chelates and no reaction took place. This was done to show that the active 
oxidant in the reaction was indeed the hydroxyl radicals produced. 
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The study focused on the mechanism of radical production, which was shown to favour the 
Haber-Weiss reaction rather than that of the Fenton or Fenton-like copper peroxo 
mechanisms. In his last paper in 1934, Professor Fritz Haber conceptualised that utilising 
both hydrogen peroxide and superoxide, a highly reactive hydroxyl radical could be 
produced.[43-44] Once it was discovered that free radicals were produced in biological systems, 
the reaction was seen as a pathway to produce more toxic radicals from less reactive 
species.[44] The Haber-Weiss reaction is, however, thermodynamically unfavourable and 
therefore requires a catalyst. In the original paper it was shown that a metal catalyst can be 
used in two separate reactions which afford the overall Haber-Weiss reaction.[44] The Fenton 
reaction is the reaction of hydrogen peroxide with a metal-catalyst resulting in the formation 
of a hydroxyl radical.[43] Pamatong et al. used superoxide dismutase to remove the O2
- from 
the reaction which leaves only the reducing agent and hydrogen peroxide. This is key to the 
Fenton reaction and lead to no products being formed.[42] These reactions are shown below: 
 
Fenton reaction: 
Mn+ + H2O2 → M




●- + H2O2 → O2 + 
●OH + OH- 
 
These examples show the biological significance of copper(II) and suggest that it is likely to 
be an effective metal for use as chemotherapeutic agents in this project. 
 
1.8 Project Objectives 
The literature survey has shown there is room for expansion in the library of bleomycin 
analogues for use as anti-cancer agents. Analogues are created in order to simplify 
manufacturing and to create smaller molecules that allow for the same or better activity. The 
ligands for this project were therefore based on a known bleomycin analogue[1], (5-amino-5-
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methyl-3,7-diazanonanedioate)copper(II). The compounds comprise a tetradentate ligand 
consisting of two nitrogen and two oxygen donors with a square planar geometry at the metal 
centre. Coordination of the ligands with concomitant deprotonation of the hydroxyl groups 
affords a dianionic, N2O2 tetradentate ligand. A phenyl ring was included as a substituent in 
the design of the ligands as copper complexes with phenyl ring substituents have been 
observed to have a higher chemotherapeutic activity and more specific, or non-random, DNA 
cleavage activity,[1]. This is possibly due to enhanced binding to the DNA strands. Following 
full characterisation of the novel ligands, chelation to copper(II) will create novel complexes 
that should act as hydroxyl radical producing, bleomycin analogues. Nickel(II) and zinc(II) 
will also be chelated in an attempt to vary the activity of the compounds because these metals 
are commonly grouped together in such studies. Since nickel(II) and zinc(II) do not produce 
hydroxyl radicals in solution, enhanced activity of the copper chelates, relative to nickel(II) 
and zinc(II) would suggest that hydroxyl radical generation is the likely mode of action. 
 
The following specific objectives have been identified for the project: 
· To produce novel ligands, structurally similar to known bleomycin analogues. 
· To form novel metal complexes of Cu(II), Ni(II) and Zn(II) using these ligands. 
· To fully characterise all ligands and metal complexes using NMR, IR, EPR/ESR and 
UV/visible spectroscopy as well as single crystal X-ray crystallography. 
· Perform computational modelling on the metal complexes. 
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2. Experimental 
2.1 Instrumentation and Chemicals 
All solvents used were reagent grade and acquired from Merck. All reagents were purchased 
from Sigma-Aldrich and used as received, except zinc acetate which was purchased from 
SAARCHEM. No special conditions were used in any of the reactions. 
 
1H and 13C NMR spectra were recorded on either a Bruker Avance III 500 or Bruker Avance 
III 400 spectrometer at frequencies of 500 MHz/400 MHz (1H) and 125 MHz/100 MHz (13C) 
using either a 5 mm BBOZ probe or a 5 mm TBIZ probe. All proton and carbon chemical 
shifts are quoted relative to the relevant solvent signal (e.g. DMSO-d6: 
1H, 2.50 ppm, 13C, 
39.5 ppm). Proton-proton coupling constants are reported in Hertz. All experiments were 
conducted at 30 °C unless specified otherwise. 
 
Liquid-chromatography-mass-spectrometry was carried out using a Waters Micromass LCT 
Premier TOF Mass Spectrometer using the ES+ ionisation mode. Infrared spectra were 
collected using solids on a Bruker Alpha-P spectrometer with an Attenuated Total Reflection 
Platinum Diamond 1 reflectance accessory.  
 
UV-visible spectra were collected from 1000 nm to 200 nm using a Shimadzu UV-1800 
Spectrophotometer using DMF as the solvent in 1.0 cm pathlength quartz cuvettes.  
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2.2 Ligand Synthesis 





Figure 2.1: Diagrams depicting the numbering schemes used for the assignment of the 
NMR spectra of H3L
1; A = 1H NMR and B = 13C NMR. 
 
To 2,4-dihydroxybenzophenone (5.790 g, 27.03 mmol) in methanol (40 mL) was added 1,3-
diamino-2-hydroxypropane (1.310 g, 14.53 mmol) in methanol (10 mL) with magnetic 
stirring which afforded an orange solution. This solution was heated to reflux for 24 hours, 
during which time the product precipitated as a bright yellow powder. This was isolated by 
filtration, washed with methanol and allowed to air dry. Yield: 71 % (4.603 g, 9.540 mmol). 
A portion of the powder was recrystallised in a test tube by slow diffusion of diethyl ether 
into a solution of the ligand in dimethylformamide (DMF). The crystals formed were cubic in 
shape and yellow in colour. 
 
1H NMR (ppm) (DMSO-d6): δ 3.19-3.28 (m, 5 H, B & C), 3.88 (br s, 1 H, A), 6.06 (dd,  
J = 2.4 Hz, J = 8.8 Hz, 2 H, G), 6.17 (d, J = 2.4 Hz, 2 H, I), 6.45 (d, J = 8.8 Hz,  
2 H, F), 7.17-7.19 (m, 4 H, D), 7.48-7.50 (m, 6 H, E), 9.42 (br s, 2 H, H), 15.83 (s, 2 H, J).  
13C NMR (ppm) (DMSO-d6): δ 54.0 (t, 2), 69.7 (d, 1), 103.2 (d, 12), 105.9 (d, 10), 111.9 (s, 
8), 127.2 (d, 5), 128.6 (d, 6), 128.9 (d, 7), 132.6 (d, 9), 133.2 (s, 4), 161.7 (s, 11), 166.8 (s, 
13), 173.7 (s, 3). HRMS (TOF) C29H26N2O5: calculated 482.5271, found m/z 483.1923 
[M+1]. UV-vis (DMF) [λmax, nm (ε, M
-1 cm-1)]: 389 (2.99 × 103), 312 (2.07 × 104), 281  
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(2.54 × 104). IR (cm-1): 3440 [w br, ν(O-H)], 3251 [w br, ν(O-H)], 1567 [m, ν(C=N)], 1540 
[m, ν(C=N)], 1226 [s, ν(C-O)]. 
 





Figure 2.2: Diagrams depicting the numbering schemes used for the assignment of the 
NMR spectra of H2L
2, A = 1H NMR and B = 13C NMR. 
 
To a solution of 2,4-dihydroxybenzophenone (5.874 g, 27.42 mmol) in methanol (40 mL) 
was added 1,3-diamino-2,2-dimethylpropane (1.518 g, 14.86 mmol) in methanol (10 mL) 
with magnetic stirring resulting in no change in colour (the solution remained yellow). This 
solution was heated to reflux for 24 hours yielding the product as a pale yellow powder. This 
was filtered and washed with methanol and allowed to air dry. Yield: 81% (5.320 g, 11.08 
mmol). A portion of the powder was recrystallised by slow diffusion of diethyl ether into a 
saturated solution of the ligand in DMF. The crystals formed were cubic in shape and yellow 
in colour. 
 
1H NMR (ppm) (DMSO-d6): δ 0.92 (s, 6 H, A), 3.04 (s, 4 H, B), 6.08 (dd, J = 8.8 Hz,  
J = 2.4 Hz, 2 H, F), 6.21 (d, J = 2.4 Hz, 2 H, H), 6.45 (d, J = 8.8 Hz, 2 H, E), 7.11-7.12 (m, 4 
H, C), 7.45-7.48 (m, 6 H, D), 9.72 (br s, 2 H, G), 15.94 (s, 2 H, I). 13C NMR (ppm)  
(DMSO-d6): δ 23.8 (q, 1), 35.7 (s, 2), 58.5 (t, 3), 103.1 (d, 13), 106.1 (d, 11), 111.9 (s, 9), 
127.0 (d, 6), 128.6 (d, 7), 128.9 (d, 8), 132.5 (d, 10), 133.2 (s, 5), 161.7 (s, 12), 166.3 (s, 14), 
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173.6 (s, 4). HRMS (TOF) C31H30N2O4: calculated 494.5809, found m/z 495.2289 [M+1].  
UV-vis (DMF) [λmax, nm (ε, M
-1 cm-1)]: 393 (2.40 × 103), 313 (2.01 × 104), 281 (2.57 × 104). 
IR (cm-1): 3637 [w br, ν(O-H)], 1583 [m, ν(C=N)], 1242 [s, ν(C-O)]. 
 





Figure 2.3: Diagrams depicting the numbering schemes used for the assignment of the 
NMR spectra of H2L
3, A = 1H NMR and B = 13C NMR. 
 
To a solution of 2,4-dihydroxybenzophenone (5.950 g, 27.78 mmol) in methanol (40 mL) 
was added 1,3-diaminopropane (1.396 g, 18.83 mmol) in methanol (10 mL) with magnetic 
stirring which afforded a yellow solution. This solution was heated to reflux for 24 hours 
yielding the product as a yellow powder. This was then filtered and washed with methanol 
and allowed to air dry. Yield: 85% (5.538 g, 11.87 mmol). 
 
1H NMR (ppm) (DMSO-d6): δ 1.84 (q, J = 6.9 Hz, 2 H, A), 3.22 (m, 4 H, B), 3.50 (br s, 2 H, 
G), 6.06 (dd, J = 2.4 Hz, J = 8.8 Hz, 2 H, F), 6.17 (d, J = 2.4 Hz, 2 H, H), 6.44 (d, J = 8.7 Hz,  
2 H, E), 7.19 (m, 4 H, C), 7.47-7.57 (m, 6 H, D), 15.85 (br s, 2 H, I). 13C NMR (ppm)  
(DMSO-d6): δ 31.4 (t, 1), 47.3 (t, 2), 103.2 (d, 12), 106.1 (d, 10), 111.7 (s, 8), 127.0 (d, 5), 
128.65 (d, 6), 128.9 (d, 7), 132.5 (d, 9), 133.1 (s, 4), 161.9 (s, 11), 166.6 (s, 13), 173.4 (s, 3). 
HRMS (TOF) C29H26N2O4: calculated 466.52774, found m/z 467.1965 [M+1]. UV-vis 
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(DMF) [λmax, nm (ε, M
-1 cm-1)]: 390 (2.99 × 103), 312 (2.09 × 104), 281 (2.56 × 104). 
 IR (cm-1): 3056 [w br, ν(O-H)], 1571 [s, ν(C=N)], 1241 [s, ν(C-O)], 1190 [m, ν(C-O)]. 
 
2.3 Metal Chelate Synthesis 
2.3.1 Synthesis of [Cu2(L
1)(OAc)(DMF)], where L1 = 6,6'-((1E,1'E)-((2-
oxidopropane-1,3-diyl)bis(azanylylidene))bis(phenylmethanylylidene)) 
bis(3-hydroxyphenolate), OAc = acetate and DMF = dimethylformamide 
 
 




1 (0.208 g, 0.4310 mmol) in methanol (10 mL), ethanol (5 mL) and DMF (10 mL) 
was added copper acetate monohydrate (0.173 g, 0.867 mmol) turning the solution a dark 
emerald green. This was refluxed further for 2 hours. This yielded the product as a green 
precipitate. Yield: 84% (0.238 g, 0.357 mmol). A portion of the powder was recrystallised by 
slow diffusion of diethyl ether into a portion of the reaction mixture. This gave diamond-
shaped emerald green crystals.  
 
HRMS (TOF) C31H27N2Cu2O7: calculated 666.6478, found m/z 687.0232 [M-1+23 sodium 
adduct]. UV-vis (DMF) [λmax, nm (ε, M
-1 cm-1)]: 360 (1.93 × 104), 293 (3.41 × 104).  
Page | 27  
 
IR (cm-1): 3196 [w br, ν(O-H)], 3355 [w br, ν(O-H)], 1649 [s, ν(C=N)], 1210 [m, ν(C-O)], 
1238 [s, ν(C-O)]. 
 






Figure 2.5: Structure of [Cu3(L
2)2Cl2(DMF)2]. 
 
To a stirred solution of H2L
2 (0.204 g, 0.412 mmol) in metanol (10 mL), ethanol (5 mL) and 
DMF (5 mL) was added a solution of copper chloride dihydrate (0.111 g, 0.651 mmol). The 
solution was heated to reflux yielding a bright red-brown solution. The product formed as a 
brown precipitate. This was filtered and washed with cold THF. Yield: 39% (0.226 g, 0.1623 
mmol). Recrystallisation was achieved by slow evaporation of the reaction mixture. The 
crystals formed were red and rectangular. 
 
HRMS (TOF) C31H28N2CuO4: calculated 556.1110, found m/z 556.1429 [Cu(L
2)+1] 
dissociation of the bridging copper occurs. UV-vis (DMF) [λmax, nm (ε, M
-1 cm-1)]: 598  
(4.49 × 102) 362 (3.05 × 104), 295 (7.36 × 104). IR (cm-1): 3055 [w br, ν(O-H)], 3345 [w br, 
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ν(O-H)], 3588 [w br, ν(O-H)], 1660 [s, ν(C=N)], 1198 [s, ν(C-O)], 1216 [s,ν(C-O)], 1246 [s, 
ν(C-O)]. 
 





Figure 2.6: Diagrams depicting the numbering schemes used for the assignment of the 
NMR spectra of [Ni(L2)], A = 1H NMR and B = 13C NMR. 
 
To a refluxing solution of H2L
2 (0.225 g, 0.4549 mmol) in methanol (10 mL), an ethanol  
(5 mL) and DMF (10 mL) mixture containing nickel chloride hexahydrate (0.118 g,  
0.4964 mmol) was added; this resulted in a clear yellow solution with some precipitate 
present. Reflux was maintained for two hours, which led to the solution turning brown. This 
gave the product in solution. Crystals were formed by slow evaporation of the reaction 
mixture. The crystals that formed were red and needle-like. Yield: 50% (0.128 g,  
0.232 mmol). 
 
1H NMR (ppm) (DMSO-d6): δ 0.72 (s, 6 H, A), 3.35 (br s, 4 H, B), 5.78 (dd, 2H,  
J = 9.0 Hz, J = 2.2 Hz, 2 H, F), 6.04 (d, J = 2.2 Hz, 2 H, H), 6.20 (d, J = 8.9 Hz, 2 H, E),  
7.09-7.11 (m, 4 H, C), 7.40-7.48 (m 6 H, D), 9.65 (br s, 2 H, G). 13C NMR (ppm)  
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(DMSO-d6): δ 25.7 (q, 1), 33.8 (s, 2), 61.1 (t, 3), 104.9 (d, 11), 106.2 (d, 13), 117.6 (s, 9), 
127.4 (d, 6), 128.3 (d, 7), 128.5 (d, 8), 133.9 (d, 10), 137.8 (s, 5), 161.9 (s, 14), 165.7 (s, 12), 
171.2 (s, 4). HRMS (TOF) C31H28N2NiO4: calculated 551.2584 found m/z 573.1290  
[M+23 sodium adduct]. UV-vis (DMF) [λmax, nm (ε, M
-1 cm-1)]: 404 (1.07 × 104), 349  
(1.31 × 104). IR (cm-1): 3575 [w br, ν(O-H)], 3631 [w br, ν(O-H)], 1616 [m, ν(C=N)], 1561 
[m, ν(C=N)], 1220 [m, ν(C-O)], 1190 [m, ν(C-O)], 1164 [s, ν(C-O)]. 
 








Figure 2.7: Structure of [Cu3(L
3)2(H2O)2]Cl2. 
 
To a stirred solution of H2L
3 (0.226 g, 0.484 mmol) in methanol (10 mL), ethanol (5 mL) and 
DMF (5 mL) was added a solution of copper chloride dihydrate (0.109 g, 0.640 mmol). This 
turned the solution a dark red-brown colour. The solution was stirred and allowed to slowly 
evaporate, which afforded the product as a brown powder. Yield: 21% (0.115 g,  
0.0995 mmol). Recrystallisation was achieved by slow evaporation of the reaction mixture. 
The crystals formed were red and rectangular. 
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HRMS (TOF) C29H24N2CuO4: calculated 528.0584, found m/z 550.0935 [Cu(L
3)+23; sodium 
adduct] dissociation of the copper bridge occurs. UV-vis (DMF) [λmax, nm (ε, M
-1 cm-1)]: 596 
(5.83 × 102) 358 (2.43 × 104), 295 (5.68 × 104). IR (cm-1): 3417 [w, ν(O-H)], 3267 [m,  
ν(O-H)], 3143 [m, ν(O-H)], 1599 [m, ν(C=N)], 1251 [m, ν(C-O)], 1222 [s, ν(C-O)], 1191 [s, 
ν(C-O)]. 
 




Figure 2.8: Diagrams depicting the numbering schemes used for the assignment of the 
NMR spectra of [Ni(L3)], A = 1H NMR and B = 13C NMR. 
 
To a refluxing solution of H2L
3 (0.217 g, 0.4651 mmol) in methanol (10 mL), ethanol  
(5 mL) and DMF (10 mL) was added nickel chloride hexahydrate (0.167 g, 0.7025 mmol); 
the solution turned clear brown. Reflux was maintained for 2 hours. This produced the 
product in solution. Crystals were obtained by slow evaporation of the reaction mixture. The 
crystals formed were brown and cubic. Yield: 75% (0.169 g, 0.3230 mmol). 
 
1H NMR (ppm) (DMSO-d6): δ 1.34 (m, 2 H, A), 3.31 (signal obscured by water, B), 5.82 (dd, 
J = 9.0 Hz, J = 2.4 Hz, 2 H, F), 6.09 (d, J = 2.4 Hz, 2 H, H), 6.13 (d, J = 8.9 Hz, 2 H, E), 
7.08-7.10 (m, 4 H, C), 7.43-7.47 (m, 6 H, d), 9.97 (br s, 2 H, G). 13C NMR (ppm)  
Page | 31  
 
(DMSO-d6): δ 26.8 (1), 48.2 (2), 104.3 (12), 104.7 (10), 117.3 (8), 127.1 (5), 128.5 (6), 129.0 
(7), 134.0 (9), 136.0 (4), 161.9 (11), 166.1 (13), 171.0 (3). HRMS (TOF) C29H24N2NiO4: 
calculated 523.2053, m/z 522.1093 [M+]. UV-vis (DMF) [λmax, nm (ε, M
-1 cm-1)]: 407  
(6.29 × 103), 348 (8.67 × 103) 313 (1.45 x 104). IR (cm-1): 3621 [w, ν(O-H)], 1605 [s, 
ν(C=N)], 1580 [s, ν(C=N)], 1234 [s, ν(C-O)], 1177 [m, ν(C-O)], 1166 [m, ν(C-O)]. 
 
2.3.6 Synthesis of [Zn2(L
3)2] where L




Figure 2.9: Structure of [Zn2(L
3)2]. 
 
To a refluxing solution of H2L
3 (0.205 g, 0.439 mmol) in methanol (10 mL), ethanol  
(5 mL) and DMF (10 mL) was added zinc acetate dihydrate (0.100 g, 0.456 mmol). The 
solution was then a clear yellow colour which contained the product. The reaction mixture 
was then placed in a vapour diffusion chamber with diethyl ether for recrystallisation which 
yielded yellow cubic crystals. 
 
NMR was unassigned, refer to Chapter 4 (Section 4.1). UV-vis (DMF) [λmax, nm (ε,  
M-1 cm-1)]: 349 (1.50 × 104), 285 (2.53 × 104). IR (cm-1): 3054 [w, ν(O-H)], 1658 [w, 
ν(C=N)], 1531 [s, ν(C=N)], 1239 [s, ν(C-O)], 1183 [m, ν(C-O)].  
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3. Synthesis 
3.1  Imines and Schiff bases 
An imine is simply a compound that has a nitrogen-carbon double bond. If the imine was 
synthesised using a carbonyl and primary amine with an aryl group present it is referred to as 
a Schiff base. The key defining factor is that a Schiff base will not contain hydrogen bonded 
to the imine nitrogen atom.[18]  
 
There are many ways to synthesise an imine. A Stieglitz rearrangement[45] is one of the 
common methods. It is the rearrangement of an alkyl group from the carbon to the nitrogen in 
trityl N-haloamines using either a base or phosphorous pentachloride.[46] This rearrangement 
is shown below in Figure 3.1.  
 
 
Figure 3.1: Imine formation via a Stieglitz rearrangement.  
 
The Schmidt reaction utilises an alcohol or an alkene with hydrazoic acid to form an alkyl 
azide. During the reaction the alkyl azide will undergo a Curtius rearrangement to form an 
imine. The Curtius rearrangement functions using pyrolysis; the method of using elevated 
temperatures to alter organic compounds without oxygen participation.[46] The reaction for 
the alkene is illustrated in Figure 3.2. 
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Figure 3.2: Imine formation via a Schmidt reaction. 
 
The Hoesch reaction involves a phenol and nitrile with zinc chloride and hydrochloric acid at 
low temperatures to form an imine as an intermediate.[20] The reaction mechanism is shown 
below in Figure 3.3. 
 
 
Figure 3.3: Imine formation via a Hoesch reaction. 
 
The most commonly used reaction to form an imine is that of a simple condensation reaction. 
This is the addition of a primary amine to an aldehyde or ketone to form a hemiaminal as an 
unstable intermediate. This intermediate has a hydroxyl attached to the same carbon as the 
amine and thus can undergo dehydration to yield the desired imine.[46] The stepwise 
mechanism is illustrated in Figure 3.4. The aforementioned condensation reaction is the most 
widely used due to the high yield and simplicity.  
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Figure 3.4: Condensation reaction of a carbonyl and a primary amine. 
 
Imines or Schiff bases are well known compounds and are widely used as ligands as they are 
easy to synthesise and have flexibility in their applications. They are also ideal as they can 
chelate a variety of metals.[13, 47-49] These metals include, but are not limited to: Cu(II), 
Mo(IV), Ni(II), Pd(II) and Zn(II).[13] 
 
The condensation of a primary amine and ketone was the method employed in the synthesis 
of the ligands used in this project. The overall reaction is shown in Figure 3.5. Although 
removal of the water from the reaction mixture can help to drive the reaction forward, and is 
a technique often employed in Schiff base synthesis, it was found to be unnecessary in this 
synthesis. 
 
Figure 3.5: General reaction scheme for the synthesis of the ligands in this work. 
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In this project, four novel ligands were synthesised. The ligands are all Schiff base salen-type 
compounds. The ligands were synthesised using a 1:2 mol ratio of the selected diamine and 
1,3-diamino-2-hydroxypropane in a methanol and refluxed for twenty-four hours. Relatively 
high yields were obtained from this reaction mechanism; H3L
1: 71%, H2L
2: 81% and H2L
3: 
85%. The product was then crystallised by slow diffusion in DMF and diethyl ether.  
 
3.2 Metal Complexation 
There are many starting materials that could be utilised in the synthesis of the metal 
complexes. The most commonly used salts for copper being copper(II) chloride, copper(II) 
nitrate, copper(II) sulphate and copper(II) acetate. Copper(II) acetate was used in order to 
produce a dinuclear complex as the acetate ions would allow for bridging between the two 
copper centres. When this same reaction was attempted with copper nitrate, no chelation was 
detected. For synthesis of the mononuclear complexes, both copper(II) nitrate and copper(II) 
chloride were utilised.  
 
With regard to the nickel starting materials, the most commonly used salts for nickel are 
nickel(II) chloride, nickel(II) acetate, nickel(II) nitrate and nickel(II) sulphate. Although 
nickel(II) acetate was used in the same reaction as the above copper(II) acetate reaction in an 
attempt to form a similar dinuclear complex, the reaction was unsuccessful. Again, both 
nickel(II) chloride and nickel(II) nitrate were used to form the mononuclear complexes. The 
reactions with nitrate salts took longer and therefore nickel(II) chloride was favoured in the 
subsequent reactions.  
 
The chelation process was a simple two hour reflux of the ligand and metal salt. The 
chelation was achieved with concomitant deprotonation of the ligands yielding N2 O2 
tetradentate, dianionic ligands. The complexes are therefore neutral. The overall reaction 
scheme is shown below in Figure 3.6. 
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Figure 3.6: Reaction scheme employed in the chelation of metal ions by the ligands. 
 
In this project, six novel metal chelates were synthesised utilising the three ligands 
synthesised. The metal chelates were synthesised using a 1:1 mol ratio of the ligand and 
chosen metal salt in a mixture of methanol, ethanol and DMF and refluxed for two hours. 
However, it was expected that for H2L
1 a ratio of 2:1 for metal salt and ligand would be 






3)2(H2O)2]Cl2: 21% and [Ni(L
3)]: 75%. Crystallisation occurred via evapouration 
of the reaction mixture. The combination of hard nitrogen and oxygen atoms makes the 
ligands ideal for coordination to small, hard metal ions such as copper(II), nickel(II) and 
zinc(II).  
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4. Spectroscopy 
4.1 NMR Spectroscopy 
Nuclear magnetic resonance (NMR) spectroscopy is one of the most widely used 
characterisation methods in synthetic chemistry. It exploits the magnetic properties of certain 
isotopes. In 1H NMR spectroscopy, each proton in a specific magnetic environment will 
resonate at a specific frequency as it is shielded or deshielded by its neighbouring atoms. 
NMR spectroscopy was used to characterise the ligands and the nickel(II) complexes 
synthesised in this work. The 1H and 13C NMR spectra of the ligands and metal chelates are 
expected to differ as the metal ion will either shield or deshield the 1H and 13C nuclei. If the 
metal shields the nuclei an upfield shift will be observed, whereas if the metal deshields the 
nuclei a downfield shift will be observed.[50] All NMR spectroscopy experiments were 
conducted in DMSO-d6 for consistency. The solvent signals and impurities have been marked 
on the NMR spectra to simplify assignment. The DMF assigned peaks originate from the 
reaction mixture used to synthesise the compounds. The 1H NMR spectra of ligand H2L
2 and 
its nickel(II) complex are shown in Figures 4.1 and Figure 4.2, as exemplary spectra. 
 
 
Figure 4.1: 1H NMR spectrum of H2L
2 in DMSO-d6. 
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Figure 4.2: 1H NMR spectrum of [Ni(L2)] in DMSO-d6. 
  
In the ligand, the protons of the methyl groups on the bridgehead carbon atom resonate the 
most upfield and ortho hydroxyl protons resonate the most downfield. The aromatic protons 
are in the range of 6-8 ppm. In Figure 4.1, the two different types of hydroxyl groups give 
two separate signals with signal G being much broader then signal I. This suggests that the 
protons G are subject to chemical exchange with other hydroxyl protons and that the protons 
I are hydrogen bonded in solution; the chemical shift of ~16 ppm for the latter is consistent 
with strong hydrogen bonding in solution. When comparing the two NMR spectra a key 
feature is that the signal at 15.94 ppm has disappeared due to the loss of these hydroxyl 
protons upon chelation of the metal. This is also noticeable in the 1H NMR spectra of H2L
3 
and [Ni(L3)]. With the exception of the methylene (B) protons, the protons of the ligand 
experienced a slight upfield shift upon coordinaton of the ligand to nickel(II). This shows that 
the nickel(II) ion is acting in a shielding manner. A comparison of the chemical shifts and 
assignments for H2L
2 and [Ni(L2)] is shown in Table 4.1. All additional NMR spectra are 
available in Appendix A. 
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Table 4.1: Comparison of the chemical shifts of H2L
2 and [Ni(L2)]. 
Proton 
Chemical Shift (ppm) 
H2L
2 [Ni(L2)] 
A 0.92 0.72 
B 3.04 3.35 
C 6.08 5.78 
D 6.21 6.04 
E 6.45 6.20 
F 7.11-7.12 7.09-7.11 
G 7.45-7.48 7.40-7.48 
H 9.72 9.65 
I 15.94 - 
  
The 1H NMR of the zinc complex showed only broad unresolved signals (Figure 4.3). This is 
attributed to the quadrupole moment of the zinc atom, Q = 0.15 x 10-28 m2 A, preventing 
acquisition of high-resolution spectra. There may also be a dynamic monomer ↔ dimer 
equilibrium that leads to a more complex spectrum and thus creating the broadening. For 
these reasons, no further NMR spectroscopic characterisation was attempted for the zinc 
complex. 
 
Figure 4.3: 1H NMR spectrum of [Zn2(L
3)2] in DMSO-d6. 
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As the copper(II) ion is paramagnetic in nature, the copper(II) complexes of the ligands were 
not studied through NMR spectroscopy. They were, however, studied by electron spin 
resonance (ESR) or electron paramagnetic resonance (EPR) spectroscopy as discussed in 
Section 4.4. 
 
4.2 UV-vis Spectroscopy 
Electronic energy level transitions are observed in the ultraviolet and visible regions of the 
electromagnetic spectrum i.e. transition frequencies in the range 104 to 106 cm-1 are 
observed.[50] The most important electronic transition for molecules in general is from the 
highest occupied molecular orbital (HOMO) to the lowest unoccupied molecular orbital 
(LUMO). This HOMO-LUMO transition is a π-π* transition for conjugated organic 
molecules (like the Schiff base ligands studied in this work) and usually gives rise to very 
intense absorption bands.[50] However, other transitions are possible for Schiff base ligands in 
view of the lone pairs on the imine nitrogen atoms. These are n-π* transitions, which involve 
an electron being transferred from the non-bonding (n) lone pair orbital on the nitrogen atom 
to the π* orbitals of the ligand. These transitions are generally weaker than the π-π* 
transitions, and are further distinguished by usually appearing at somewhat lower energies.[51] 
Once the ligand is bonded to the metal through coordination of the lone pair on the 
heteroatom, additional bands are possible due to the transfer of an electron from a metal-
based orbital (usually a d orbital) to the LUMO of the ligand i.e. the π* orbital. These d-π* 
transitions give rise to metal-to-ligand charge transfer (MLCT) bands that are lower in energy 
and generally relatively weak.[6] We finally note that d-d bands associated purely with the 
metal are sometimes observed in the absorption spectra of Schiff base ligand complexes: this 
is due to “intensity stealing” brought about by the mixing of ligand π-orbitals with metal  
d-orbitals.[6, 51-54]  
 
We show in Figure 4.4 the absorption spectrum measured in DMF for the Schiff base ligand 
which has a propylene spacer between the two imine nitrogen atoms (previously labelled 
H2L
3). Three bands are observed: a weak band at 390 nm and two more intense bands at 312 
and 281 nm. The weak low energy band is assigned to a n-π* transition: as discussed above 
this involves the excitation of a lone pair electron in a non-bonding orbital (n) on the imine 
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nitrogen atom to the higher energy π* orbital on the ligand. The intense bands are assigned to 
intraligand π-π* transitions associated with the conjugated framework of the ligand. 
  
 
Figure 4.4: UV-vis spectrum of H2L
3 in DMF at 298 K. 
 
For comparison purposes we also show in Figure 4.5 the absorption spectrum measured in 
DMF for the Schiff base ligand which has a dimethyl substituted propylene spacer between 
the two imine nitrogen atoms (previously labelled H2L
2). As expected, essentially the same 
set of bands is observed as for the parent unsubstituted ligand, and so the same assignments 
apply: the two high energy intense bands in Figure 4.5 are assigned to π-π* transitions and 
the weak low energy band at 393 nm is assigned to a n-π* transition. 
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Figure 4.5: UV-vis spectrum of H2L
2 in DMF at 298 K. 
 
We now examine the absorption spectra measured in DMF for complexes of the above two 
ligands: that for the di-zinc complex (previously labelled [Zn2(L
3)2]) is shown in Figure 4.6. 
Only two intense high energy bands at 285 and 349 nm are observed. We assign these to 
intraligand π-π* transitions, and note that they are red-shifted as compared to the π-π* bands 
recorded at 281 and 313 nm for the ligand itself. This is due to the influence of the metal on 
the spacing of the π orbitals of the ligand, in particular due to back donation of electron 
density from the electron-rich metal centre to the π* orbitals of the ligand. Also note that the 
n-π* transition recorded at 390 nm for the ligand has disappeared – as expected, as the 
nitrogen atom lone pair is now involved in bonding to the zinc and is not available for 
excitation to the π* orbital of the ligand. Finally, note that there is no expectation of a MLCT 
band, as the d10 configuration of zinc(II) is one of enhanced stability; as a result absorption 
spectra of zinc(II) complexes of π-acceptor ligands generally only display intraligand 
bands.[55] 
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Figure 4.6: UV-vis spectrum of [Zn2(L
3)2] in DMF at 298 K. 
 
We now turn to the absorption spectrum measured in DMF for the trinuclear copper(II) (i.e. 
d
9) complex (previously labelled [Cu3(L
3)2(H2O)2]Cl2) shown in Figure 4.7. Note the insert 
to the figure which shows the presence of a weak band at 596 nm that is not observed in the 
spectrum measured for the zinc complex. This band is assigned to a d-d transition and, 
indeed, fits with the d-d transitions in the 570-580 nm range for the copper(II) complexes 
reported by Klement et al.[56] These d-d transitions generally have extinction coefficients 
below 100 M-1 cm-1. However, the transition can borrow intensity from nearby  
π-π* bands the extinction coefficient can increase as is the case here. The two intense high 
energy bands at 295 and 358 nm are assigned to π-π* transitions and, as for the zinc complex, 
are red shifted as compared to the π-π* bands recorded for the ligand itself – see Figure 4.4. 
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Figure 4.7: UV-vis spectrum of [Cu3(L
3)2(H2O)2]Cl2 in DMF at 298 K. 
  
The absorption spectrum measured in DMF for the mononuclear Ni(II) complex (previously 
labelled [Ni(L3)]) is shown in Figure 4.8. This spectrum is also distinguished from the 
spectrum recorded for the zinc complex by the presence of a MLCT band which, in this case, 
appears at 407 nm – there are also intraligand π-π* absorption bands at 348 nm and 313 nm. 
As already noted, MLCT transitions occur when the transition metal atom has an incomplete 
d-subshell and the ligand has an empty π* orbital, as is the case for this d8 nickel(II) complex 
– it is then possible for an electron to transfer from the metal centre to an empty orbital on the 
ligand.  
 
Figure 4.8: UV-vis spectrum of [Ni(L3)] in DMF at 298 K. 
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Table 4.2 provides a list of the absorption wavelengths and band assignments for all three 
ligands and the six complexes which have been studied. All the assignments follow from the 
discussions above. As expected there is little variation in the spectra recorded for the ligands 
as these are dominated by intraligand π-π* absorptions that are essentially unaffected by 
changes in the alkyl bis(imine) linkages. More interesting are the differences in the 
absorption spectra measured for zinc, copper and nickel complexes that depend on the 
presence or absence of MLCT bands. This, in turn, depends on the electronic configuration of 
the metal. Of most interest is the absorption spectrum of the nickel(II) complex with its 
relatively strong MLCT absorption band. Irradiation into this band could well lead to strong 
emission by the complex as has been observed for other d8 metal complexes with aromatic 
ligands.[57] This will be the subject of further investigations.  
 
Table 4.2: Comparison of UV-visible transitions for all ligands and complexes. 
 Wavelengths (nm) and extinction coefficients (M-1 cm-1) 
 (π-π*) n-π* MLCT d-d 
H3L
1 
281 (2.54 × 104) 
312 (2.07 × 104) 
389 (2.99 × 103) - - 
H2L
2 
281 (2.57 × 104) 
313 (2.01 × 104) 
393 (2.40 × 103) - - 
H2L
3 
281 (2.56 × 104) 
312 (2.09 × 104) 
390 (2.99 × 103) - - 
[Cu2(L
1)(OAc)(DMF)] 
293 (3.41 × 104) 
360 (1.93 × 104) 
- - - 
[Cu3(L
2)2Cl2(DMF)2] 
295 (7.36 × 104) 
362 (3.05 × 104) 
- - 598 (4.49 × 102) 
[Ni(L2)] 349 (1.31 × 104) - 404 (1.07 × 104) - 
[Cu3(L
3)2(H2O)2]Cl2 
295 (5.68 × 104) 
358 (2.43 × 104) 
- - 596 (5.83 × 102) 
[Ni(L3)] 
313 (1.45 × 104) 
348 (8.67 × 103) 
- 407 (6.29 × 103) - 
[Zn2(L
3)2] 
285 (2.53 × 104) 
349 (1.50 × 104) 
- - - 
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All additional spectra are available in Appendix B. 
 
For further discussion some literature examples of copper(II) and nickel(II) salen complexes 
have been compared to the copper(II) and nickel(II) chelates of this work. A range of 
copper(II) complexes with derivatives of salen and tetrahydrosalen were synthesised by 
Klement et al.[56] and studied using UV-vis spectroscopy. These complexes are shown in 
Figure 4.9. A separate range of copper(II) complexes with tetradentate imine-phenols type 
ligands were synthesised and characterised using UV-vis spectroscopy by Yao et al.[15] and 
are shown in Figure 4.10.  
 
 
Figure 4.9: Copper(II) complexes with derivatives of salen and tetrahydrosalen. 
Redrawn from Ref. [56]. 
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Figure 4.10: Copper(II) complexes with tetradentate imine-phenol type ligands. 
Redrawn from Ref. [15]. 
 
Complexes CuL1 to CuL4 were studied in acetone, whereas, complexes 1-4 were studied in 
methanol. All transition wavelengths and extinction coefficients for the literature chelates and 
copper(II) chelates of this work are shown in Table 4.3. The intense bands in the 380 nm 
region for the CuL series of chelates were assigned as metal-to-ligand charge transfer bands. 
The weak bands in the region of 570 nm were assigned to d-d transitions. For complexes 1-4 
the intense bands at 216-270 nm and 350-390 nm have been assigned as π-π* transitions in 
the benzene ring and as charge transfer n-π* transitions, respectively. Finally, the weak bands 
in the 560-570 nm range were assigned to d-d transitions. The band maxima are in favourable 
agreement to those found in the literature, however, the intensity of the bands of the 
copper(II) chelates studied in this work is almost ten times higher than those of the literature 
compounds. This may be due to the increased electron density on the ligand in comparison to 
that of a salen ligand.  
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Table 4.3: UV-visible absorption data for copper(II) chelates.  
Complex Absorption maxima: λmax (nm), (εmax (M
-1 cm-1) 
CuL1a - - 380 (10 700) - 572 (580) 
CuL2a - - 380 (12 000) - 570 (650) 
CuL3a - - 380 (14 000) - 570 (600) 
CuL4a - - 405 (13 700) 444 (19 500) 580 (540) 
1b 218 (8 799) 270 (11 324) 356 (9 888) - 570 (328) 
2b 218 (6 482) 266 (7 035) 386 (5 628) - 560 (200) 
3b 216 (5 412) 268 (5 347) 386 (4 999) - 566 (332) 
4b 215 (5 638) 268 (6 422) 382 (5 118) - 560 (268) 
[Cu3(L
3)2(H2O)2]Cl2 - 295 (56 786) 358 (24 314) - 596 (583) 
[Cu3(L
2)2Cl2(DMF)2] - 295 (73 566) 362 (30 483) - 598 (449) 
[Cu2(L
1)(OAc)(DMF)] - 293 (34 060) 360 (19 268) - - 
a Ref. [56]; b Ref. [15]. 
 
The following nickel(II) chelates of salen complexes were studied by Jamshid et al.[58] and 
Garg et al.[59] These compounds are shown in Figure 4.11.  
 
Figure 4.11: Nickel(II) chelates as synthesised by Jamshid et al.[58] (A, B) and Garg et 
al.[59] (C-E). Redrawn form Ref. [59]. 
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Jamshid et al.[58] determined the spectrum of A and B in chloroform, whereas, Garg et al.[59] 
used DMSO for complexes C-E. The visible transitions for the literature nickel(II) chelates 
are shown in Table 4.4 along with the nickel(II) chelates in this work. No extinction 
coefficients were given in the referenced papers. The band in B at <300 nm in complex B is 
assigned as π-π* band which is overlapped with chloroform bands. The band at 330 nm in 
complex B is assigned as π-π* transition. A  point of interest in the data is to note how the 
MLCT band has changed from complex A to complex B due to the addition of the 
dimethyltin(IV) dichloride; 412 nm to 338 nm respectively. The tabulated bands for 
complexes C-E have all been assigned as charge transfer bands. However, Garg et al.[59] 
noted that the complexes with aliphatic imines were noted to have weaker bands in the 530-
600 nm range which were assigned as unresolved d-d transitions and these bands were not 
visible in aromatic imine bridges due to the high-intensity charge transfer transitions masking 
them. The complexes studied in this work show a similarity in band wavelength and 
assignment with slightly lower wavelength maxima for each band. This may be due to 
solvent differences and, as can be seen from complex B, axial ligand binding. 
 
Table 4.4: UV-visible absorption data for nickel(II) chelates. 
Complex Absorption maxima: λmax (nm) 
Aa - 330 412 - 
Ba <300 338 - - 
Cb - 380 450 479 
Db 354 386 450 481 
Eb 300 386 422  486 
[Ni(L2)] - 349 404  - 
[Ni(L3)] 313 348 407 - 
a Ref. [58]; b Ref. [59]. 
 
A simple Zn(salen) complex was studied by Pagadala et al.[60] in DMSO. The Zn(salen) 
complex gave two bands at 261 nm and 366 nm. The band at 261 nm was assigned by 
Pagadala et al.[60] as a π-π* transition and the band at 366 nm was assigned as a ligand to 
metal charge transfer. However, Zheng and Chen[61] point out that the assignments are 
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complex and possibly less like LMCT. The zinc(II) chelate synthesised here exhibited band 
maxima at 285 nm and 349 nm, which were both assigned as π-π* transitions.  
 
4.3 Infrared Spectroscopy 
Sir William Herschel used sunlight passing through a prism to divide light into its spectral 
colours. He then used several mercury thermometers with blackened reservoirs to study the 
thermal distribution for each colour. He found that this was not a new type of radiation but 
instead obeyed the laws of optics like visible light and so named this range infrared.[62] 
Infrared spectroscopy is the study of vibrational transitions. It is used by analytical chemists 
in the same way as NMR and UV-vis spectroscopy or mass spectrometry.[62] Every substance 
has a unique IR spectrum which could be likened to the fingerprint of a person. Vibrational 
energy levels do not have large energy gaps between them and so the transitions will be seen 
in the lower infrared region. The absorption bands are due to vibrations of nuclei in 
molecules. Each band in an infrared spectrum is due to absorption of photons by transitions 
between vibrational levels in the ground state of the compound being studied.[50] Due to the 
number of infrared bands observed in the spectra of these complexes, only the most 
characteristic peaks have been assigned and discussed.  
 
The most characteristic band of a Schiff base type ligand is the product of its defining feature, 
the imine group. This band is generally found in the region of 1615-1630 cm-1.[62] The next 
characteristic band for the compounds prepared in this work is that of the phenolic-OH 
groups present in the region of 3125-3705 cm-1.[62] Also identified are the C-O bands which 
cover the region of 1180-1260 cm-1.[62] Assigned spectra for H2L
2 and [Cu3(L
2)2Cl2(DMF)2] 
are shown in Figures 4.12 and 4.13, respectively and the assigned bands are shown in  
Table 4.5 for all the ligands and metal chelates synthesised in this work. 
 
Page | 51  
 
 
Figure 4.12: Infrared spectrum of H2L
2 with assigned bands. 
 
 
Figure 4.13: Infrared spectrum of [Cu3(L
2)2Cl2(DMF)2] with assigned bands. 
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As can be seen from Figure 4.12 and Figure 4.13, the O-H region of the metal complex 
becomes more intense than the ligand. This trend is seen in all the ligands and their 
associated metal complexes and is attributed to the large number of water molecules present 
in their crystal lattices, as shown by single-crystal X-ray diffraction. A notable feature in the 
spectra of the compounds is that the ligands show a single band for the C-O stretch whereas 
there are more bands in the metal complexes after chelation. Another feature is that of an 
increase in the frequency of the C=N vibration in some compounds when chelation occurs. 
This is typical of ligands coordinated to metal ions through the imine nitrogen atom as 
discussed below in the comparison done of some literature examples. The spectra of each 
compound are available in Appendix C. 
 
Table 4.5: Observed frequencies (cm-1) for the absorption bands in the solid IR spectra 
of ligands and complexes synthesised in this work. 
Compound ν(O-H) ν(C=N) ν(C-O) 
H3L
1 
3251 (br w) 





2 3637 (br w) 1528 (m) 1242 (s) 
H2L
3 3056 (br w) 1571 (s) 1241 (s) 
 [Cu2(L
1)(OAc)(DMF)] 
3196 (br w) 







3055 (br w) 
3345 (br w) 






3575 (br w) 






















3)2] 3054 (w) 1531 (s)  
1183 (m) 
1239 (s) 
Abbreviations: w, weak; m, medium; s, strong; br, broad. 
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3)2] due to the presence of DMF 
solvate molecules. The nickel(II) compounds, however, had no DMF present in the X-ray 
structures. 
 
The copper(II) chelates shown in Figure 4.9 and Figure 4.10 will again be used as a 
literature comparison for the copper(II) chelates in this work. As the chelates being studied 
are of the salen type system the comparison between the literature IR work done by both 
Klement et al.[56] and Yao et al.[15] will be focused only on the assignment of the ν(C=N) 
bands. The assignments of these bands are shown in Table 4.6. As can be seen from the 
assignments in Table 4.6 the copper(II) chelates compare very favourably to the literature 
compounds.  
 
Table 4.6: Frequencies of copper(II) chelates in this work and literature. 














a Ref. [56], Figure 4.9; b Ref. [15], Figure 4.10. 
 
The nickel(II) chelates used for comparison are those shown in Figure 4.11 synthesised by 
Jamshid et al.[58] The frequencies of the ν(C=N) bands of the literature nickel(II) chelates and 
the nickel(II) chelates of this work are shown in Table 4.7. A notable feature here is the 
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appearance of two bands in the chelates synthesised in this work in comparison to that of the 
literature chelates. The bands at higher frequencies seem to correlate favourably with those in 
the literature; the appearance of two bands for the C=N groups of the present complexes is 
consistent with the presence of the expected symmetric and antisymmetric modes for the 
functional group pair. 
 
Table 4.7: Frequencies of nickel(II) chelates characterised in this work and related 
structures from the literature. 
Chelate ν(C=N) (cm-1) 
Aa 1624 
Ba 1659 
NiL2 1561, 1616 
NiL3 1580, 1605 
a Ref. [58], Figure 4.11. 
 
[Zn2(L
3)2] gave a ν(C=N) band at 1531 cm
-1 which is a favourable comparison with the 
literature compund Zn(salen) complex as studied by Pagadala et al.[60] which gave a ν(C=N) 
band at 1633 cm-1. 
 
4.4 Electron Spin Resonance 
Electron Spin Resonance (ESR) is a method of studying paramagnetic solids and solutions. A 
paramagnetic compound is a compound that has a permanent magnetic dipole and so the ESR 
spectrum depends upon the magnetic properties of the complex being studied. A continuous 
wave is formed as the magnetic field is swept. At the centre of the spectrum is the g-factor, 
which is one of the factors used to characterise the complex present. Nuclei with spin I not 
equal to zero create line splitting which give further information on metal centre geometry.[63] 
Hyperfine coupling in ESR is the equivalent to spin-spin coupling in NMR.[64] Hyperfine 
coupling is when the electron magnetic moment couples to the magnetic moment of the 
closest nucleus, typically that of the atom housing the unpaired spin.[64] Super-hyperfine 
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coupling is when an electron couples to the nucleus of another atom.[64] This method was 
used to study the copper complexes, [Cu3(L
2)2Cl2(DMF)2] and [Cu3(L
3)2(H2O)2]Cl2 as both 
are paramagnetic. Both solution and solid studies were done on both compounds.  
 
The energy of a magnetic dipole (Em) in a magnetic field (B) which is directed along z is 
calculated by[63]: 
Em = -µ · B = µB · B · ml, µB =eh/4πme = Bohr magneton 
This means the energy will split into (2l + 1) levels. In a hydrogen atom the ground state has 
no orbital angular momentum (l = 0) but it does however have a spin angular momentum of 
its electron which therefore gives rise to its magnetic dipole. The energy is therefore 
calculated as[63]: 
Em = g µBBms, ms = ± ½  
Where g for a hydrogen atom is 2.00228[63] and so the energy is split into two Zeeman levels 
as shown in Figure 4.14. 
 
 
Figure 4.14: Energy levels of an electron in a magnetic field redrawn from ref [63]. 
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There are three typical spectra that can be obtained through ESR. The first is where gx = gy = 




Figure 4.15: Spectra of a typical isotropic g-tensor. 
 
Another typical spectrum would be a tetragonal g-tensor. This is where gx = gy ≠ gz. The 
shape of this spectrum is illustrated in Figure 4.16. 
 
 
Figure 4.16: Spectra of a typical tetragonal g-tensor. 
 
The last of the three typical spectra is where gx ≠ gy ≠ gz. This is a rhombic g-tensor and the 
shape of the spectrum is illustrated in Figure 4.17. 
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Figure 4.17: Spectra of a typical rhombic g-tensor. 
 
Working from this a few similar copper(II) chelates were researched and will be discussed 
briefly so as to give some background as to what may be expected in the copper(II) chelates 
of this work. 
 
An ESR study was done on three copper(II) Schiff-base complexes by Losada et al.[65] The 
complexes are synthesised by chelation of one copper(II) ion to two ligands. The copper(II) 
chelates are shown in Figure 4.18. They found that in a frozen solution of chloroform the 
complexes had axial spectra. Axial spectra have a tetragonal g-tensor, meaning that the tensor 
components gx = gy. 
 
Figure 4.18: Copper(II) Schiff-bases as synthesised by Losada et al.[65] 
 
Losada et al.[65] found that all the complexes synthesised displayed the order gǁ > g+ and  
Aǁ > A+. They state that often the ratio of gǁ / Aǁ can be used as an index of tetrahedral 
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distortions. The value of this ratio for the complexes studied by Losada et al.[65] was 125 - 
135 cm which is indicative of complexes without any tetrahedral distortions of the CuN2O2 
plane. It was also found that the data for A decreased slightly due to the electron-withdrawing 
effect of substituents on the ligands which meant that the spin density of the unpaired 
electron on the copper(II) ion was lowered slightly. The data for these complexes is shown in 
Table 4.8. 
 
Table 4.8: ESR data for copper(II) complexes studied by Losada et al.[65] 
 







Aiso gǁ / Aǁ (cm) 
Cu(L1)2 2.239 2.031 2.100 175 24 72 127 
Cu(L2)2 2.241 2.046 2.111 171 21 71 130 
Cu(L3)2 2.246 2.052 2.181 166 19 68 134 
 
Another copper(II) complex (Figure 4.19) studied by Dyers Jr. et al.[66] which gave 11 
discernible hyperfine lines both at room temperature and at low temperature in THF. These 
lines were attributed to two 14N and two imine 1H nuclei present. The spectra of the complex 
showed no sensitivity to alternative solvents which indicates that the solvents do not bind 
axially to the copper(II) ion. Aǁ and A+ were found to be 197.25 Gs (184 x 10
-4 cm-1) and 
36.50 Gs (34.1 x 10-4 cm-1), and gǁ and g+ were determined as 2.2091 and 2.0470, 
respectively. This data was found to be consistent with the square-planar structure Dyers Jr. 
et al.[66] determined via X-ray crystallography. 
 
 
Figure 4.19: Copper(II) salen complex with bulky groups synthesised by Dyers Jr. et 
al.[66] 
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In the study done by Klement et al.[56] discussed in Sections 4.2 and  
4.3, the ESR spectra of the copper(II) complexes (Figure 4.9) were recorded at both room 
temperature and at 77 K in a toluene-acetone solution (20% v/v acetone). The spectra of these 
compounds in toluene showed weak signals of the dimeric species due to aggregation, 
whereas, the more intense signals were attributed to monomeric species. Upon addition of the 
acetone no signals due to the dimeric species were observed. The ESR spectra of the 
copper(II) complexes in toluene-acetone solutions exhibit axial symmetry with hyperfine and 
super-hyperfine coupling. Klement et al.[56] observed an interaction of the unpaired electron 
spin with the copper(II) nuclear spin (I = 3/2), two equivalent nitrogen donor nuclei(I = 1), 
and with two hydrogens attached to the carbon adjacent to the imine nitrogen (I = ½). 
Klement et al.[56] reported a gǁ / Aǁ ratio of approximately 105 cm for these complexes which 
is in agreement with the square-planar copper(II) geometry confirmed by the X-ray structure 
obtained. All the data for the complexes synthesised by Klement et al.[56] is illustrated in 
Table 4.9. 
 
Table 4.9: ESR data for the salen type copper(II) complexes synthesised by Klement et 
al.[56] 
 giso gǁ g+ Aiso (MHz) Aǁ (MHz) A+ (MHz) 
CuL1 2.094 2.194 2.041 253 621 87  
CuL2 2.094 2.194 2.041 253 621 94 
CuL3 2.094 2.191 2.040 270 627 80 
CuL4 2.096 2.198 2.041 260 625 87 
 
Two S-methylisothiosemicarbazide salen-type copper(II) complexes (Figure 4.20) were 
synthesised by Arion et al.[67] These complexes were studied via ESR in a solution of 
CH2Cl2/DMF at both the X-band (~9 GHz, 80K) and at the Q-band (35 GHz, 2 K) and 
determined to be essentially axial. The complexes were found to display similar spin 
Hamiltonian parameters to other copper(II) complexes that have the coordination sphere of 
N2O2. The data for Cu
IIL is as follows: g+ is ~ 2.055, gǁ is ~ 2.226 which is within the range 
of 2.20-2.25 and Aǁ is ~ 640 MHz which is within the range of 600 – 660 MHz as was 
determined by Peisach and Blumberg.[68] 
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Figure 4.20: Two S-methylisothiosemicarbazide salen-type copper(II) complexes 
synthesised by Arion et al.[67] 
 
The copper(II) complexes that formed part of the design of the complexes in this work were 
also studied using EPR. Balla et al.[69] synthesised two copper(II) amino acid based 




Figure 4.21: Structures of [Cu(mnpama)] and [Cu(ampama] as synthesised by Balla et 
al.[69] where R is the chosen amino acid. 
 
The ESR spectra of complexes [Cu(ampama)] and [Cu(mnpama)] were measured in a 
solution of dimethylformamide and water (1:2) at 298 K and 77 K. Balla et al.[69] reported 
that all these complexes involving α-amino acids have similar spectra. They display a 
spectrum typical for square planar geometry with N2O2 coordination sphere and weakly 
bound axial ligands. The ESR data as given by Balla et al.[69] is summarised in Table 4.10. 
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Table 4.10: ESR data of amino acid derived copper complexes synthesised by Balla et 
al.[69] 
 gǁ g+ Aǁ / 10
-4 cm-1 A+ / 10
-4 cm-1 
[Cu((S,S)-mnpala)] 2.24 2.06 194 22 
[Cu((S,S)-Hampala)]+ 2.24 2.06 192 27 
[Cu((R,S)-mnpala)] 2.24 2.05 201 21 
[Cu((R,S)-Hampala)]+ 2.25 2.07 191 22 
[Cu((S,S)-mnpphe)] 2.24 2.06 192 20 
[Cu((S,S)-Hampphe)]+ 2.24 2.06 189 18 
[Cu((R,S)-mnpphe)] 2.23 2.05 196 19 
[Cu((S,S)-mnpval)] 2.23 2.05 196 18 
[Cu((R,S)-mnpval)] 2.23 2.05 202 20 
[Cu((R,S)-mnpleu)] 2.25 2.06 189 22 
[Cu((R,S)-mnptleu)] 2.22 2.05 201 18 
[Cu(mnp-β-ala)] 2.29 2.07 174 23 
[Cu((R,S)-mnpaba)] 2.27 2.08 178 24 
 
The solid state ESR spectrum of [Cu3(L
2)2Cl2(DMF)2] (Figure 4.22) was measured using 
crushed crystals at room temperature (298 K).  
 
 
Figure 4.22: Solid state ESR spectrum of [Cu3(L
2)2Cl2(DMF)2] at 298 K. 
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This spectrum is consistent with two of the three Cu(II) ions being antiferromagnetically 
coupled, leaving the third S = ½ ion unchanged and thus responsible for the ESR spectrum 
Figure 4.22 does not show characteristic signalling that would be indicative of a 
magnetically coupled copper system.[70] The spectrum is consistent with the X-ray crystal 
structure of this complex. This spectrum is the typical shape for an isotropic g-tensor, where 
gx = gy = gz. An interesting feature of this complex is the fact that it is trinuclear and is still a 
paramagnetic compound. This may indicate that two of the unpaired electrons centred on 
adjacent Cu(II) ions are antiferromagnetically coupled, leaving the third Cu(II) centre EPR-
active and thus responsible for the spectrum. Alternatively, the ESR spectrum reflects the 
sum of the contributions from the three independent paramagnetic Cu(II) centres. The 
possible pairing of the electrons in the dx2-y2 orbitals of adjacent Cu(II) centres would have to 
be between the two centres closer together, Cu1 with Cu2 not Cu1 with Cu1 or Cu3 with Cu4 
not Cu3 with Cu3. This coupling would then leave the terminal Cu(II) ion carrying the 
unpaired spin that would generate the ESR spectrum. The structure of [Cu3(L
2)2Cl2(DMF)2] 
is shown in Figure 4.23 to illustrate which nuclei would couple antiferromagnetically. 
 
 
Figure 4.23: X-ray structure of [Cu3(L
2)2Cl2(DMF)2] illustrating the two independent 
trinuclear complexes of the asymmetric unit and highlighting the arrangement between 
adjacent Cu(II) ions that might facilitate antiferromagnetic spin-coupling. 
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The solid state ESR spectrum for [Cu3(L
3)2(H2O)2]Cl2 (Figure 4.24) was obtained using a 
clean fine powder at room temperature (298 K). 
 
 
Figure 4.24: Solid state ESR spectrum of [Cu3(L
3)2(H2O)2]Cl2 at 298 K. 
 
This unusual spectral shape seems to be indicative of a trinuclear system. The spectrum in 
Figure 4.24 is almost identical to that of [Cu3(L
2)2Cl2(DMF)2] in the solid state. This is due 
to the complex also being a trinuclear copper complex thus allowing for two of the Cu(II) 
ions exhibiting antiferromagnetic coupling leaving a third terminal Cu(II) ion unpaired to 
create the ESR spectrum.  
 
Figure 4.25 shows the solution ESR spectrum for [Cu3(L
2)2Cl2(DMF)2] recorded in 
dimethylformamide (DMF) at room temperature. The expected spectrum from a mononuclear 
Cu(II) complex with an isotropic g-tensor would be a quartet pattern (1: 3: 3:1 intensity ratio) 
due to the unpaired spin coupling with I = 3/2 nucleus. This is inconsistent with the spectrum 
of [Cu3(L
2)2Cl2(DMF)2]. In the case of a mononuclear Cu(II) complex with a tetragonal  
g-tensor, the xy tensor component accounts for the most intense absorption or derivative 
feature at high magnetic field. This intense feature is, furthermore, split into three 
progressively weaker lines at lower field due to the unpaired electron coupling with the I = 
3/2 nucleus of the Cu(II) ion. The spectrum in Figure 4.25 as a whole reflects this type of 
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pattern; the weakest lines at the lowest field, however, are overlapped and thus an imperfect 
4-line pattern is observed. In short, [Cu3(L
2)2Cl2(DMF)2] gives a tetragonal type ESR 
spectrum (gz > gxy) in fluid solution at room temperature with gz essentially unresolved and 
visibly absent from the spectrum. Interestingly, the main spectral feature close to 3500 G 
exhibits three sharp peaks in both the positive and negative maxima of the derivative 
spectrum. This is consistent with super-hyperfine coupling to two I = 1 nuclei such as 14N to 
give 5 lines. Clearly the unpaired electron on a terminal Cu(II) centre shows long-range 
super-hyperfine coupling to 2 N atoms.  
 
 
Figure 4.25: ESR spectrum of [Cu3(L
2)2Cl2(DMF)2] in DMF at 298 K. 
 
The hyperfine coupling shows four peaks overall as was to be expected. The first two peaks 
are broad and so overlap which results in what is seen in Figure 4.25 as the initial broad 
band. The four line pattern seen is due to the electron in each Cu(II) ion spin coupling with 
the I = 3/2 nucleus. The peak-to-peak separation gives the hyperfine coupling constant, 76 G 
(710 x 10-4 cm-1). Note that the hyperfine coupling is seen for gxy only as gz is very weak.  
 
Multiplicity  = 2nI + 1 = 2(1)(3/2) + 1 = 4 
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Shown in Figure 4.26 is the spectrum of [Cu3(L
2)2Cl2(DMF)2] in DMF with the super-
hyperfine splitting labelled. The super-hyperfine coupling is to another nucleus beyond 
copper. This is visible as three sharp peaks on the high-field line in the spectrum (on both the 
positive and negative derivative). This is due to the electron coupling to a single I = 1 14N 
nucleus in the molecule. The two nitrogen atoms are spectroscopically equivalent and the 
radical is localised on one end of the trinuclear structure as the middle Cu(II) ion is 
antiferromagnetically coupled with the other end’s Cu(II) ion. The super-hyperfine coupling 
constant was measured as 11 G (10.3 x 10-4 cm-1). 
 
Multiplicity  = 2nI + 1 = 2(2)(1) + 1 = 5 
 
The spectrum is consistent with the structures determined as it shows that the unpaired spin is 




Figure 4.26: ESR Spectrum of [Cu3(L
2)2Cl2(DMF)2] in DMF at 298 K with peaks 
labelled to highlight the super-hyperfine coupling. 
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Shown in Figure 4.27 is the solution ESR spectrum of [Cu3(L
3)2(H2O)2]Cl2 in DMF at room 
temperature (298 K). The spectrum is almost identical to that of [Cu3(L
2)2Cl2(DMF)2] which 
is to be expected due to the similarity in X-ray structure of the two compounds.  
 
 
Figure 4.27: ESR spectrum of [Cu3(L
3)2(H2O)2]Cl2 in DMF at 298 K. 
 
The ESR spectrum reflects typical hyperfine coupling to the I = 3/2 copper nucleus for a 
tetragonal g-tensor with incomplete resolution of the low-field lines due to line broadening. 
The most intense signal of the pattern at approximately 3300 G exhibits splitting into several 
lines consistent with super-hyperfine coupling to two I = 1 N atoms. The fact that the 
spectrum of [Cu3(L
3)2(H2O)2]Cl2 is very similar to that of [Cu3(L
2)2Cl2(DMF)2] supports the 
idea that two of the three Cu(II) centres in the latter complex are anitferromagnetically 
coupled, leaving the third Cu(II) centre responsible for the ESR spectral pattern of  
Figure 4.27. 
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Figure 4.28: ESR Spectrum of [Cu3(L
3)2(H2O)2]Cl2 in DMF at 298 K with peaks labelled 
to highlight the super-hyperfine coupling. 
 
Shown in Figure 4.28 is the spectrum of [Cu3(L
3)2(H2O)2]Cl2 in DMF with the super-
hyperfine splitting labelled. The peak-to-peak separation gives the hyperfine coupling 
constant, 77 G (719 x 10-4 cm-1). As was the case for [Cu3(L
2)2Cl2(DMF)2], the hyperfine 
coupling is seen for gxy only as gz is very weak. The super-hyperfine coupling constant 
measured for this compound was 13 G (12.2 x 10-4 cm-1). 
 
The hyperfine coupling constants for [Cu3(L
2)2Cl2(DMF)2] and [Cu3(L
3)2(H2O)2]Cl2, 
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4.5 Conclusions 
The NMR spectra of the ligands show two broad bands indicating the two hydroxyl groups 
present. Once the metal has chelated to the ligand, only the more upfield broad band is found 
in the spectra. This is indicative of the metal chelating to the two ortho hydroxyls and 
therefore the loss of the most downfield broad band. The UV-vis spectra show little variation 
in the ligand spectra as would be expected. The metal complexes show variations in the 
presence or absence of MLCT bands or d-d transitions. The infrared spectra of the ligands 
showed only one band for the C-O stretch as compared to multiple bands in the metal 
complexes. The nickel complexes showed two bands for the ν(C=N) mode at different 
frequencies which is consistent with the presence of symmetric and asymmetric modes for 
this functional group. The complexes of this work compared favorably with those of a similar 
nature in the literature. The ESR data confirmed that the trinuclear solid state structure is 
maintained in solution. Two of the three copper(II) ions couple antiferromagnetically, leaving 
the third as an S = ½ centre with hyperfine coupling constant to the I = 3/2 Cu nucleus of ca. 
76 G. In a DMF solution, super-hyperfine coupling (ca. 12 G) was found to occur to two 
nitrogen atoms which is consistent with the donor atom set of the terminal copper(II) centres 
being the site of the unpaired spin density. 
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5. X-ray Crystallography 
5.1 Introduction 
Schiff bases have been synthesised and chelated to various metals all around the world. Both 
the ligands and their complexes have shown a variety of uses ranging from anion sensors[12], 
antimicrobial agents[13], photo- and thermochromism[14] to displaying solvatochromism[15]. A 
review by Kumar et al.[13] reported that chromium azomethine and a Schiff base cobalt 
complex were used as dyes for items such as leathers, food packages and wools. As was 
mentioned in Chapter 1 a copper(II) complex, [N,N’-bis(4-methyoxysalicylidene)-1,2-
diaminoethane]copper(II) (Figure 1.6), was synthesised by Yao et al. [15] and due to the σ 
donor capacity of the solvent increasing the solvent would coordinate to the metal centre via 
substitution of a water molecule, and this would in turn change the energy of the transitions 
leading to the solvatochromic effect. A zinc(II) Schiff base complex that was studied by Yu 
et al.[71] was found to exhibit bright pure blue emission. Yu et al.[71] examined the complex 
through absorption, emission and thermal analysis and found the complex to be suitable for 
use as an organic light-emitting diode. These are used in full-colour, flat panel displays and 
the blue emission is quite coveted. 
 
The Cambridge Structural Database[72] (CSD) was used to find crystal structures related to 
those synthesised in this work. Neither the ligands synthesised, nor their metal chelates are 
reported in the CSD[72]. Three literature structures were chosen for discussion due to their 
similarity to the compounds crystallised in this project. 
 
KUVLIX[73] (Figure 5.1.1) is a dibenzophenone derivative with an ortho hydroxyl group. It 
crystallised in the monoclinic space group P 21/c with Z = 4. The only hydrogen bonding 
present in the crystal is intramolecular hydrogen bonding between the imine nitrogen atom 
and the ortho phenolic hydrogen atoms. 
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Figure 5.1.1: Diagram of a single molecule of 2,2′-(propane-1,3-diylbis(nitrilo 
(phenylmethylylidene))) diphenol. Redrawn from the CSD[72] coordinates of 
KUVLIX[73]. 
 
A copper chelate of similar ligand structure, AQETEV (Figure 5.1.2), was crystallised by 
Datta et al.[74] It crystallised in the monoclinic space group P 21/n with Z = 2. The compound 
is a trinuclear complex of copper(II). The ortho phenolic oxygens are bridging two copper(II) 
ions. The charge is then neutralised by the copper(II) ions bound within each ligand and the 
axially-bound perchlorate ions. There was no hydrogen bonding present in the lattice and 
very few short contacts existed. This structure is quite significant in that it is trinuclear and 
the copper(II) chelates studied in this work also adopted a trinuclear structure. 
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Figure 5.1.2: Diagram of a single molecule of diperchlorato-bis(m2-2,2′-(1,3-propane 
diylbis(nitriloethylidyne))bisphenolato)-tri-copper(II). Redrawn from the CSD[72] 
coordinates of AQETEV[74]. 
 
Table 5.1.1: Average coordination bond lengths and angles for AQETEV[74]. 
Bond Lengths (Å) Bond Angles (°) 
Cu1-N 1.961(4) N1-Cu1-N2 101.18(1) 
Cu1-O 1.929(3) N1-Cu1-O1 88.79(1) 
Cu1-Os 2.617(6) N2-Cu1-O2 91.64(1) 
Cu2-O  1.954(3) O1-Cu1-O2 78.15(1) 
  N1-Cu1-O3 103.90(2) 
  N2-Cu1-O3 98.60(2) 
  O1-Cu1-O3 81.86(2) 
  O2-Cu1-O3 79.21(2) 
  O1-Cu2-O2 76.95(1) 
  O-Cu2-OB av 103.05(1) 
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A nickel(II) complex of a related ligand was reported by Ray et al.[75] It crystallised in the 
monoclinic space group P 21/c with Z = 4. The nickel(II) ion is in the expected square planar 
coordination geometry for a tetradentate dianionic ligand. The nickel(II) balances the ligand’s 
charge giving a neutral molecule overall. The structure is solvated by methanol. An 
interesting structural feature in this compound is the presence of a bifurcated hydrogen bond 
between the phenolic oxygens and the alcoholic hydrogen present in the methanol molecule. 
Of further interest is the fact that the same ligand with nickel(II) favours the formation of  
mononuclear complexes opposed to the bridged trinuclear structure observed with copper(II). 
 
Figure 5.1.3: Diagram of a single molecule of (N,N′-bis((1-(2-oxyphenyl)ethyl)imino) 
propane)-nickel(II) methanol solvate. Redrawn from the CSD[72] coordinates of 
LOFXIO[75]. 
 
Table 5.1.2: Coordination bond lengths and angles for LOFXIO[75] 
Bond Lengths (Å) Bond Angles (°) 
N1-Ni1 1.883(2) N1-Ni1-N2 94.58(8) 
N2-Ni1 1.901(2) N1-Ni1-O2 90.79(7) 
O1-Ni1 1.855(2) N2-Ni1-O1 89.43(8) 
O2-Ni1 1.828(1) O1-Ni1-O2 85.48(7) 
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As can be seen from the above examples the coordination of the ligand to a metal ion can 
vary quite drastically. This is made clearly visible by the differences in structure between the 
nickel(II) and copper(II) complexes. The nickel complex is found to be mononuclear, whilst 
the copper(II) complex trinulcear and this could be attributed to the differences in ionic radii. 
As nickel(II) ion has a smaller ionic radius (0.069 nm vs 0.072 nm), it is possibly unable to 
form trinuclear bridged structures like those observed for copper(II) ion.  
 
5.2 Objectives 
The crystal structure of each of the two ligands and six metal chelates that were successfully 
crystallised will be determined and reported along with an analysis of the relevant bond 
lengths and angles. Any features of interest will be highlighted and discussed. 
 
5.3 Experimental Methods 
5.3.1 General Crystallographic Procedures 
X-Ray diffraction data were collected on an Oxford Diffraction Xcalibur2 CCD 4-circle 
diffractometer equipped with an Oxford Instruments Cryojet. The data were collected at room 
temperature unless otherwise stated, with Mo Kα (λ = 0.71073 Å) radiation at a crystal-to-
detector distance of 50 mm using omega scans at θ = 29.389°, with varying exposure times 
taken at 2.01 kW X-ray power with 0.75° frame widths. The data were reduced with the 
program CrysAlis RED[76] using outlier rejection, scan speed scaling, as well as standard 
Lorentz and polarization correction factors. A multi-scan absorption correction was applied to 
the data[77]. Unless otherwise stated, direct methods (SHELXS-97, WinGX32)[78-79] were used 
to solve the structures. All non-H atoms were located in the E-map and refined 
anisotropically with SHELXL-97.[80] All hydrogen atoms in each of the structures resolved 
were included as idealized contributors in the least squares process with standard SHELXL-
97[80] parameters.  
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For some crystals, X-ray diffraction data were recorded on a Brüker APEX-II Duo CCD 
diffractometer equipped with an Oxford Instruments Cryojet and Incoatec IuS microsources 
(Mo and Cu) with Quazar multilayer optics. The data were collected at room temperature 
unless otherwise stated, using Mo Κα (λ = 0.71073 Å) radiation and ϕ‒ω scans. Data 
collection and reduction were performed by the program SAINT[81]. Empirical (multi-scan) 
absorption corrections were applied using SADABS. The structure was solved by direct 
methods using direct methods (SHELXS-97, WinGX32) [78-79] and further refined by full-
matrix least-squares on F2 using SHELXL-97.[80] The H atoms were located by difference 
Fourier synthesis; those attached to carbon atoms were refined in idealized positions using 
the standard riding model employed in SHEXL-97.[80]  
 
5.4 Experimental Data for Ligands 
5.4.1 X-ray Structure of H3L
1 
Yellow cubic crystal (0.30 × 0.40 × 0.40 mm). C32H33N3O6, fw = 555.61 amu,  
a = 12.631(5) Å, b = 15.619(5) Å, c = 14.201(5) Å, α = 90°, β = 92.792(5)°, γ = 90°,  
V = 2798.3(17) Å3. Monoclinic, P 21/n, Z = 4, Dc = 1.319 g cm
-3, µ = 0.092 mm-1, T = 296(2) 
K, R1 (wR2) = 0.0703 (0.2000) for 3340 unique data with I > 2σ(I), R1 (wR2) = 0.1247 
(0.2301) for all 6298 data (Rint = 0.0487). 
 
The asymmetric unit of H3L
1 contained a single ligand molecule and one DMF molecule with 
Z = 4. The final value of R1 was 0.0703 and wR2 was 0.2000. A semi-empirical multi-scan
[82] 
absorption correction was applied to the data. The maximum and minimum electron densities 
on the final difference Fourier map were 0.911 and -0.956 e Å-3, respectively. All data 
relating to the X-ray structures (atomic coordinates, structure refinement details and the 
IUCR CheckCIF[83] report) are available in Appendix D. 
 
5.4.2 X-ray Structure of H2L
2 
Colourless block crystal (0.12 × 0.15 × 0.35 mm). C31H30N2O4, fw = 494.57 amu,  
a = 9.014(2) Å, b = 21.434(4) Å, c = 13.680(2) Å, α = 90°, β = 103.228(10)°, γ = 90°, 
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V = 2572.93(8) Å3. Monoclinic, P 21/c, Z = 4, Dc = 1.277 g cm
-3, µ = 0.085 mm-1, T = 
100(2) K, R1 (wR2) = 0.0466 (0.1091) for 4875 unique data with I > 2σ(I), R1 (wR2) = 0.0637 
(0.1160) for all 6342 data (Rint = 0.0483). 
 
The asymmetric unit of H2L
2 contained a single molecule with Z = 4. The final value of R1 
was 0.0466 and wR2 was 0.1160. A semi-empirical multi-scan
[82] absorption correction was 
applied to the data. The maximum and minimum electron densities on the final difference 
Fourier map were 0.277 and -0.237 e Å-3, respectively. All data relating to the X-ray 
structures (atomic coordinates, structure refinement details and the IUCR CheckCIF[83] 
report) are available in Appendix D. 
 
5.5 Experimental Data for Metal Complexes 
5.5.1 X-ray Structure of [Cu2(L
1)(OAc)(DMF)] 
Brown shard (0.10 × 0.30 × 0.30 mm). C34H33Cu2N3O8, fw = 738.71 amu, a = 9.014(5) Å, b 
= 14.696(5) Å, c = 28.716(5) Å, α = 90°, β = 92.625(5)°, γ = 90°, V = 3800(3) Å3. 
Monoclinic, P 21/n, Z = 4, Dc = 1.291 g cm
-3, µ = 1.167 mm-1, T = 100(2) K, R1 (wR2) = 
0.0505 (0.1408) for 5761 unique data with I > 2σ(I), R1 (wR2) = 0.0701 (0.1513) for all 8506 
data (Rint = 0.0000). 
 
The asymmetric unit of [Cu2(L
1)(OAc)(DMF)] contained a single molecule with Z = 4. The 
final value of R1 was 0.0505 and wR2 was 0.1408. The maximum and minimum electron 
densities on the final difference Fourier map were 0.768 and -0.567 e Å-3, respectively. The 
residual peak lay closest to the Cu2 atom. All data relating to the X-ray structures (atomic 
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5.5.2 X-ray Structure of [Cu3(L
2)2Cl2(DMF)2] 
Red planar crystal (0.10 × 0.20 × 0.30 mm). C20.67H18.67Cl0.67CuN1.33O2.67, fw = 415.54 amu,  
a = 10.7378(4) Å, b = 15.8005(6) Å, c = 22.1628(10) Å, α = 87.018(3)°, β = 79.714(4)°,  
γ = 81.185(3)°, V = 3654.9(3) Å3. Triclinic, P-1, Z = 4, Dc = 1.133 g cm
-3, µ = 0.984 mm-1,  
T = 110(2) K, R1 (wR2) = 0.0493 (0.1119) for 7809 unique data with I > 2σ(I), R1 (wR2) = 
0.0821 (0.1181) for all 14347 data (Rint = 0.0000). 
 
The asymmetric unit of [Cu3(L
2)2Cl2(DMF)2] contained two half molecules with Z = 4. The 
final value of R1 was 0.0493 and wR2 was 0.1119. A semi-empirical multi-scan
[82] absorption 
correction was applied to the data. The maximum and minimum electron densities on the 
final difference Fourier map were 1.864 and -0.801 e Å-3, respectively. The residual peak lay 
closest to H4AA. All data relating to the X-ray structures (atomic coordinates, structure 
refinement details and the IUCR CheckCIF[83] report) are available in Appendix D. 
 
5.5.3 X-ray Structure of [Ni(L2)] 
Red plate crystal (0.03 × 0.20 × 0.60 mm). C31H28N2NiO4, fw = 551.26 amu,  
a = 25.0542(13) Å, b = 9.6539(5) Å, c = 27.3083(13) Å, α = 90°, β = 98.568(5)°, γ = 90°,  
V = 6531.4(6) Å3. Monoclinic, P 21/c, Z = 8, Dc = 1.121 g cm
-3, µ = 0.626 mm-1, T =  
296(2) K, R1 (wR2) = 0.0603 (0.1237) for 5416 unique data with I > 2σ(I), R1 (wR2) = 0.1403 
(0.1395) for all 12840 data (Rint = 0.1225). 
 
The asymmetric unit of [Ni(L2)] contained two independent molecules, giving Z = 8 for the 
unit cell contents. The final value of R1 was 0.0603 and wR2 was 0.1237. A semi-empirical 
multi-scan[82] absorption correction was applied to the data. The maximum and minimum 
electron densities on the final difference Fourier map were 0.396 and -0.386 e Å-3, 
respectively. The residual peak lies closest to O1A. All data relating to the X-ray structures 
(atomic coordinates, structure refinement details and the IUCR CheckCIF[83] report) are 
available in Appendix D. 
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5.5.4 X-ray Structure of [Cu3(L
3)2(H2O)2]Cl2 
Brown flat crystal (0.20 × 0.07 × 0.01 mm). C29H26ClCu1.5N2O5, fw = 613.28 amu,  
a = 9.1151(4) Å, b = 25.6003(11) Å, c = 11.5667(6) Å, α = 90°, β = 100.219(3)°,  
γ = 90°, V = 2656.3(2) Å3. Monoclinic, P 21/c, Z = 4, Dc = 1.534 g cm
-3, µ = 1.355 mm-1,  
T = 100(2) K, R1 (wR2) = 0.0437 (0.0963) for 4299 unique data with I > 2σ(I), R1 (wR2) = 
0.0495 (0.0986) for all 4761 data (Rint = 0.0206). 
 
The asymmetric unit of [Cu3(L
3)2(H2O)2] Cl2 contained a half molecule and a chloride ion 
with Z = 4. The final value of R1 was 0.0437 and wR2 was 0.0963. A semi-empirical multi-
scan[82] absorption correction was applied to the data. The maximum and minimum electron 
densities on the final difference Fourier map were 1.155 and -0.418 e Å-3, respectively. The 
residual peak lay closest to H4A. All data relating to the X-ray structures (atomic coordinates, 
structure refinement details and the IUCR CheckCIF[83] report) are available in Appendix D. 
 
5.5.5 X-ray Structure of [Ni(L3)] 
Green plate-like crystal (0.06 × 0.16 × 0.20 mm). C29H26N2NiO6, fw = 557.208 amu,  
a = 24.261(2) Å, b = 9.0885(8) Å, c = 26.956(2) Å, α = 90°, β = 111.1090(10)°, γ = 90°,  
V = 5546(3) Å3. Monoclinic, C 2/c, Z =8, Dc = 1.335 g cm
-3, µ = 0.743 mm-1, T = 100(2) K, 
R1 (wR2) = 0.0412 (0.1221) for 5202 unique data with I > 2σ(I), R1 (wR2) = 0.0525 (0.1326) 
for all data (Rint =0.0340). 
 
The asymmetric unit of [Ni(L3)] contained a single molecule with two water molecules, 
giving Z = 8 for the unit cell contents. The final value of R1 was 0.0412 and wR2 was 0.1221. 
A numerical absorption correction multi-scan[82] was applied to the data. The maximum and 
minimum electron densities on the final difference Fourier map were 0.625 and -0.303 e Å-3, 
respectively. The residual peak lies closest to H27. All data relating to the X-ray structures 
(atomic coordinates, structure refinement details and the IUCR CheckCIF[83] report) are 
available in Appendix D. 
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5.5.6 X-ray Structure of [Zn2(L
3)2] 
Colourless block crystal (0.15 × 0.21 × 0.27 mm). C73H83N9O13Zn2, fw = 1425.27 amu,  
a = 23.1017(3) Å, b = 18.1096(3) Å, c = 16.6460(3) Å, α = 90°, β = 90°, γ = 90°,  
V = 6964.06(4) Å3. Orthorhombic, Pna21, Z = 12, Dc = 1.359 g cm
-3, µ = 1.100 mm-1,  
T = 100(2) K, R1 (wR2) = 0.0561 (0.1459) for 10839 unique data with I > 2σ(I), R1 (wR2) = 
0.0765 (0.1607) for all 13623 data (Rint = 0.0503). 
 
The asymmetric unit of [Zn2(L
3)2] contained a single molecule with Z = 12. The final value of 
R1 was 0.0561 and wR2 was 0.1459. A numerical absorption correction multi-scan
[82] was 
applied to the data. The maximum and minimum electron densities on the final difference 
Fourier map were 0.844 and -0.676 e Å-3, respectively. The residual peak lies closest to Zn2. 
All data relating to the X-ray structures (atomic coordinates, structure refinement details and 
the IUCR CheckCIF[83] report) are available in Appendix D. 
 
5.6 Results and Discussion 
5.6.1 Analysis of the X-ray Structure of H3L
1 
H3L
1 crystallised in the monoclinic space group P 21/n. Each asymmetric unit consists of an 
H3L
1 molecule and a DMF molecule with Z = 4. Shown in Figure 5.6.1 is the thermal 
ellipsoid plot of H3L
1. H3L
1 has two configurations possible for the central hydroxyl group. 
The hydroxyl group can either be in an up position or in a down position which gives rise to 
the disorder seen in the crystal structure. Due to this only the major configuration (62%) of 
the CHOH group is shown. H3L
1 has crystallised as a zwitterion, meaning that it has both a 
positive and a negative charge within the molecule, but has no overall charge. This has 
occurred by the hydroxyl proton migrating to the nitrogen of the imine bond, thus creating a 
negatively charged oxygen atom and a positively charged imine nitrogen atom. This suggests 
that the imine nitrogen atom is more basic than the hydroxyl group.  
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Figure 5.6.1: Partially labelled thermal ellipsoid plot of H3L
1. Thermal ellipsoids are 
drawn at 50% probability, only the major component of the disordered CHOH group is 
shown for clarity, hydrogen atoms have been omitted for clarity and the DMF solvent 
molecule was draw with isotropic thermal parameters. 
 
The structure exhibits intramolecular hydrogen bonding between the zwitterion N-H and the 
ortho phenolic oxygen atoms. This is illustrated by Figure 5.6.2. 
 
  
Figure 5.6.2: Intramolecular hydrogen bonding in H3L
1. 
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Table 5.6.1 shows the bond lengths and angles of the intramolecular hydrogen bonds found 
in the crystal structure. The lengths are reasonably short (between 1.5 - 2.2 Å)[84] and so can 
be classified as moderate hydrogen bonds, although as pointed out by Steiner[84], the H-bond 
distance is often only an approximate measure of hydrogen bond strength. 
 
Table 5.6.1: Intramolecular hydrogen bond and short contact lengths (Å) and angles (°) 
for H3L
1. 
D-H•••A D-H H•••A D•••A D-H•••A 
N1-H1•••O1 0.879(1) 1.948(9) 2.629(2) 133.17(8) 
N2-H2A•••O3 0.901(1) 1.782(8) 2.532(2) 139.04(8) 
 
There are three additional hydrogen bonds that occur between the hydroxyl hydrogens of one 
ligand and the zwitterion oxygen of an adjacent molecule; and between the hydrogen on the 
bridging hydroxyl group and the oxygen on the hydroxyl group of and adjacent ligand 
molecule. The hydrogen bonding in the lattice means that each ligand molecule is connected 
to five other H3L
1 molecules. The hydrogen bonding is shown below in Figure 5.6.3. 
 
Figure 5.6.3: Hydrogen bonding in the lattice of H3L
1. 
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This hydrogen bonding leads to a two-dimensional stacking in layers in the lattice as shown 
in Figure 5.6.4.  
 
Figure 5.6.4: Stacking of H3L
1 molecules in the crystal lattice. 
 
There are also short contacts that occur in the crystal lattice of H3L
1. There are short contacts 
between a hydrogen on the ligand bridge, H14B, and a hydroxyl group oxygen, O2, on an 
adjacent ligand molecule; and between a hydrogen on a bridging carbon, H16B, and the 
oxygen on a DMF molecule, O1s, and between a hydrogen on the free ring, H12, and the 
hydroxyl oxygen of another ligand, O4. These contacts also help in the stacking, extending 
the connection between the layers formed by hydrogen bonds. The short contacts are shown 
in Figure 5.6.5. 
 
 
Figure 5.6.5: Short contacts present in the crystal lattice of H3L
1. 
Page | 82  
 
All hydrogen bonds and short contacts described are summarised below in Table 5.6.2. The 
hydrogen bonds in this compound are a mixture of shorter, stronger bonds (1.2 – 1.5 Å)[84] 
and longer, weaker bonds (>2.2 Å)[84]. 
 
Table 5.6.2: Intermolecular hydrogen bond and short contact lengths (Å) and angles (°) 
for H3L
1. 
D-H•••A D-H H•••A D•••A D-H•••A 
O2-H2B•••O3 0.878(2) 1.688(2) 2.552(2) 167.48(2) 
O4-H4A•••O1 0.915(2) 1.660(2) 2.563(2) 168.37(2) 
O5′-H5′•••O4 0.820(5) 1.997(2) 2.766(5) 155.89(4) 
C12-H12•••O4 0.930(2) 2.565(2) 3.352(3) 142.65(1) 
C14-H14B•••O2 0.970(2) 2.537(2) 3.457(3) 158.34(1) 
C16-H16B•••O1s 0.971(2) 2.603(2) 3.474(3) 149.41(1) 
 
5.6.2 Analysis of the X-ray Structure of H2L
2 
H2L
2 crystallised in the monoclinc space group P 21/c. There are four asymmetric units in the 
unit cell with a single molecule in the asymmetric unit, thus Z = 4. Figure 5.6.6 shows the 
thermal ellipsoid plot of the asymmetric unit of H2L
2. H2L
2 has crystallised as a zwitterion, 
the same as H3L
1. Again suggesting the imine nitrogen atom is more basic than the hydroxyl 
group. This means the oxygen atom will carry a negative charge and the imine nitrogen atom 
will be positively charged.  
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 Figure 5.6.6: Partially labelled thermal ellipsoid plot of H2L
2. Thermal ellipsoids are 
drawn at 50% probability, hydrogen atoms have been omitted for clarity. 
 
The structure exhibits intramolecular hydrogen bonding between the imine hydrogen atoms 
and the ortho hydroxyl oxygen atoms. This is shown in Figure 5.6.7. These form a six-
membered hydrogen-bonded ring structure. 
 
 
Figure 5.6.7: Intramolecular hydrogen bonding of H2L
2. 
 
Table 5.6.3 summarises the bond lengths and angles of the intramolecular hydrogen bonds 
found in the crystal structure. The lengths are reasonably short, between 1.5 – 2.2 Å[84] and so 
can be classified as moderate hydrogen bonds. 
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Table 5.6.3: Intramolecular hydrogen bond lengths (Å) and angles (°) for H2L
2. 
D-H•••A D-H H•••A D•••A D-H•••A 
N1-H1•••O1 0.957(2) 1.636(2) 2.496(1) 147.40(2) 
N3-H2A•••O3 0.942(1) 1.690(2) 2.530(2) 146.66(2) 
 
There are two additional intermolecular hydrogen bonds with each ligand molecule 
hydrogen-bonded via the hydroxyl groups on the phenyl rings. One ligand molecule is 
hydrogen-bonded to three other ligand molecules as shown in Figure 5.6.8. 
 
 
Figure 5.6.8: Hydrogen bonding between H2L
2 molecules. 
 
This hydrogen bonding leads to a two-dimensional network, parallel to the ab plane, with 
stacking of the ligand molecules in two directions which creates the lattice as shown in 
Figure 5.6.9. The packing is supported by hydrogen bonding of different ligand hydroxyl 
groups. There is an interplanar distance of 8.395 Å between two adjacent C20-C25 rings. The 
two-dimensional network is supported by hydrogen bonds between the ortho and para 
hydroxyl groups of two adjacent molecules. The hydrogen bond between O1 and H4 is 
particularly short with an A•••H distance of 1.618(2) Å. Although hydrogen bond length does 
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not necessarily correlate linearly with bond strength[84], due to packing constraints in the 
lattice, it is likely that these short bonds are moderate to strong. It is likely that there are π•••π 
interactions between the planar aromatic rings that further stabilises the structure. 
 
 
Figure 5.6.9: Stacking of H2L
2 molecules in the lattice due to hydrogen bonding. 
 
Table 5.6.4 shows the bond lengths and angles of the intermolecular hydrogen bonds found 
in the crystal structure. The first two lengths are reasonably short (between 1.5 – 2.2 Å)[84] 
and so can be classified as moderate hydrogen bonds. However, the last two bond lengths 
exceeds 2.2 Å[84] and so would be weak bonds. 
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Table 5.6.4: Intermolecular short contacts and hydrogen bond lengths (Å) and angles (°) 
for H2L
2. 
D-H•••A D-H H•••A D•••A D-H•••A 
O4-H4•••O1 0.927(2) 1.618(2) 2.545(1) 178.61(2) 
O2-H2•••O3 0.934(2) 1.705(2) 2.605(2) 160.60(2) 
C22-H22•••O1 0.950(1) 2.554(1) 3.211(2) 126.46(9) 
C12-H12•••O4 0.950(2) 2.566(1) 3.438(2) 152.68(1) 
 
5.6.3 Analysis of the X-ray Structure of [Cu2(L
1)(OAc)(DMF)].DMF 
[Cu2(L
1)(OAc)(DMF)] crystallised in the monoclinic space group P 21/n. Each asymmetric 
unit comprises one [Cu2(L
1)(OAc)(DMF)] molecule, with Z = 4. Shown below in 




Figure 5.6.10: Partially labelled thermal ellipsoid plot of [Cu2(L
1)(OAc)(DMF)]. 
Thermal ellipsoids are drawn at 50% probability, hydrogen atoms have been omitted 
for clarity. Solvent molecule removed by PLATON’s SQUEEZE[85]. 
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Note that diffuse reflection data associated with disordered solvent was removed using 
PLATON’s SQUEEZE[85] algorithm. It is estimated that there is one DMF molecule in the 
asymmetric unit. The ligand has not coordinated the metal in the expected manner, forming a 
square planar coordination geometry. The hydroxyl group of the di(azomethine) linkage has 
bridged two copper(II) ions. Each of the two metals centres is coordinated to the ligand via 
the ortho phenolic oxygen and an imine nitrogen atom. The bridging hydroxyl group is 
deprotonated making a pentadentate trianionic ligand. Additionally the metal centres are 
bridged by an acetate ion. The acetate balances the charge on the complex, which is neutral 
overall. There is a coordinated DMF molecule bridging the two copper centres. The metal 
centres thus possess square pyramidal coordination geometry.  
 
The unit cell is illustrated in Figure 5.6.11 and shows that each of the four 
[Cu2(L
1)(OAc)(DMF)] molecules is situated on a general position. There are two short 
contacts within the unit cell. One involving the hydroxyl oxygen atom of one molecule, O4, 
and a hydrogen on the bridge, H9; and the other between a metal chelated oxygen, O6, and a 
phenyl ring hydrogen, H20. 
 
 
Figure 5.6.11: Packing in the unit cell of [Cu2(L
1)(OAc)(DMF)] as viewed along the 
a-axis. 
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As would be expected there are hydrogen bonds and short contacts present in the lattice. Each 
[Cu2(L
1)(OAc)(DMF)] molecule is hydrogen bonded to an adjacent [Cu2(L
1)(OAc)(DMF)] 
molecule via two hydrogen bonds. The two hydrogen bonds between the 
[Cu2(L
1)(OAc)(DMF)] molecules are the same, O5-H5•••O1. There are a further three short 
contacts between adjacent  [Cu2(L
1)(OAc)(DMF)] molecules. One is from the oxygen on the same 
hydroxyl group that forms the hydrogen bond, O5, and a phenyl oxygen, H2. The other two are 
between an acetate oxygen, O7, and two hydrogens on the DMF molecule, H32 and H33B. This is 
shown in Figure 5.6.12. 
 
 




All hydrogen bonds and short contacts are summarised in Table 5.6.5. 
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Table 5.6.5: Hydrogen bond and short contact lengths (Å) and angles (°) for 
[Cu2(L
1)(OAc)(DMF)]. 
D-H•••A D-H H•••A D•••A D-H•••A 
C2-H2•••O5 0.949(3) 2.602(2) 3.312(4) 131.94(2) 
O5-H5••O1 0.839(3) 1.906(2) 2.724(3) 164.58(2) 
C33-H33B•••O7 0.981(4) 2.369(2) 3.324(4) 164.37(2) 
C32-H32•••O7 0.949(3) 2.613(2) 3.467(4) 149.91(2) 
C9-H9•••O4 1.000(4) 2.605(3) 3.405(5) 136.93(2) 
C20-H20•••O6 0.950(4) 2.549(2) 3.243(4) 130.06(2) 
C33-H33A•••O2 0.980(4) 2.378(3) 3.349(5) 170.55(2) 
 
The geometry around each copper(II) ion is square pyramidal. The bond lengths between 
copper and its coordinated elements are shown in Table 5.6.6. The bond angles between 
copper and its coordinated elements are shown in Table 5.6.7. The bond lengths and angles 
are all within the range of similar structures.[15]  
 
Table 5.6.6: Table of coordination bond lengths for [Cu2(L
1)(OAc)(DMF)]. 
Bond Length (Å) Bond Length (Å) 
Cu1-N1 1.939(3) Cu2-N2 1.948(3) 
Cu1-O1 1.902(2) Cu2-O3 1.875(2) 
Cu1-O2 1.936(3) Cu2-O2 1.939(2) 
Cu1-O6 1.938(2) Cu2-O7 2.000(3) 
Cu1-O8 2.513(3) Cu2-O8 2.295(3) 
 
The bond lengths are similar, with the exception of the bonds to the acetate and DMF 
molecules. This is to be expected as the distance between the copper ions sharing these 
bridging molecules would place restrictions on the bond lengths. 
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Table 5.6.7: Table of coordination bond angles in [Cu2(L
1)(OAc)(DMF)]. 
Bond Angle Angle (°) Bond Angle Angle (°) 
N1-Cu1-O2 86.04(1) N2-Cu2-O2 85.41(1) 
N1-Cu1-O1 93.36(1) N2-Cu2-O3 94.20(1) 
O2-Cu1-O6 91.94(1) O2-Cu2-O7 90.44(1) 
O1-Cu1-O6 88.09(1) O3-Cu2-O7 89.84(1) 
N1-Cu1-O8 87.23(1) N2-Cu2-O8 111.83(1) 
O1-Cu1-O8 105.42(9) O3-Cu2-O8 94.81(1) 
O2-Cu1-O8 79.73(9) O2-Cu2-O8 85.49(1) 
O6-Cu1-O8 98.55(9) O7-Cu2-O8 93.18(1) 
 
The bond angles are slightly distorted from the typical square pyramidal angles of 90°[86]. 
This could possibly be attributed to the constraints put on the bonds as each copper(II) ion 
forms a five membered ring with the bridging oxygen as well as a six membered ring with the 
other coordinated nitrogen and oxygen from the ligand. 
 
5.6.4 Analysis of the X-ray Structure of [Cu3(L
2)2Cl2(DMF)2].5H2O.DMF 
[Cu3(L
2)2Cl2(DMF)2] crystallised in the triclinic space group of P-1. Each asymmetric unit 
comprises two half [Cu3(L
2)2Cl2(DMF)2] molecules, giving Z = 2. Shown below in 
Figure 5.6.13 is the thermal ellipsoid plot of [Cu3(L
2)2Cl2(DMF)2]. PLATON’s SQUEEZE 
algorithm was used to remove diffuse reflection data associated with the disordered solvent 
molecules; one DMF and five water molecules are estimated to be present in the asymmetric 
unit. 
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Figure 5.6.13: Partially labelled thermal ellipsoid plot of [Cu3(L
2)2Cl2(DMF)2]. Thermal 
ellipsoids are drawn at 50% probability, hydrogen atoms and co-crystallised solvent 
molecules have been omitted for clarity. 
 
Each ligand has coordinated a copper(II) ion. The metal centre is coordinated to the ligand 
via the ortho phenolic oxygen atoms and imine nitrogen atoms, thus forming a tetradentate 
dianionic ligand. However, two of these metal chelates are bridged by a copper(II) ion to 
form one metal chelate molecule. Each ligand-chelated metal has a chloride ion bound to it 
thus balancing the charge created by the bridging copper(II) ion and so allowing for an 
overall neutral molecule. The coordination geometry of the bridging copper(II) ion is square 
planar as it is chelated via the four ortho phenolic oxygens of the two ligands. The ligand-
chelated copper ions have distorted square pyramidal geometries. 
 
The unit cell is illustrated in Figure 5.6.14 and shows that each general position is comprised 
of two half [Cu3(L
2)2Cl2(DMF)2] molecules which are related by inversion symmetry. There 
is one short contact present in the unit cell between the meta hydroxyl oygen atom, O3A, and 
a hydrogen atom on a nearby dihydroxy ring of an adjacent molecule. 
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Figure 5.6.14: Packing in the unit cell of [Cu3(L
2)2Cl2(DMF)2] viewed along the a-axis. 
 
There is only one other short contact in the lattice of [Cu3(L
2)2Cl2(DMF)2] and no hydrogen 
bonds present. The contact is between the hydroxyl oxygen atom, O3B, and a hydrogen atom 
on an adjacent molecules benzene ring. Table 5.6.8 details the data of the short contacts.  
 
Table 5.6.8: Short contact lengths (Å) and angle (°) for [Cu3(L
2)2Cl2(DMF)2]. 
D-H•••A D-H H•••A D•••A D-H•••A 
C4B-H4BA•••O3A 0.948(4) 2.616(3) 3.466(6) 149.33(3) 
C23B-H23B•••O3B 0.950(5) 2.685(3) 3.418(6) 134.49(3) 
 
The bond lengths and bond angles of [Cu3(L
2)2Cl2(DMF)2] A and [Cu3(L
2)2Cl2(DMF)2] B 
involving the metal ions and their coordinated elements have been averaged and are shown in 
Table 5.6.9 and Table 5.6.10, respectively. 
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Table 5.6.9: Table of average coordination bond lengths in [Cu3(L
2)2Cl2(DMF)2]. 






The bond lengths of the coordinated ligand atoms are fairly similar in length and relatively 
short which indicates a fairly strongly bound metal. The axial chloride ions have longer 
Cu-Cl bond lengths than bonds to the other donor atoms, which may be due to steric 
hindrance around the copper consistent with the larger ionic radius of chlorine relative to 
nitrogen or oxygen. The bond angles are distorted from the typical square pyramidal 
geometry (90°) which is attributed to the steric constraints within the six-membered ring 
formed around the ligand coordinated copper ion. The bridging copper ion’s bond angles are 
also distorted from the typical square planar geometry. This phenomenon would be caused by 
the distortions in the geometries of Cu1 and Cu3. The bond lengths and angles are all within 
the range of similar structures.[74, 86] 
 
Table 5.6.10: Table of average coordination bond angles in [Cu3(L
2)2Cl2(DMF)2]. 







*X = O1, O2, N1 and N2 in [Cu3(L
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5.6.5 Analysis of the X-ray Structure of [Ni(L2)].4H2O.DMF 
[Ni(L2)] crystallised in the monoclinic space group P 21/c. Each asymmetric unit comprises 
two independent [Ni(L2)] molecules, making Z = 8. Shown below in Figure 5.6.15 is the 
thermal ellipsoid plot of [Ni(L2)]. 
 
 
Figure 5.6.15: Partially labelled thermal ellipsoid plot of [Ni(L2)]. Thermal ellipsoids are 
drawn at 50% probability, hydrogen atoms and solvent molecules have been omitted for 
clarity. Solvent molecules were removed by PLATON’s SQUEEZE[85]. 
 
There are two independent molecules in the asymmetric unit labelled A and B. Note that 
PLATON’s SQUEEZE[85] algorithm was used to remove diffuse reflection data associated 
with the disordered solvent molecules; one DMF and four H2O molecules are estimated to be 
present in the asymmetric unit. The ligand chelates the metal forming a square planar 
coordination geometry with no axial ligands. The nickel(II) ion is coordinated to the ligand 
via the imine nitrogen atoms and the ortho phenolic oxygen atoms. The deprotonation of the 
ortho hydroxyl groups creates a tetradentate dianionic ligand. The molecule is neutral overall 
when coordinated to the nickel(II) ion. 
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The unit cell is illustrated in Figure 5.6.16. There is one short contact in the unit cell between 
adjacent [Ni(L2)] molecules. This complex shows no hydrogen bonding present in the crystal 
lattice in the solvent-free model illustrated above. In the solvated model, even though the 
solvent molecules were disordered, intermolecular hydrogen-bonds were evident. A water 
molecule formed a bifurcated hydrogen-bond with the oxygen donor atoms of a [Ni(L2)]. In 
this unsolvated model, the hydroxyl group oxygen, O4A, forms a short contact with a close 
proximity phenyl hydrogen, H4AA. 
 
 
Figure 5.6.16: Packing in the unit cell of [Ni(L2)] as viewed down the b-axis. Disorded 
solvent molecules have been omitted for clarity in the diagram and in the final structure 
model. 
 
The crystal lattice is supported by four short contacts between adjacent [Ni(L2)] molecules. 
Molecule B only has one short contact which links adjacent B molecules together. The other 
short contacts connect one [Ni(L2)] A to three other [Ni(L2)] A molecules. Shown in 
Figure 5.6.17 are all the short contacts present. The contacts mentioned occur between the 
uncoordinated hydroxyl oxygen, O4A, on one [Ni(L2)] A molecule and nearby [Ni(L2)] A 
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hydrogen, H4AA, on the dihydroxyl ring; as well as between the uncoordinated hydroxyl 
oxygen, O3B, on one [Ni(L2)] B molecule and nearby [Ni(L2)] B hydrogen, H28B, on the 
dihydroxyl ring; as well as between  the hydroxyl oxygen of [Ni(L2)] A, O4A, and another benzene 
ring hydrogen, H21A, and finally between the coordinated oxygen, O2A, on a [Ni(L2)] A molecule 
and a hydrogen atom, H24A, on a nearby benzene ring of an adjacent [Ni(L2)] molecule. 
 
 
Figure 5.6.17: Short contacts present between [Ni(L2)] molecules. 
 
Table 5.6.11 summarises the bond lengths and angles of all short contacts mentioned above.  
 
Table 5.6.11: Short contact lengths (Å) and angles (°) for [Ni(L2)]. 
D-H•••A D-H H•••A D•••A D-H•••A 
C4A-H4AA•••O4A 0.931(5) 2.512(3) 3.310(6) 143.93(3) 
C24A-H24A•••O2A 0.930(6) 2.559(3) 3.342(6) 142.07(3) 
C21A-H21A•••O4A 0.930(5) 2.516(4) 3.442(6) 174.21(3) 
C28B-H28B•••O3B 0.930(5) 2.486(3) 3.328(6) 150.77(3) 
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The geometry around the nickel(II) ions is square planar, as would be expected from a 
tetradentate ligand. The average lengths of each bond between the nickel atom and its 
coordinated elements are shown in Table 5.6.12. The average angles of the separate nickel 
atoms and their coordinated elements are shown in Table 5.6.13. 
 
Table 5.6.12: Table of average coordination bond lengths in [Ni(L2)]. 






Short bond lengths are indicative of a fairly strongly bound metal. The bond angles are 
slightly distorted from the typical square planar geometry which could be attributed to the six 
membered chelate rings of the complex. The bond lengths and angles are all within the range 
reported for similar structures.[75, 86] 
  
Table 5.6.13: Table of average coordination bond angles for [Ni(L2)]. 






5.6.6 Analysis of the X-ray Structure of [Cu3(L
3)2(H2O)2]Cl2 
[Cu3(L
3)2(H2O)2]Cl2 crystallised in the monoclinic space group of P 21/c. Each asymmetric 
unit comprises half a [Cu3(L
3)2(H2O)2]Cl2 molecule and one chloride ion, giving Z = 4. 
Shown below in Figure 5.6.18 is the thermal ellipsoid plot of [Cu3(L
3)2(H2O)2]Cl2. 
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Figure 5.6.18: Partially labelled thermal ellipsoid plot of [Cu3(L
3)2(H2O)2]Cl2. Thermal 
ellipsoids are drawn at 50% probability. 
 
Each ligand has coordinated a copper(II) ion via the ortho phenolic oxygen atoms and imine 
nitrogen atoms, thus forming a tetradentate dianionic ligand. Two of these copper(II) chelates 
are bridged by a copper(II) ion to form a trinuclear [Cu3(L
3)2(H2O)2]Cl2 molecule. The 
ligand-chelated copper(II) ion is further bridged to the bridging copper(II) ion by a water 
molecule. There is also a chloride ion that is hydrogen-bonded to the hydrogen on the ortho 
phenolic oxygen atom and a hydrogen on one of the bridging water molecules. The 
coordination geometry of the bridging copper(II) ion is square planar as it is chelated via the 
four ortho phenolic oxygens of the two ligands.  
 
The unit cell is illustrated in Figure 5.6.19. The only hydrogen bonding in the unit cell is 
between the chloride ions and the ortho phenolic oxygen atom and a hydrogen atom on one 
of the bridging water molecules. 
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Figure 5.6.19: Packing in the unit cell of [Cu3(L
3)2(H2O)2]Cl2 viewed along the a-axis. 
 
As can be seen in Figure 5.6.20 the only hydrogen bonding in the lattice is by the chloride 




Figure 5.6.20: Hydrogen bonding in the lattice of [Cu3(L
3)2(H2O)2]Cl2. 
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There is one short contact present in the lattice between Cl1 and H23 on the phenyl ring. This 
short contact and the hydrogen bonds of [Cu3(L
3)2(H2O)2]Cl2 are shown in Figure 5.6.21. 
Table 5.6.14 is a summary of the bond lengths and angles of the hydrogen bonds and the 
short contact mentioned. 
 
 
Figure 5.6.21: Short contact and hydrogen bonds in the lattice of [Cu3(L
3)2(H2O)2]Cl2. 
 
Table 5.6.14: Hydrogen bonds and short contact lengths (Å) and angles (°) for 
[Cu3(L
3)2(H2O)2]Cl2. 
D-H•••A D-H H•••A D•••A D-H•••A 
C10-H10A•••O4 0.989(4) 2.652(3) 3.570(5) 154.41(2) 
O4-H4•••Cl1 0.840(4) 2.194(1) 3.025(4) 169.84(2) 
C23-H23•••Cl1 0.951(3) 2.883(8) 3.727(3) 148.41(2) 
O5-H5B•••Cl1 0.740(4) 2.520(4) 3.258(3) 176.45(5) 
O3-H3•••Cl1 0.841(3) 2.403(8) 3.183(3) 154.60(2) 
O5-H5A•••Cl1 0.810(4) 2.280(5) 3.059(3) 161.69(4) 
 
All the copper(II) centres adopted a square planar geometry. The bond lengths of 
[Cu3(L
3)2(H2O)2]Cl2 involving the metal ions and their coordinated elements have been 
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averaged and are shown in Table 5.6.15. The bond angles of [Cu3(L
3)2(H2O)2]Cl2 are shown 
in Table 5.6.16.  
 
Table 5.6.15: Table of coordination bond lengths in [Cu3(L
3)2(H2O)2]Cl2. 
Bond Length (Å) Bond Length (Å) 
N1-Cu1 1.951(3) O5-Cu1 2.410(3) 
N2-Cu1 1.966(3) O1-Cu2 1.936(2) 
O1-Cu1 1.942(3) O2-Cu2 1.960(2) 
O2-Cu1 1.946(3) O5-Cu2 2.695(3) 
 
The metal-to-ligand bond lengths involving the different ligand donor atoms are fairly similar 
in length and relatively short, which indicates a fairly strongly-bound metal. The Cu-O bond 
lengths to the coordinated water molecule are quite long and would suggest it is weakly 
bound, consistent with its bridging role in the structure. The bond angles are distorted from 
those typical of a square planar ion, which is attributed to the six membered ring formed 
around the ligand-bound copper(II) ions. The bridging copper ions bond angles are also 
distorted from the typical square planar geometry. This phenomenon would be caused by the 
distortions in the geometries of Cu1. The bond lengths and angles are all within the range of 
similar structures.[74, 86] 
 
Table 5.6.16: Table of coordination bond angles in [Cu3(L
3)2(H2O)2]Cl2. 
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5.6.7 Analysis of the X-ray Structure of [Ni(L3)].2H2O 
[Ni(L3)] crystallised in the monoclinic space group of C 2/c. Each asymmetric unit comprises 
one [Ni(L3)] molecule and two water molecules with Z = 8. Shown below in Figure 5.6.22 is 
the thermal ellipsoid plot of [Ni(L3)]. 
 
 
Figure 5.6.22: Partially labelled thermal ellipsoid plot of [Ni(L3)]. Thermal ellipsoids are 
drawn at 50% probability, hydrogen atoms have been omitted for clarity. 
 
The ligand coordinated the metal forming a nominally square planar coordination geometry 
with no axial ligands present. The nickel(II) ion is coordinated to the ligand via the imine 
nitrogen atoms and the ortho phenolic oxygen atoms. The deprotonation of the ortho 
hydroxyl groups creates a tetradentate dianionic ligand.  
 
The unit cell is illustrated in Figure 5.6.23. There is hydrogen bonding in the unit cell 
between the [Ni(L3)] molecules and water; this is also shown in the unit cell diagram.  
 
Page | 103  
 
 
Figure 5.6.23: Packing in the unit cell of [Ni(L3)] viewed along the b-axis. 
 
The structure is solvated by two water molecules for every [Ni(L3)] molecule. The crystal 
lattice is supported by hydrogen bonds between the [Ni(L3)] molecules and the water 
molecules and short contacts between the complex molecules themselves. There are four 
water molecules shared between two [Ni(L3)] molecules. An interesting feature to note is the 
bifurcated hydrogen bond that forms between the hydrogen on a water molecule, H1WB, and 
both metal chelated oxygen atoms, O1 and O2. The hydrogen bonding is shown in Figure 
5.6.24.  
 
Figure 5.6.24: Hydrogen bonding in the crystal lattice of [Ni(L3)]. 
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There are short contacts present between the O3 free hydroxyl group and the hydrogens in 
close proximity to it and one short contact between each coordinated oxygen, O1 and O2, and 
a hydrogen atom of a benzene ring of an adjacent molecule, H26 and H28, respectively. 
These short contacts are shown below in Figure 5.6.25. 
 
Figure 5.6.25: Short contacts present in the crystal lattice of [Ni(L3)]. 
 
The hydrogen bonds and short contacts mentioned have been tabulated with the associated 
bond lengths and angles in Table 5.6.17. 
 
Table 5.6.17: Hydrogen bond and short contact lengths (Å) and angles (°) for [Ni(L3)]. 
D-H•••A D-H H•••A D•••A D-H•••A 
C26-H26•••O1 0.950(2) 2.607(1) 3.481(2) 153.01(1) 
C28-H28•••O2 0.949(2) 2.602(1) 3.238(2) 124.72(1) 
C20-H20•••O3 0.951(2) 2.483(2) 3.246(3) 137.18(1) 
C16-H16A•••O3 0.990(2) 2.582(1) 3.518(2) 157.55(1) 
C13-H13•••O3 0.950(2) 2.519(1) 3.422(2) 158.79(1) 
O4-H4•••O1W 0.840(2) 1.739(2) 2.575(3) 174.20(1) 
O1W-H1WB•••O1 0.864(2) 2.176(2) 2.930(2) 145.52(3) 
O1W-H1WB•••O2 0.864(2) 2.149(3) 2.905(2) 145.86(3) 
O3-H3•••O2W 0.839(1) 1.869(2) 2.692(2) 166.70(1) 
O2W-H2WA•••O4 0.848(2) 1.911(2) 2.755(2) 172.61(3) 
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The geometry around the nickel ion is square planar as would be expected from a tetradentate 
ligand. The bond lengths and bond angles between the nickel ion and its coordinated 
elements are listed in Table 5.6.18.  
 
Table 5.6.18: Table of coordination bond lengths and bond angles in [Ni(L3)]. 
Bond Length (Å) Bond Angle Angle (°) 
N1-Ni 1.883(1) N1-Ni-N2 92.73(7) 
N2-Ni 1.883(2) N1-Ni-O1 93.28(6) 
O1-Ni 1.834(2) N2-Ni-O2 92.37(6) 
O2-Ni 1.848(1) O1-Ni-O2 82.71(6) 
 
The bond lengths are very similar in magnitude. They are short, consistent with a strongly 
bound nickel(II) ion. The bond angles are slightly distorted from the typical square planar 
geometry which could be attributed to the six membered chelation ring and mixed donor 
atom set. The bond lengths and angles are all within the range of similar structures.[75, 86] 
 
5.6.8 Analysis of the X-ray Structure of [Zn2(L
3)2].5DMF 
[Zn2(L
3)2] crystallised in the orthorhombic space group Pna21. Each asymmetric unit 
comprises one [Zn2(L
3)2] molecule with Z = 12. Shown below in Figure 5.6.26 is the thermal 
ellipsoid plot of [Zn2(L
3)2]. PLATON’s SQUEEZE
[85] algorithm was used to remove diffuse 
reflection data associated with the disordered solvent molecules; five DMF molecules are 
estimated to be present in the asymmetric unit. Disordered solvent molecules have been 
omitted for clarity. 
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Figure 5.6.26: Partially labelled thermal ellipsoid plot of [Zn2(L
3)2]. Thermal ellipsoids 
are drawn at 50% probability, hydrogen atoms have been omitted for clarity. 
 
The ligand coordinated the metal in the expected trigonal bipyramidal coordination geometry, 
however the metal complex then formed a dimer by coordination of the zinc atom to one 
ortho phenolic oxygen of the alternative chelate. The zinc(II) ion is coordinated to the ligand 
via the imine nitrogen atoms and the ortho phenolic oxygen atoms. The deprotonation of the 
ortho hydroxyl groups creates a tetradentate dianionic ligand. The molecule is neutral overall, 
with the zinc(II) ions coordinated balancing the charge of the ligands. 
 
There are no hydrogen bonds present in the lattice of [Zn2(L
3)2]. This is because the final 
structure model had disordered solvent (DMF) removed using PLATON’s SQUEEZE 
algorithm) and the solvent molecules ordinarily would hydrogen-bond to the phenolic 
hydrogen bond donors/acceptors in the molecule. There are, however, two short contacts that 
occur which results in one [Zn2(L
3)2] molecule being connected to two adjacent [Zn2(L
3)2] 
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molecules. This is shown in Figure 5.6.27. The short contacts mentioned are tabulated with 
the associated bond lengths and angles in Table 5.6.19.  
 
Figure 5.6.27: Short contacts present in the lattice of [Zn2(L
3)2]. 
 
Table 5.6.19: Short contact lengths (Å) and angles (°) for [Zn2(L
3)2]. 
D-H•••A D-H H•••A D•••A D-H•••A 
C12-H12•••O5 0.949(4) 2.553(3) 3.341(5) 140.63(3) 
C39-H39•••O1 0.950(5) 2.547(3) 3.283(6) 134.41(3) 
 
The geometry around the zinc(II) ions in the dinuclear structure is trigonal bipyramidal. The 
bond lengths of each zinc atom and its coordinated elements are shown in Table 5.6.20. The 
bond angles of the separate zinc atoms and their coordinated elements are given in  
Table 5.6.21. 
 
Table 5.6.20: Table of coordination bond lengths in [Zn2(L
3)2]. 
Bond Length (Å) Bond Length (Å) 
N1-Zn1 2.073(3) N3-Zn2 2.096(3) 
N2-Zn1 2.077(3) N4-Zn2 2.054(3) 
O1-Zn1 1.927(3) O5-Zn2 1.921(3) 
O3-Zn1 2.084(3) O7-Zn2 2.081(3) 
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The bond distances between Zn1, N1, N2, and O3; and Zn2, N3, N4, O3 and O7 despite the 
difference in donor atom type and consistent with similar zinc(II) structures in literature.[87-88] 
These bond lengths are above 2 Å, which would indicate a fairly weakly bound metal ion. 
This is implied by the zinc(II) ion being easily removed from the ligand during 
characterisation such as mass spectrometry. An interesting feature to note is that two of the 
Zn-O bonds are notably longer; this is due to the hydrogen-bonding that occurs in the 
solvated model of this compound. The donor oxygen atoms form a hydrogen bond with 
hydrogen atoms on a nearby DMF molecule. The bond angles are slightly distorted from the 
typical trigonal bipyramidal geometry which could be attributed to the six membered ring 
formed by chelation as well as the geometric adjustments required for the formation of a 
dinuclear complex bearing two sterically bulky tetradentate chelate ligands. The bond lengths 
and angles are all within the range of similar structures.[86] 
 
Table 5.6.21: Table of coordination bond angles for [Zn2(L
3)2]. 
Bond Angle (°) Bond Angle (°) 
N1- Zn1-N2 95.05(1) N3-Zn2-N4 93.32(2) 
N1- Zn1-O1 91.14(1) N3-Zn2-O5 91.41(1) 
N2- Zn1-O3 84.50(1) N4-Zn2-O7 84.70(2) 
O1- Zn1-O3 94.62(1) O5-Zn2O7 95.26(1) 
 
The bond lengths and angles around the bonds holding the dinuclear zinc(II) cluster together 
are tabulated below in Table 5.6.22. 
 
Table 5.6.22: Table of coordination bond lengths and bond angles between zinc(II) ions 
in the dinuclear structure [Zn2(L
3)2]. 
Bond Length (Å) Bond Angle (°) 
Zn1-O3 2.084(3) O3-Zn1-O7 76.78(1) 
Zn1-O7 2.021(3) Zn1-O3-Zn2 102.21(1) 
Zn2-O7 2.081(3) O3-Zn2-O7 76.58(1) 
Zn2-O3 2.034(3) Zn2-O7-Zn1 102.76(1) 
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5.7 Concluding Remarks 
The two ligand structures reported both had monoclinic space groups. H3L
1 crystallised with 
one DMF molecule in the space group of P 21/n and H2L
2 crystallised in the space group 
P 21/c. Two of the three copper(II) complexes, [Cu2(L
1)(OAc)(DMF)] and 
[Cu3(L
3)2(H2O)2]Cl2, crystallised in monoclinic space groups of P 21/n and P 21/c, 
respectively and the third, [Cu3(L
2)2Cl2(DMF)2], adopted the triclinic space group of P-1. All 
three copper(II) complexes crystallised with solvents and had a proclivity for the formation of 
multinuclear complexes. The nickel(II) complexes both crystallised in monoclinic space 
groups. [Ni(L2)] crystallised with four water molecules and one DMF molecule in the space 
group of P 21/c and [Ni(L
3)] with two water molecules in C 2/c.  [Zn2(L
3)2] was the only 
complex to adopt an orthorhombic space group of Pna21. Following the copper(II) 
complexes, the zinc(II) complex also formed a multinuclear complex and was solvated by 
five DMF molecules. Also noteworthy is that the extended structures of these complexes are 
highly complex as a result of extensive intra- and intermolecular hydrogen bonding 
associated with their crystallisation as water and DMF solvates. Because of the significant 
level of disorder in all solvent regions of the solvated crystal structures, final crystallographic 
models were generated by removing reflection data associated the disordered solvent by 
employing PLATON’s SQUEEZE algorithm. While this allows for favourable CIFcheck 
results and uncomplicated analysis of the structures of the metal complexes, it precludes 
extensive analysis of the extended structures of the compounds and any hydrogen bonding 
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6. Computational Chemistry 
6.1 Introduction 
By using mathematics and the laws of physics, computational chemistry calculates structures, 
reactions, UV-vis spectra, infrared vibrations and NMR spectra. The basis of DFT 
simulations is due to their popularity in literature to theorise experimental data and then make 
a comparison. This can also be helpful in the analysis and assignment of data. Some literature 
examples will be discussed and then an analysis and comparison of the experimental data and 
calculated data of the compounds of this work will be done. The method used most 
commonly is that of Density Functional theory (DFT). It provides more realistic results as it 
takes into account electron correlation and its effects whereas other computational methods 
only consider the effects as an average, which lowers their accuracy when compared to 
experimental data.[89]  
 
In ab initio methods a variety of quantum chemical properties are calculated; the main 
calculation being to determine the wavefunction. These calculations are all done via 
Schrödinger mathematics.[90] As is the norm for these types of calculations, the Born-
Oppenheimer approximation is applied to the nuclei of the molecule being studied. This 
simply means that the nuclei are seen as fixed which creates an external potential energy 
where the electrons are moving. This gives the stationary electronic state which can be 
described by a wavefunction (Ψ) using the Schrödinger equation, as given below.  
 
ĤΨ(r1, r2,..., rN) = E Ψ(r1, r2,..., rN) 
where Ĥ is the Hamiltonian operator and is made up of three terms; kinetic energy, the 
interaction with external potential energy (the interaction of electrons with the atomic nuclei) 
and electron-electron interaction: 
 




Simply put, the wavefunction is a description of where electrons are situated, the electron 
density distribution. Computational chemistry utilises basis sets in appropriate software to 
calculate the wavefunction of a molecule. Once the wavefunction is calculated and therefore 
the electron density distribution, it can be used to determine other properties of the molecule 
being studied, for instance its molecular wavefunction, orbitals, infrared spectrum and so 
forth. The basis set employed in this work allows for the inner and outer shell electrons to be 
treated separately as core electrons and valence electrons are not equivalent. This means the 
core electron contribution is not calculated as thoroughly as the valence electrons in these 
calculations and with the application of the double-zeta method (doubly split electron basis 
set), the valence electrons are calculated twice. DFT focuses on the electron density of the 
molecule and therefore calculates the wavefunction indirectly which allows for the further 
calculation of a range of electronic properties.[89] 
 
In 2009 Salehzadeh et al.[91] did a study on an acyclic pentadentate nickel(II) Schiff base 
complex and used the X-ray structure acquired to generate fully optimised gas phase 
structures. The calculations were done by Gaussian 98 using both the Hartree-Fock and DFT 
levels of theory. The LanL2DZ basis set was used for the metal ion and 6-31G or 3-21G[92-94] 
for ligand atoms in the DFT calculations for the complex [NiL33(MeOH)]
2+ as shown in 
Figure 6.1. DFT calculations were done on different isomers of [NiL33(MeOH)]
2+ to 
determine whether the complex had indeed adopted the most stable structure in the solid 
state. The results were positive and confirmed that the gas phase calculation of the most 
stable isomer (in Figure 6.1 the most left-hand side structure) matched the solid state X-ray 
structure of [NiL33(MeOH)]
2+. Shown in Table 6.1 are the X-ray bond lengths for 
[NiL33(MeOH)]
2+ as determined by Salehzadeh et al.[91] 
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Figure 6.1: Structure and isomers of [NiL33(MeOH)]
2+ as determined by Salehzadeh et 
al.[91] Adapted from Salehzadeh et al.[91] 
 
Table 6.1: Calculated and experimental bond lengths (Å) of [NiL33(MeOH)]
2+. 
 X-ray 6-31G (LanL2DZ for Ni) 3-21G (LanL2DZ for Ni) 
N1-Ni 2.097(6) 2.115 2.094 
N2-Ni 2.073(7) 2.116 2.094 
N3-Ni 2.108(7) 2.161 2.118 
N4-Ni 2.040(7) 2.078 2.071 
N5-Ni 2.061(6) 2.140 2.117 
O1-Ni 2.192(6) 2.277 2.154 
 
In 2010 Trujillo et al.[95] studied unsymmetrical nickel(II) complexes that were substituted 
with organometallic donor-acceptor compounds. The nickel(II) complexes are shown in  
Figure 6.2. The DFT calculations run by Trujillo et al.[95] were carried out using the 
Amsterdam Density Functional program.[96] The basis set used was that of ADF TZP. It was 
found that the computational results were in good agreement with that obtained 
experimentally. Shown in  Table 6.2 are the calculated values for the nickel(II) chelates 
reported by Trujillo et al.[95] The experimental values are given in parentheses when reported. 
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Figure 6.2: Structures of the nickel(II) chelates studied by Trujillo et al.[95] Diagram 
adapted from Trujillo et al.[95] 
 
Table 6.2: Experimental and calculated bond lengths (Å) in nickel(II) chelates reported 
by Trujillo et al.[95] 
Bond A B C D 
Ni-N(1) 1.887 (1.868) 1.875 1.869 (1.856) 1.866 (1.834) 
Ni-O(1) 1.904 (1.842) 1.882 1.901 (1.846) 1.873 (1.825) 
Ni-N(2) 1.889 (1.848) 1.892 1.862 (1.851) 1.871 (1.881) 
Ni-O(2) 1.886 (1.849) 1.901 1.894 (1.844) 1.921 (1.852) 
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Trujillo et al.[95] did further investigations using TDDFT calculations to determine the 
theoretical electronic transition energies. It was found that the major features reported in the 
experimental spectra were reproduced well by the calculated spectra.  
 
In 2011 Chandra et al.[97] synthesised 16-membered mixed-donor macrocyclic Schiff base 
nickel(II) chelates which were then modelled using MOPAC 2007[98] in the gas phase with 
PM6 level of theory. They reported that the root mean square gradient for the molecules were 
all less than one. The structure of the nickel(II) chelates are shown in Figure 6.3. 
 
 
Figure 6.3: 16-membered mixed-donor nickel(II) chelates synthesised by Chandra et 
al.[97] 
 
Another study done in 2011 by Cao et al.[99] on nickel(II) phosphasalen chelates utilised 
Gaussian 03[100] in order to carry out DFT calculations. The study included a comparison of 
nickel(II) salen experimental and DFT calculated data. The functional applied was that of 
B3PW91[101-102] with the associated triple zeta[103] basis set. The calculations were done in 
both the singlet and triplet states. The structures of the nickel(II) chelates are shown in 
Figure 6.4. The optimisation proved successful and the calculated parameters for the 
optimised singlet state were in excellent agreement with the experimental data. The data for 
the bond angles and bond lengths of these complexes is given in Table 6.3. 
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Figure 6.4: Structures of the nickel(II) chelates of salen and phosphasalen ligands. 
 
Table 6.3: Calculated and experimental bond lengths (Å) and bond angles (°) of the 
nickel(II) chelates of salen and phosphasalen ligands. 
 Ni(salen) Ni(phosphasalen) 
 X-ray Singlet Triplet X-ray Singlet Triplet 
Ni-N2 1.851(3) 1.857 1.986 1.888(4) 1.897 1.966 
Ni-N1 1.849(3) 1.856 1.989 1.905(4) 1.894 2.011 
Ni-O2 1.853(3) 1.847 1.900 1.863(4) 1.865 1.914 
Ni-O1 1.851(5) 1.848 1.899 1.881(3) 1.883 1.953 
O2-Ni-N2 94.1(4) 94.3 91.6 95.4(2) 94.7 97.5 
O1-Ni-N1 94.2(4) 94.0 91.5 95.4(2) 95.1 96.3 
O1-Ni-O2 85.5(4) 85.4 105.2 83.9(2) 84.4 101.1 
N1-Ni-N2 86.3(5) 86.4 82.9 85.4(2) 85.8 85.8 
  
Furthermore,  Cao et al.[99] ran electronic transition energy calculations and determined that 
the singlet state gave the more stable complex rather than the triplet state  and was in 
agreement with the experimental evidence of a low spin state complex. 
 
When all the literature data is compared it shows that theoretical chemistry calculations can 
be a valuable source of information when considering complexes and their experimental data. 
There is also evidence that a wide variety of basis sets can be used to optimise data with 
accurate results. A key advantage of DFT simulations, therefore, is that when an experimental 
solid state structure is absent, a simulated structure may be sufficiently accurate to allow 
reliable interpretations of spectroscopic and other data to be made. 
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6.2 Experimental 
DFT geometry optimisation calculations on all metal complexes were performed using 
Gaussian 09W.[104] The X-ray coordinates were used where possible as input structures for 
the optimisation calculations. The calculations used B3LYP as the hybrid functional. The 
basis set used was LANL2DZ[92, 105-107] (Los Alamos National Laboratory 2-double-zeta) for 
the metal complexes and the input structures of the propyl-bridged molecule, [Ni(L3)], was 
C2-symmetrised. Infrared spectra were calculated using the same settings as the geometry 
optimisation calculations for the metal chelates. None of the vibrational frequencies found 
were imaginary suggesting that the geometry optimised structures were true minima on the 
potential energy surface. Electronic spectra were calculated using the TD-SCF method 
solving for 20 states. TD-DFT is one of the computationally most efficient and most recent 
methods for calculating electronic spectra with moderate to good accuracy. The electronic 
spectra were also set to include solvation, with a dielectric constant of 38 Debye to represent 
DMF. The HOMO and LUMO of each were calculated for each molecule. The results of all 
the DFT calculations were analysed using GaussView version 5.0.9.[108] All the Gaussian job 
files are available in Appendix E. 
 
6.3 DFT Calculations of Metal Chelates 
6.3.1 Geometry Optimisations 
These calculations were used to determine the lowest-energy, optimised structure for each of 
the nickel(II) chelates. The calculated structures were then compared to the experimental X-
ray structures. Note that the in vacuo calculated structures are not affected by intermolecular 
forces as would be the case in the X-ray structures. Despite numerous attempts, the 
optimisations of the polynuclear metal chelates failed to converge and therefore have not 
been included in this Chapter. The root mean square deviations for the calculated and 
experimental structures were determined using Discovery Studio Visualiser to measure their 
similarity. Shown in Figure 6.5 is the overlay of the X-ray structure (orange) and the 
calculated structure (blue) with the least-squares fit similarity coefficient.  
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Figure 6.5: Overlay of the X-ray structure (orange) and DFT-optimised structure (blue) 
of [Ni(L3)], similarity coefficient = 0.990. 
 
The overlay similarity is measured as a fraction between 0 and 1 and so the similarity 
coefficient for [Ni(L3)] is very favourable consistent with a high similarity between the 
calculated and X-ray structures. The slight changes seen are attributed to the unchelated 
phenyl rings. The free phenyl rings have greater rotational freedom and so can be easily 
distorted from the lowest-energy conformation to allow for more efficient packing of the 
molecule in the lattice and minimization of unfavourable intermolecular interactions. The 
bond lengths and bond angles calculated also differ in comparison to the experimentally 
determined values. The calculated bond lengths are slightly larger than those experimentally 
determined; however, the percentage differences are still quite low. The bond lengths and 
bond angles of the DFT calculated and X-ray structures are shown in Table 6.4. 
 
Table 6.4: Comparison of selected bond lengths (Å) and angles (°) of the calculated and 
experimental structure of [Ni(L3)]. 
Bond  Expt. (Å) Calc. (Å) % Diff Bond Expt. (°) Calc. (°) % Diff 
N1-Ni 1.882(2) 1.922 -2.1 N1-Ni-N2 92.76(8) 93.06 -0.3 
N2-Ni 1.883(2) 1.922 -2.1 N1-Ni-O1 93.21(7) 91.32 2.0 
O1-Ni 1.834(2) 1.863 -1.6 N2-Ni-O3 92.37(7) 91.32 1.1 
O3-Ni 1.849(1) 1.863 -0.8 O1-Ni-O3 82.75(6) 85.04 -2.8 
*Atom numbers are those of the X-ray structure (Figure 5.6.24). 
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These bond lengths and bond angles show that the coordination sphere of the metal has been 
well modelled. This is expected as coordination to the metal centre reduces the number of 
degrees of freedom of the ligand. The present structural data indicate that the DFT 
calculations at the chosen level of theory suffice to provide an excellent model of the 
experimental structure against which additional electronic structure information may be 
reliably determined. 
 
Tunring our attention to the structure of [Ni(L2)], as there are two separate [Ni(L2)] molecules 
in the asymmetric unit, the calculated lowest-energy structure was determined by arbitrarily 
selecting molecule A from the crystal structure of the complex. This is due to the two 
molecules being enantiomers of each other and therefore the fit of A will not be optimised to 
the twist in the di(azomethine) linkage of molecule B. Figure 6.6 shows an overlay of the 
DFT calculated and experimental structures of molecule A in [Ni(L2)]. 
 
 
Figure 6.6: Overlay of the X-ray structure of molecule A (orange) and DFT optimised 
structure (blue) of [Ni(L2)], overlay similarity coefficient = 0.982. 
 
As would be expected, the overlay similarity of molecule B with this optimised structure is 
0.789, which is much lower than that for molecule A, 0.982. The phenyl groups adopt only 
slight variations in their orientations in the gas phase DFT-calculated structures to those seen 
in the X-ray structures as the latter are affected by nonbonded contacts in the crystal lattice. 
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Table 6.5 is a comparison of the calculated and observed bond lengths and bond angles for 
molecule A of [Ni(L2)].  
 
Table 6.5: Comparison of selected bond lengths (Å) and angles (°) of the calculated and 
experimental structure of [Ni(L2)]. 
Bond length 
(Å) 
Expt. Calc. % Diff 
Bond angle  
(°) 
Expt. Calc. % Diff 
N1A-NiA 1.905(4) 1.933 -1.5 N1A-NiA-N2A 95.14(2) 94.75 0.4 
N2A-NiA 1.895(3) 1.933 -2.0 N1A-NiA-O2A 91.75(1) 91.91 -0.2 
O2A-NiA 1.846(3) 1.860 -0.8 N2A-NiA-O3A 92.16(1) 91.77 0.4 
O3A-NiA 1.835(3) 1.860 -1.4 O2A-NiA-O3A 82.89(1) 83.46 -0.7 
*Atom numbers are those of the X-ray structure (Figure 5.6.16). 
 
The bond lengths are slightly longer in the calculated structures than in the X-ray structures, 
whereas the bond angles of the chelated atoms compare quite favourably. Again, the 
similarity in the bond lengths and bond angles at the chosen level of theory has sufficed to 
provide excellent modelling of the coordination sphere of the metal as would be expected 
against which additional structure information may be reliably determined. 
  
6.3.2 Electronic Transition Calculations 
The results of the TD-DFT electronic transition energy calculations were compared with the 
experimental UV-visible spectra of each metal chelate. Overall, the calculated and 
experimental data for the nickel chelates are in reasonably close agreement. Overlays of the 
calculated and experimental UV-visible spectra of [Ni(L3)] and [Ni(L2)] are shown in 
Figures 6.7 and 6.9, respectively. The energy calculations also provide further information 
regarding which orbitals are likely involved in the transitions that give rise to the spectra. 
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Figure 6.7: Overlay of the calculated and experimental UV-visible spectra of [Ni(L3)]. 
 
Figure 6.7 shows that the calculated spectrum is not a perfect reflection of the experimentally 
obtained spectrum. The calculated spectrum shown in Figure 6.7 is a result of a mixture of 
electronic transitions, and not solely a HOMO→LUMO transition. The transitions 
responsible for the peaks in the spectra have been listed and assigned below in Table 6.6. 
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Table 6.6: Experimental and calculated electronic transitions for [Ni(L3)]. 




















390.4 HOMO→LUMO π→π* 0.0863 
 
Figure 6.8 is a reference for the Cartesian axes used to assign the molecular orbitals of 
[Ni(L3)] and Figure 6.9 illustrates the orbitals that are involved in the transitions responsible 
for the UV-vis spectrum of [Ni(L3)]. The HOMO is an admixture of a ligand π-symmetry 
molecular orbital (MO) with the 3dxy atomic orbital of the metal ion. The substituent phenyl 
groups of the ligands are not part of the MO and the bonding electron pair is therefore 
localised in the xy plane over the framework of the metal and chelating Schiff base ligand. 
The unoccupied 3dyz atomic orbital is mixed with a ligand π* MO (LUMO+1 and LUMO+2) 
and some wavefunction amplitude is observed on the peripheral or substituent phenyl rings. 
Note that because the z- and y- vectors of the Cartesian axis system do not lie along the Ni-N 
bonds, the atomic orbital labelled 3dyz has its lobes pointing along the Ni-N bond vectors and 
is thus akin to the 3dx2-y2 orbital in a conventional coordination complex with the x- and y- 
axes colinear with the relevant metal-ligand bond vectors. The remaining orbitals with π-
symmetry are admixtures of ligand π MOs and the 3dxz MO. Interestingly, the LUMO is an 
almost pure ligand π* MO with a negligible contribution from the metal. 
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Figure 6.8: Cartesian axes of [Ni(L3)]. 
 
Based on the qualitative descriptions of the orbitals involved in the electronic transitions of 
the complex, the assignment of the MLCT band at ca. 407 nm in the experimental spectrum 
(390.4 nm in the calculated spectrum) of [Ni(L3)] is correct as this transition is between the 
HOMO and LUMO. Since the former MO has appreciable metal character (3dxy) and the 
latter virtually pure ligand π* character, the transition is correctly assigned as a charge 
(electron) transfer from a metal-based MO to a ligand-based MO. 
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Figure 6.9: Frontier molecular orbitals of [Ni(L3)] involved in the UV-visible electronic 




LUMO+ J LUMO+2 
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Figure 6.10: Overlay of the calculated and experimental UV-visible spectra for [Ni(L2)]. 
 
In Figure 6.10 the similarity of the two spectra is clearly visible. The calculated spectrum 
shown in Figure 6.10 is not the result of HOMO and LUMO transitions only. It involves 
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Table 6.7: Experimental and calculated electronic transitions for [Ni(L2)]. 





















391.0 HOMO→LUMO π→π* 0.0850 
 
The Cartesian axes of [Ni(L2)] are shown in Figure 6.11. The orbitals responsible for the 
transitions in the UV-vis spectrum of [Ni(L2)] are shown in Figure 6.12. The HOMO in 
[Ni(L2)] is an admixture of the 3dxz metal ion atomic orbital with a ligand π-symmetry MO. 
As was the case in [Ni(L3)], the substituent phenyl groups of the ligands are not part of the 
MO. This implies the bonding electron pair is therefore localised in the xz plane over the 
framework of the metal and chelating Schiff base ligand. The ligand π* MO is mixed with a 
unoccupied 3dxy atomic orbital on the metal ion (LUMO+2) and very little wavefunction 
amplitude is observed on the peripheral or substituent phenyl rings. Note that because the x- 
and y- vectors of the Cartesian axis system do not lie along the Ni-N bonds, the atomic orbital 
labelled 3dxy has its lobes pointing along the Ni-N bond vectors. The remaining orbitals with 
π-symmetry are admixtures of ligand π MOs and the 3dyz MO on the metal ion. As was noted 
for [Ni(L3)], the LUMO is an almost pure ligand π* MO with a negligible contribution from 
the metal. 
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Figure 6.11: Cartesian axes of [Ni(L2)]. 
 
The assignment of the MLCT band at ca. 404 nm in the experimental spectrum (391.0 nm in 
the calculated spectrum) of [Ni(L2)] is confirmed as this transition is between the HOMO and 
LUMO. Since HOMO has appreciable metal character (3dxz) and the LUMO virtually pure 
ligand π* character, the transition is correctly assigned as a charge (electron) transfer from a 
metal-based MO to a ligand-based MO.  
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Figure 6.12: Frontier molecular orbitals of [Ni(L2)] involved in the UV-visible electronic 
transitions of the metal complex. 
 
The NBO 3d atomic orbital energies for the two nickel(II) chelates and their electron 
populations are given below in Table 6.8. 
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Figure 6.13: Comparative Ni(II) 3d orbital energy level diagram. 
 
Figure 6.13 reflects the changes in the Cartesian axes between the molecules plus the 
perturbations on the d-orbital energies from the different ligand conformations and structures. 
It shows clearly that the addition of two methyl groups onto the bridge of the ligand has a 
significant influence over the ligand conformation. The dyz, dx2-y2 and dxz orbitals have all 
been lowered in energy by the methyl group addition, whereas the dxy and dz2 orbitals have 
increased in energy.  
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Table 6.8: NBO 3d atomic orbital energies and electron populations of [Ni(L2)] and 
[Ni(L3)]. 
 [Ni(L2)] [Ni(L3)] 
 Population Energy (eV) Population Energy (eV) 





 1.99 -8.67 1.96 -7.13 
dxz 1.99 -7.39 1.95 -7.30 
dxy 0.790 -5.17 1.99 -7.34 
dz
2
 1.95 -6.65 1.97 -8.14 
 
In the study done by Trujillo et al.[95] a theoretical investigation of the electronic spectra was 
done through TDDFT calculations for complexes C and D. They found a good agreement 
between the experimental and theoretical data, however, the long wavelength bands were 
found to be red-shifted and the corresponding short wavelength bands were found to be blue-
shifted. The study assigned the red-shift of the complexes to the TDDFT calculations 
underestimating the low-lying excitation energies associated with charge transfer. The blue-
shift was said to be due to the overestimation of the energy of the excited states as TDDFT 
does not account for electronic relaxation effects. Despite these shortcomings, TDDFT is 
nevertheless useful for identification of low-lying charge transfer and higher-lying π-π* states 
for such transition metal complexes. 
 
6.3.3 Infrared Calculations 
The vibrational frequencies are calculated not only for comparison with actual infrared 
spectra, but also to determine if the optimised structure is a minimum energy structure on the 
potential energy surface. The calculated and experimental spectra were compared visually on 
the same axis system. Figure 6.14 shows the overlayed spectra of [Ni(L3)]. 
 
Page | 130  
 
 
Figure 6.14: Overlay of the calculated and experimental frequency data for [Ni(L3)]. 
 
The spectra of [Ni(L3)] show some similarities, however, the relative intensities of the peaks 
in the calculated spectrum do not correlate well with the experimental spectrum. The ν(O-H) 
peak is a good estimation, although the region is broadened by the presence of water 
molecules in the crystals used. A comparison of the experimental and calculated data for 
[Ni(L3)] and [Ni(L2)] are shown in Table 6.9. 
 
The overlay of the experimentally determined infrared spectrum of [Ni(L2)] and the DFT 
calculated spectrum is shown in Figure 6.15.  
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Figure 6.15: Overlay of the calculated and experimental frequency data for [Ni(L2)]. 
 
The spectra do show a similarity with an improvement in the correlation of the intensities of 
the peaks. This may be due to the two conformers present in the solid-state structure. The 
ν(O-H) peak is much smaller than the estimated one and this region is broadened by the 
presence of water molecules in the crystals. 
 
A plot of the experimental frequencies versus the calculated frequencies was done for the  
O-H, C=N and C-O stretches. If the error between the experimental and calculated 
frequencies was systematic the slope of this graph could be used to correct for these errors. 
This proved true for only the imine stretches and the plot is given below in Figure 6.16. An 
interesting feature to note is that there are two imine stretches in the DFT calculated data and 
this is due to the left hand imine giving a different peak to the right hand imine. 
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Figure 6.16: Plot of experimental frequency versus calculated frequency for the imine 
C=N stretching vibrations of both nickel(II) chelates. 
 
By using the calculated slope and y-intercept the function of the plotted graph can be used to 
determine the experimental frequency using the calculated, or vice versa. 
 
Experimental frequency = 0.973 x calculated frequency + 50.0 cm-1 
 
Table 6.9 is a comparison of the regions of interest in the compounds. Although the 
experimental and calculated frequencies were not exact the percentage differences were 
reasonably low allowing for a satisfactory comparison. 
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Expt. Calc. % Diff Expt. Calc. % Diff 
ν(O-H) 3620.83 3701.40 -2.2 3631.41 3705.81 -2.0 
 3620.83 3701.22 -2.2 3574.60 3701.22 -3.5 
ν(C=N)  1608.05  1616.25 1605.19 0.7 
 1605.19 1605.34 -0.0  1592.88  
 1579.69 1566.29 0.8 1561.24 1559.55 0.1 
  1563.99   1553.92  
ν(C-O)  1333.05   1237.48  
  1330.14   1232.83  
 1233.95 1225.10 0.7 1220.47 1227.92 -0.6 
  1223.99  1190.33 1171.98 1.5 
 1177.12 1165.17 1.0 1164.02 1163.78 0.0 
 1166.62 1163.41 0.3  1147.47  
 




As the correlations between the calculated and experimental data were reasonably good it is 
clear from this study that the use of the B3LYP/LAND2DZ level of theory was adequate for  
calculating molecular structures, IR frequencies, and electronic excitation energies for 
[Ni(L3)] and [Ni(L2)]. A particularly interesting result is that a small change in the 
substitution pattern of the alkyl chain linking the imine groups of the ligands was capable of 
substantially affecting the conformation and symmetry of the metal chelates. This had a 
significant impact on the d-orbital energy level sequence for each complex and also lead to 
notable differences in the electronic spectra of the two complexes. 
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7. Biological Studies 
7.1 Introduction 
Biological studies are a key objective of most drug discovery research programs. In most 
cases, biological studies involve an initial screening of the synthesised ligands and chelates 
against their intended targets to determine their half maximal inhibitory concentration (IC50). 
In this particular instance the focus was on bleomycin type anti-cancer agents and therefore 
one of the synthesised ligands and five metal complexes were sent to AuTek Biomed’s 
Advanced Material Division at Mintek for cancer screening in the final stages of the project.  
 
It is in a scientist’s best interest to design a compound with specific structural features and 
pharmacological effects.[109] Humans have been practicing biological screening as far back as 
can be documented by treating disease with a variety of natural products. This was a trial and 
error method of discovery. These plant materials could possibly have one or more active 
components. Over the years scientists have researched these compounds to determine the 
relationship between these naturally occurring materials and the diseases they are used to 
treat. Biological screening could date back as far as Shen Nong (2737 B.C. to 2697 B.C.), 
who tested hundreds of plants for use as medicines.[109] Biological and chemical methods can 
be combined to elucidate structure and mechanisms that lead to single compounds being 
synthesised for therapeutics. Modern drug screening techniques include animal testing, 
electronic and optical instruments, behaviour observation, mathematical modelling and cell 
cultures.[109] These screening methods allow for further modifications to be made on the 
drugs screened in order for improvements to be made to optimise a drug’s toxicity and to 
reveal major side-effects to allow for them to be reduced.[109]  
 
Due to copper being a biologically active metal, it is naturally found in all living organisms 
and is vital to their functioning, for example in redox chemistry and growth.[110] Our specific 
interest in copper complexes is due to their potential uses in medicines, for example as 
anticancer agents.[111] There are many examples of copper complexes with good anti-tumour 
activities.[110-111] Many of these compounds contain Schiff base type ligands.[110-111] 
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Gokhale et al.[112] synthesised two Schiff base ligands and chelated them to copper(II) for 
anti-cancer testing; [Cu(N1-(2-acetylpyridine)pyridine-2-carboxamidrazone)Cl2] (1) and 
[Cu(N1-(2-acetylthiophene)pyridine-2-carboxamidrazone) (2).[112] Only one cell line was 
tested, mouse melanomal cell line B16F10. Compound (1) is shown in Figure 7.1. 
 
Figure 7.1: Structure of [Cu(N1-(2-acetylpyridine)pyridine-2-carboxamidrazone)Cl2]. 
 
These compounds were studied by Gokhale et al.[112] and it was found that the ligands would 
slow cell proliferation whereas the copper compounds would halt cell proliferation altogether. 
Gokhale et al.[112] suggested that result indicated that chelation of the copper(II) ion was 
facilitating intracellular transportation which resulted in the estrogen receptor blocking which 
was suggested by Predki and Sarkar[113]. The copper(II) chelate shown in Figure 7.1 was the 
more potent of the two compounds having an IC50 of 6.8 µM whereas (2) was found to be 
>10 µM.  
 
Hindo et al.[114] synthesised three copper(II) complexes, two of which had a 1:1 stoichiometry 
of copper(II) to ligand respectively and the third had a 1:2 stoichiometry. These complexes 
are illustrated in Figure 7.2. 
 
Figure 7.2: Structures of copper(II) complexes of 2,4-diiodo-6-((pyridine-2-ylmethyl 
amino)methyl)phenol redrawn from Hindo et al.[114] 
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Hindo et al.[114] found that [Cu(L1)Cl] and [Cu(L1)OAc] showed effective proteasome-
inhibitory activity. The following explanation was put forward as viable. The active species 
of these compounds could be either [Cu(L1)]+ or solvated versions of this, [Cu(L1)(H2O)]
+ or 
[Cu(L1)(H2O)2]
+. This active form could then bind a threonine amino-terminal residue of the 
chymotryptic active centre in 20S proteasome. They based this theory on known lactacystin, 
ester, epoxyketone, peptide derivative and boronate mechanisms. The IC50 values of these 
compounds against human leukemia Jurkat T cells were found to be low with [Cu(L1)Cl] as 
3.82 ± 0.01 µM, [Cu(L1)OAc] as 4.46 ± 0.01 µM and [Cu(HL1)(L1)OAc] as  
3.98 ± 0.01 µM. Therefore, this could become a potential novel route to anti-cancer therapy 
via metal-based proteasome inhibition.  
 
Primik et al.[115] synthesised six indolo[3,2-c]quinolines modified at the lactam unit and 
chelated these ligands to copper(II) (Figure 7.3). These compounds were then tested against 
three human cancer cell lines; non-small lung (A549), ovarian cancer (CH1), and human 
colon adenocarcinoma (SW480). The results of these tests are given in Table 7.1.  
 
 
Figure 7.3: Modified indolo[3,2-c]quinolines redrawn from Primik et al.[115] 
 
A549 is a more chemoresistant cell line and this is reflected in the tenfold difference between 
the IC50 values of this cell line and the other two tested. Primik et al.
[115] found the tested 
compounds showed almost no change when substitution occurs at R2. However, substitution 
of a methyl group on R1 resulted in the decrease of the IC50 values across the cell lines. The 
mechanism of action; DNA-intercalation and DNA-cleavage potency for these compounds 
are being investigated further.  
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Table 7.1: IC50 values of the modified indolo[3,2-c]quinolines copper(II) chelates.
[115] 
 IC50 (µM) 
 A549 CH1 SW480 Average  
1a 1.72 ± 0.03 0.40 ± 0.07 1.3 ± 0.1 1.1 ± 0.07 
1b 0.18 ± 0.04 0.030 ± 0.005 0.024 ± 0.001 0.078 ± 0.015 
2a 1.7 ± 0.1 0.33 ± 0.07 0.75 ± 0.04 0.93 ± 0.07 
2b 0.14 ± 0.01 0.026 ± 0.006 0.024 ± 0.002 0.063 ± 0.006 
3a 1.4 ± 0.3 0.41 ± 0.05 0.64 ± 0.11 0.82 ± 0.15 
3b 0.23 ± 0.01 0.065 ± 0.012 0.049 ± 0.003 0.11 ± 0.008 
4a 1.6 ± 0.1 0.36 ± 0.03 0.47 ± 0.03 0.81 ± 0.05 
4b 0.20 ± 0.03 0.052 ± 0.008 0.032 ± 0.004 0.28 ± 0.01 
 
The aims of this chapter are to test the compounds synthesised in this work against four 
cancer cell lines in order to determine their efficacy as anti-cancer agents. A comparison of 
ligands and metal compounds will be made, as well as a comparison of the copper(II) 
chelates and the nickel(II) chelates. Finally, a further comparison of the IC50 values will be 
done against known commercial anti-cancer drugs and other copper(II) compounds found in 
the literature.   
 
7.2 Experimental 
The procedure followed by Mintek was as follows: 
 
Day one: Cells were trypsinised and distributed in a flat-bottomed 96 well plate to have a 
final concentration of 2 x 105 cells/mL and left to adhere overnight.  
Day two: The compounds were administered at a final starting concentration of 100 μM per 
well with subsequent serial dilutions (eight in total).  
Day four: (72 hours after compound administration), Celltiter One Solution (MTS, Promega, 
USA) was added and a reading taken after a good colour change was observed. 
Concentrations were duplicated per plate and experiments were repeated three times.  
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Finally, sigmoidal curves were fitted to the results using Origin 6.1[116] to calculate the IC50 
value. 
 
The tumour cell lines that the compounds were screened against were non-small lung (A549), 
human prostate (Du145), human colon adenocarcinoma (HT-29) and a central nervous 
system (CNS) cell line (U251).  
 
7.3 Results and Discussion 
The screening showed that several of the compounds successfully inhibited tumour cell 
growth to varying extents. The results are shown in Table 7.2. The IC50 values (inoculation 
concentration) give a measure of the cytotoxicity of the compounds. It is the concentration of 
the compound required to terminate 50% of the tumour cell population, or the compound 
concentration that leads to a 0% overall growth rate. 
 
 
Table 7.2: Tabulation of the half maximal inhibitory concentrations. 
Compound 
IC50 (µM) 
A549 Du145 HT-29 U251 Mean IC50 
H2L
2 >50 >50 >50 >50 >50 
[Cu3(L
2)2Cl2(DMF)2] 3.7 (± 0.8) 12 (± 4) 6.0 (± 1.4) 2.8 (± 0.3) 6.1 (± 1.6) 
[Ni(L2)] >50 >50 >50 >50 >50 
[Cu3(L
3)2(H2O)2]Cl2 5.6 (± 0.8) 5.2 (± 0.6) 8.9 (± 1.0) 8.0 (± 1.0) 6.9 (± 0.85) 
[Ni(L3)] 29 (± 4) 21 (± 6) 50 (± 3) 39 (± 3) 35 (± 16) 
[Cu2(L
1)(OAc)(DMF)] 20 (± 2) 31 (± 6) >50 >50 38 (± 2) 
Cisplatin* 4.0 5.0 10 2.5 5.4 
5-Fluorouracil* 0.20 0.40 0.16 1.0 0.44 
Etoposide* 4.0 1.3 40 4.0 12 
Bleomycin sulphate* 0.63 4.0 16 0.63 5.3 
*Note that no error data was supplied by the http://dtp.nci.nih.gov/ for these compounds. 
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Figure 7.4: Comparison of the –log IC50 values for all compounds averaged across the 
cell lines. 
 
Table 7.2 and Figure 7.4 clearly show only two compounds, [Cu3(L
2)2Cl2(DMF)2] and 
[Cu3(L
3)2(H2O)2]Cl2, induce significant inhibitory effects (< 10 µM). However, another 
significant feature is that the copper compounds show a better activity than the free ligand 
and nickel(II) analogues. The exception is [Cu2(L
1)(OAc)(DMF)] against the human colon 
adenocarcinoma (HT-29) and central nervous system cancer (U251) cell lines. Since the 
nickel(II) ion does not produce hydroxyl radicals in solution, the enhanced activity of the 
copper(II) chelates suggests that hydroxyl radical generation may contribute to the 
mechanism of action of the compounds. This can be further confirmed by looking at the 
literature.[117] For instance, a transition metal ion such as Fe(III) and oxygen are two essential 
components for bleomycin’s action.[117] The metal forms the active complex and oxygen is 
essential for hydroxyl radical formation. One of the most important in vitro copper redox 
reactions is that of the Haber Weiss reaction type.[118] It has also been determined that 
copper(I) salts will produce hydroxyl radicals with a greater rate constant than that of iron(II) 
salts.[119] This is pertinent as copper(II) is reduced in the bleomycin type reactions to 
copper(I) as per the Haber-Weiss reaction[44] in order to become active and bleomycin is 
naturally found to use iron(II) as its metal of chelation[32]. Hydroxyl radicals are highly 
reactive and will thus react with almost every type of molecule found in a living system, for 
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example DNA bases, phospholipids and amino acids.[119] This type of reactivity would follow 
the mode of action of bleomycin suggested by Chen and Stubbe[32].  
 
These results also show that for a compound that generates hydroxyl radicals, having two or 
three copper(II) ions is evidently advantageous and favours more efficient generation of the 
cytotoxic agent. It would appear that the trinuclear copper(II) complexes are rather efficient 
hydroxyl radical generators and it could be expected that at least two of the three copper 
centres generate hydroxyl radicals simultaneously. This theory could prove highly significant 
and could possibly be proven by the synthesis of a methoxy derivative of the ligand and 
chelating it to copper(II) to possibly force a mononuclear complex for comparison in 
cytotoxicity. This is discussed further in the future work section of this work.  
 
A few commercially available chemotherapeutic agents have been chosen to compare with 
the compounds synthesised and tested in this work. These compounds are cisplatin,  
5-fluorouracil, vinblastine sulfate, etoposide and bleomycin. The IC50 values of each 
compound have been tabulated in Table 7.2 for simplicity; however, each compound’s 
average –log IC50 value has been graphically compared to the most active compound 
synthesised in this work, [Cu3(L
2)2Cl2(DMF)2], for ease of comparison in the discussion. 
Figure 7.5 shows the structure of cisplatin, 5-fluorouracil, etoposide and bleomycin. 
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Figure 7.5: Structures of some commercially available chemotherapeutic agents. 
 
A natural starting point is cisplatin, the most commonly known anti-cancer treatment. 
Cisplatin has been in use clinically since 1971[120] and has been used for treating a wide range 
of cancers, the most important of these being testicular and ovarian cancer.[120] Ciplatin is an 
alkylating agent and is available only as an infusion intravenously and not as a tablet.[121] 
Unfortunately, it has become less useful due to its toxicity and the formation of resistance to 
its action.  
 
5-Fluorouracil is used in a variety of cancer treatments, a few being breast cancer, ovarian 
cancer, colon and rectal cancer.[121] 5-Fluorouracil is an anti-metabolite and is available as an 
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injection, infusion and topical ointment. 5-Fluorouracil has severe side effects in people with 
heart problems. 
 
Etoposide is a made from the mandrake plant and is used in chemotherapy for a variety of 
cancers, a few being Hodgkin’s and non-Hodgkin’s lymphoma, testicular, prostate, lung and 
uterine cancer. Etoposide can be given as an infusion or in tablet form. If the compound 
escapes from the vein during treatment, tissue damage and blistering occurs.[121] Etoposide 
also increases the chances of other secondary cancers developing as it can cause severe DNA 
damage.[122] This is a good example of the fact that ultra high cytotoxicity is not always 
desirable. In many instances these high activity compounds have more side effects and 
damage non-cancerous tissue and in extreme cases can cause secondary tumours. This is one 
of the reasons cisplatin has remained in clinical use for so long, even though it is not as 
effective as a drug such as etoposide, since it offers a good balance between toxicity towards 
tumour cells and relatively unlethal side-effects for the patient. Thus having a lower toxicity 
than these commercial compounds (e.g. the present trinuclear copper complexes) is not 
necessarily problematic. Moderately cytotoxic compounds have a chemotherapeutic role in 
the longer term provided that non-specific cytotoxicity due to their mode of action as radical 
generators is not generally problematic. 
 
Bleomycin is an anti-tumour antibiotic which is used in chemotherapy against squamous cell 
cancers, melanoma, sarcoma, Hodgkin’s and non-Hodgkin’s lymphoma, pleural effusion and 
most successfully, testicular cancer.[121] Its comparison is of importance as the compounds 
screened in this project are bleomycin analogues. It can be given as an injection, infusion or 
as an interpleural injection. There is no tablet form of bleomycin. Most patients will suffer 
from hair loss and skin reactions. Bleomycin can cause vascular effects such as heart attack 
or stroke.[121] 
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Figure 7.6: Comparison of –log IC50 values of [Cu3(L
2)2Cl2(DMF)2], cisplatin, 
5-fluorouracil, etoposide and bleomycin. 
 
Figure 7.6 illustrates the averages of these compounds across the same four cell lines. The 
data illustrates that [Cu3(L
2)2Cl2(DMF)2] compares well with the literature compounds. Note 
that no standard error data was supplied for the literature compounds by the National Cancer 
Institute (http://dtp.nci.nih.gov/). It has a similar potency to that of 5-fluorouracil and 
bleomycin sulphate with these compounds only having one-fold increased cytotoxicity. 
[Cu3(L
2)2Cl2(DMF)2] shows a slightly higher averaged potency than that of etoposide, 6.1 
µM versus 12 µM. These results show promise that the trinuclear copper(II) complexes may 
be useful as anti-cancer agents and should possibly be sent for further testing.  
 
Shown in Figure 7.7 is a graph of the literature copper(II) complexes (Figure 7.3) discussed 
in section 7.1  versus the most active copper(II) complex synthesised in this work, 
[Cu3(L
2)2Cl2(DMF)2]. The data compared are not completely equivalent as the cell lines used 
in each compound varies, however, for a basic comparison the data provided was utilised. 
Figure 7.7 illustrates the average of [Cu3(L
2)2Cl2(DMF)2]  across four cell lines (A549, 
Du145, HT-29, U251); (1) was tested against mouse melanomal cell line B16F10;  
[Cu(L1)Cl], [Cu(L1)OAc] and [Cu(HL1)(L1)OAc] against human leukemia Jurkat T and 
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compounds 1a-4b were averaged against the three human cancer cell lines; non-small lung 




Figure 7.7: Comparison of [Cu3(L
2)2Cl2(DMF)2] and literature copper(II) chelates. 
 
The cytotoxicity of the copper(II) chelate synthesised in this work compares favourably with 
the copper(II) chelates synthesised by Gokhale et al.[112] and Hindo et al.[114]. The IC50 values 
are very similar for these compounds however, all the compounds synthesised by Primik et 
al.[115] are much more cytotoxic than [Cu3(L
2)2Cl2(DMF)2]. Compounds 1a, 2a, 3a and 4a 
showed on average a seven-fold  increase in cytotoxicity, whereas compounds 1b, 2b, 3b and 
4b had an average of 63 times higher cytotoxicity. This does not take away from the fact that 
the copper(II) compounds of this work may be good candidates for further research as was 
mentioned before as lower cytotoxicity may mean fewer side effects as non-specific 
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7.4 Conclusions 
As was expected the ligand showed no efficacy with an average IC50 value of  >50 µM across 
all four cell lines. The nickel(II) compounds synthesised in this work were not successful in 
producing significant IC50 values to be considered for further testing or development for anti-
cancer treatment. This reflects the fact that they are redox inactive and unlikely to generate 
hydroxyl radicals. [Ni(L2)] had an average IC50 value of  >50 µM and [Ni(L
3)] had an 
average IC50 value of 35(± 4) µM across all four cell lines. The copper(II) complexes show a 
low enough IC50 value to be considered for further development and testing in anti-cancer 
treatment. [Cu3(L
2)2Cl2(DMF)2] has the lowest average IC50 value of the copper(II) chelates, 
6.1(± 1.6) µM, followed by [Cu3(L
3)2(H2O)2]Cl2 with 6.9(± 0.85) µM. A favourable 
comparison was made between the most active trinuclear copper(II) chelate and the literature 
compounds which further reinforces the need for development and further testing of these 
copper(II) chelates. 
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8. Future Work 
8.1 Future Compounds 
In a study done by Routier et al. [123] on metal salen complexes, a hydroxyl group was added 
at various positions on the ligands to study the effect on DNA cleavage. It was found that the 
cleavage activities of the compounds were dependent on the position of the hydroxyl group. 
The most effective of the three was the para isomer and then the ortho isomer; the meta 
isomer was found to be inactive (ortho, meta and para refer to the relative positions of the 
two hydroxyl groups of the ligands). If this logic is to be followed, the hydroxyl group on the 
ligand structures studied here could be rotated and the effect studied both structurally by X-
ray diffraction and biologically through tumour cell cytotoxicity screening. The structures 
synthesised in this project have the hydroxyl positioned in the meta position which, according 
to the study done by Routier et al. [123], would be a deactivating position. Proposed structures 
are shown in Figure 8.1. 
 
 
Figure 8.1: Proposed structure for hydroxyl group position rotations to the ortho and 
para positions. 
 
A proposed synthesis for the starting material for use in the ligand synthesis is shown below 
in Figure 8.2. The synthesis is a three step reaction.[124] A Grignard reaction allows for the 
addition of the benzene ring to the benzaldehyde for the backbone of the ligands. An alcohol 
oxidation or Jones oxidation[125] to reform the carbonyl group; and finally, a methoxy 
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deprotection to form the dihyroxybenzophenone ligand system. Both 2,3-dimethoxy 
benzaldehyde[126] (ortho) and 2,5-dimethoxybenzaldehyde[127] (para) starting materials are 
readily available from Sigma-Aldrich. Once these products are formed the condensation 




Figure 8.2: Proposed synthesis of the ortho and para dimethyoxybenzophenones. 
 
As these compounds are bleomycin analogues, their interaction with DNA must be studied. 
Due to solubility issues, titrations to determine the interaction of the compounds with DNA 
were not possible in the present thesis and so future work could be focused on increasing 
solubility of these compounds in solvents such as water. This will allow DNA binding studies 
to be conducted using UV-vis spectroscopy to follow the interaction. One such way would be 
to add an imidazole group, which would not only increase solubility but also permit an 
enhanced electrostatic interaction with DNA. The positive charge given by the imidazolium 
group would be attracted to the negative charge of the phosphate backbone in DNA; this 
allows for optimal positioning of the phenyl groups for intercalation. This concept was shown 
in a study on a non-Schiff base Cu(II) complex done by Pamatong et al. [1] where the ligand 
structure was designed specifically with a positively charged ammonium group to interact 
with the DNA backbone. The efficiency of the compounds was attributed to both the 
aromatic regions and the cationic ammonium group on the molecule. Shown in Figure 8.3 is 
a proposed structure for the inclusion of an imidazole functional group in the ligand. 
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Figure 8.3: Proposed structure highlighting the inclusion of an imidazole functional 
group to the compounds synthesised in this project. 
 
A proposed synthetic route for addition of imidazole is shown in Figure 8.5. To synthesise 
the ligand for the proposed structure, the 1,3-diamino-2-hydroxypropane must be di-tert-butyl 
dicarbonate protected. This is easily synthesised by the addition of di-tert-butyl dicarbonate 
to the diamine as shown in Figure 8.4. A biphasic mixture of potassium hydroxide and 
dichloromethane (DCM) is used to deprotonate the hydroxyl group in the presence of the 
imidazole and thus the SN2 reaction will occur allowing for the formation of the stable ether 
derivative. The amine groups can then be deprotected and reacted as normal with the 
benzophenone. At pH 7 the imidazole group will be present predominantly as its imidazolium 
form and give the cationic derivative necessary for DNA interaction. 
 
 
Figure 8.4: Protection of amine groups with t-Boc. 
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Figure 8.5: Synthetic route for addition of an imidazole group. 
 
Biotin tagging of compounds is becoming popular in targeted drug design research as it is 
believed to be a way to target cancer cells.[128-129] Cancer cells are rapidly proliferating and so 
therefore require more of certain vitamins. Biotin is one of those vitamins as it is used in 
growth and development of cells.[128-129] The biotin tag can be synthetically attached using the 
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same synthetic route followed in Figure 8.4 and Figure 8.5 using a commercially available 
biotinylation agent. The biotinylation agent and product are shown in Figure 8.6. 
 
 
Figure 8.6: Biotinylation agent and product for biotin tagging. 
  
However, it has been suggested that this method of cell targeting has its limitations. Two 
examples of such limitations[129] would be minimal drug delivery and one drug molecule per 
biotin molecule. And the latter is problematic as these biotin-drug molecules are small 
enough to be excreted by the kidney and reabsorbed in proximal tubules which could lead to 
to accumulation in the kidney which could be toxic. Therefore research has widened to 
include biotin polymeric carrier systems. One such system is that of dendrimers. Dendrimers 
are three dimensional macromolecules that can enclose hydrophobic molecules in a cavity 
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while the exterior can be altered to enhance solubility.[128] Yang et al. [128] and Yellepeddi et 
al. [129] studied polyamidoamine (PAMAM) dendrimers. Yellepeddi et al. [129] found that by 
biotin tagging the PAMAM dendrimer, it increased the intake of the dendrimer by human 
ovarian cancer cells by 12% with respect to human embryonic kidney cells. Yang et al. [128] 
also found that by biotin tagging the dendrimer, it increased its uptake. This would be a 
preferable method to use for the compounds synthesised in this project as they have been 
found to be hydrophobic. Figure 8.7 is an illustration of the conjugation of a PAMAM 
dendrimer to biotin as suggested by Yellepeddi et al. [129]. 
 
 
Figure 8.7: Conjugation of biotin to a PAMAM dendrimer.  
  
These examples show a few of the possible directions this research could take. Some of these 
changes could potentially transform the metal chelates from moderately cytotoxic compounds 
to more powerful ones. 
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An alternative ligand prepared from 2,4-dimethoxybenzaldehyde (commercially available 
from Sigma-Aldrich[130]) may prevent the formation of a trinuclear copper(II) complex and 
allow the synthesis of the mononuclear complex shown in Figure 8.8. This chelate could be 
evaluated in a manner similar to that of the analogous trinuclear complex and a comparison 




Figure 8.8: Methylated mononuclear copper(II) compound. 
 
A key advantage of the structure shown in Figure 8.8 is that not only would formation of 
trinuclear species be thwarted by the methoxy groups, but the complex carries a +2 charge 
and would thus be a highly soluble complex capable of electrostatically targeting the anionic 
poly(phosphate) backbone of dsDNA. 
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9 Conclusions 
The aim of the project was to synthesise a range of novel complexes that were bleomycin 
analogues with the intention of evaluating them as anti-cancer agents. The intention was to 
mimic the mode of action of bleomycin in order to cleave double-stranded DNA. Three novel 
ligands were synthesised and characterised, two of these were studied by X-ray diffraction. 
Using these three ligands, six metal complexes were synthesised and characterised - by 
NMR, IR, EPR/ESR and UV/visible spectroscopy as well as single crystal X-ray 
crystallography. Six of these complexes were studied by X-ray diffraction.  
 
Both ligands crystallised as zwitterions in monoclinic space groups. This was indicative of 
the imine nitrogen atom being more basic than the hydroxyl group which results in the 
hydroxyl proton migrating to the nitrogen of the imine bond, thus creating a negatively 
charged oxygen atom and a positively charged imine nitrogen atom. The nickel(II) complexes 
adopted the expected square planar coordination geometry (N2O2 donor set) with Ni-N and 
Ni-O average distances of 1.892(3) Å and 1.845(2) Å, respectively. The copper(II) and 
zinc(II) complexes, however, favoured formation of multinuclear complexes via bridging of 
ionised oxygen donor atoms. The mean Cu-N and Cu-O distances were 1.953(3) Å and 
2.082(3) Å, respectively. The averages for the Zn-N and Zn-O distances were 2.074(3) Å and 
2.042(3) Å, respectively. 
 
The ESR data for [Cu3(L
2)2Cl2(DMF)2] and [Cu3(L
3)2(H2O)2]Cl2,  showed two 
antiferromagnetically coupled copper(II) ions which left the third copper(II) as an S = ½ 
centre with hyperfine coupling constant to the I = 3/2 Cu nucleus of ca. 76 G. In DMF 
solution, super-hyperfine coupling (ca. 12 G) was found to occur to two nitrogen atoms 
which is consistent with the donor atom set of the terminal copper(II) centres being the site of 
the unpaired spin density. 
 
Density functional theory was used to calculate the lowest-energy, optimised structure as well 
as the electronic transition and infrared spectra of the mononuclear nickel(II) complexes. The 
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simulations produced structures for [Ni(L2)] and [Ni(L3)] with similarity coefficients of 0.982 
and 0.990, respectively. Both the calculated electronic spectra and the infrared spectra 
compared favourably with the experimental data. 
 
One ligand and the copper(II) and nickel(II) complexes were sent to MINTEK (Project 
AuTEK) for anti-cancer screening. The biological studies of each compound showed a lower 
activity than was expected, however this leaves room for further structure-based design 
modifications. The trinuclear copper(II) complexes, [Cu3(L
2)2Cl2(DMF)2] and 
[Cu3(L
3)2(H2O)2]Cl2, the bleomycin analogues that are capable of generating hydroxyl 
radicals, had IC50 values of 6(2) and 7(1) mM, respectively. The complexes [Ni(L
2)] and 
[Ni(L3)] were comparatively inactive with mean IC50 values of >50 and 35(16) mM, 
respectively. This is consistent with the fact that they do not readily generate reactive oxygen 
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Appendix A: NMR Spectra 
 
Figure A.1: 1H NMR spectrum of H3L
1 in DMSO-d6. 
 
 
Figure A.2: 1H NMR spectrum of H2L
3 in DMSO-d6. 
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Figure A.3: 1H NMR spectrum of [Ni(L3)] in DMSO-d6. 
 
 
Figure A.4: 13C NMR spectrum of H3L
1 in DMSO-d6. 
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Figure A.5: 13C NMR spectrum of H2L
2 in DMSO-d6. 
 
 
Figure A.6: 13C NMR spectrum of H2L
3 in DMSO-d6. 
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Figure A.7: 13C NMR spectrum of [Ni(L2)] in DMSO-d6. 
 
 
Figure A.8: 13C NMR spectrum of [Ni(L3)] in DMSO-d6. 
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Appendix B: UV-vis Spectra 
 
Figure B.1: UV-vis spectrum of H3L1 in DMF at 298 K. 
 
 
Figure B.2: UV-vis spectrum of [Cu2(L
1)(OAc)(DMF)] in DMF at 298 K. 
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Figure B.3: UV-vis spectrum of [Cu3(L
2)2Cl2(DMF)2] in DMF at 298 K. 
 
 





Page | 169  
 
Appendix C: Infrared Spectra 
 




Figure C.2: Infrared spectrum of [Cu2(L
1)(OAc)(DMF)]. 
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Figure C.3: Infrared spectrum of [Ni(L2)]. 
 
 
Figure C.4: Infrared spectrum of H2L
3. 
 
Page | 171  
 
 




Figure C.6: Infrared spectrum of [Ni(L3)]. 
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Figure C.7: Infrared spectrum of [Zn2(L
3)2]. 
 
Page | 173  
 
Appendix D: Crystallographic data 
Table D.1: Crystal data and structure refinement for H3L
1. 
Identification code jdp_oh_bzph 












Unit cell dimensions a = 12.631(5) Å α = 90° 
 b = 15.619(5) Å β = 92.792(5)° 
 c = 14.201(5) Å γ = 90° 
Volume 2798.3(17) Å3  
Z 4  
Density (calculated) 1.319 Mg/m3  
Absorption coefficient 0.092 mm-1  
F(000) 1176  
Crystal size 0.40 × 0.40 × 0.30 mm3 
Theta range for data collection 2.87 to 28.79°  
Index ranges -16 ≤ h ≤ 16, -19 ≤ k ≤ 18, -18 ≤ l ≤ 18 
Reflections collected 11679  
Independent reflections 6293 [R(int) = 0.0487]  
Absorption correction Semi-empirical from equivalents 
Max. and min. Transmission 0.9730 and 0.9642  
Refinement method Full-matrix least-squares on F2 
Data/ restraints/ parameters 6293 / 4 / 397 
Goodness-of-fit on F2 0.879  
Final R indices [I>2sigma(I)] R1 = 0.0532, wR2 = 0.1233 
R indices (all data) R1 = 0.1053, wR2 = 0.1404 
Largest diff. Peak and hole 0.262 and -0.199 e.Å-3  
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Table D.2: Crystal data and structure refinement for H2L
2. 
Identification code jdp_0408ni 












Unit cell dimensions a = 9.0140(2) Å α = 90° 
 b = 21.4340(4) Å β = 103.2280(10)°  
 c = 13.6800(2) Å γ = 90° 
Volume 2572.93(8) Å3  
Z 4  
Density (calculated) 1.277 Mg/m3  
Absorption coefficient 0.085 mm-1  
F(000) 1048  
Crystal size 0.21 × 0.09 × 0.08 mm3 
Theta range for data collection 1.90 to 28.28°  
Index ranges -11 ≤ h ≤ 12, -28 ≤ k ≤ 27, -17 ≤ l ≤ 18 
Reflections collected 24513  
Independent reflections 6342 [R(int) = 0.0483]  
Absorption correction Semi-empirical from equivalents 
Max. and min. Transmission 0.9933 and 0.9824  
Refinement method Full-matrix least-squares on F2 
Data/ restraints/ parameters 6342 / 0 / 352  
Goodness-of-fit on F2 1.044  
Final R indices [I>2sigma(I)] R1 = 0.0466, wR2 = 0.1091 
R indices (all data) R1 = 0.0637, wR2 = 0.1160 
Largest diff. Peak and hole 0.277 and -0.237 e.Å-3  
Page | 175  
 
 Table D.3: Crystal data and structure refinement for [Cu2(L
1)(OAc)(DMF)].  
Identification code Benz_cu_crystal2_100k 












Unit cell dimensions a = 9.014(5) Å α = 90° 
 b = 14.696(5) Å β = 92.625(5) ° 
 c = 28.716(5) Å γ = 90° 
Volume 3800(3) Å  
Z 4  
Density (calculated) 1.291 Mg/m3  
Absorption coefficient 1.167 mm-1  
F(000) 1520  
Crystal size 0.40 × 0.35 × 0.30 mm3 
Theta range for data collection 2.84 to 28.71°  
Index ranges -12 ≤ h ≤ 10, 0 ≤ k ≤ 18, -9 ≤ l ≤ 38 
Reflections collected 8506  
Independent reflections 8506 [R(int) = 0.0000]  
Absorption correction Semi-empirical from equivalents 
Max. and min. Transmission 0.7209 and 0.6524  
Refinement method Full-matrix least-squares on F2 
Data/ restraints/ parameters 8506 / 81 / 429  
Goodness-of-fit on F2 0.926  
Final R indices [I>2sigma(I)] R1 = 0505, wR2 = 0.1408 
R indices (all data) R1 = 0.0701, wR2 = 0.1513 
Largest diff. Peak and hole 0.768 and -0.567 e.Å-3  
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Table D.4: Crystal data and structure refinement for [Cu3(L
2)2Cl2(DMF)2].  
Identification code 0408cu_t52_sqz 












Unit cell dimensions a = 10.7378(4) Å α = 87.018(3)° 
 b = 15.8005(6) Å β = 79.714(4)° 
 c = 22.1628(10) Å γ = 81.185(3)° 
Volume 3654.9(3) Å3  
Z 6  
Density (calculated) 1.133 Mg/m3  
Absorption coefficient 0.984 mm-1  
F(000) 1282  
Crystal size 0.30 × 0.20 × 0.10 mm3 
Theta range for data collection 2.79 to 26.06°  
Index ranges -12 ≤ h ≤13, -19 ≤ k 19, 0 ≤ l ≤ 27 
Reflections collected 14347  
Independent reflections 14347 [R(int) = 0.0000] 
Absorption correction Semi-empirical from equivalents 
Max. and min. Transmission 0.9080 and 0.7567 
Refinement method Full-matrix least-squares on F2 
Data/ restraints/ parameters 14347 / 0 / 724  
Goodness-of-fit on F2 0.822  
Final R indices [I>2sigma(I)] R1 = 0.0493, wR2 = 0.1119 
R indices (all data) R1 = 0.0821, wR2 = 0.1181 
Largest diff. Peak and hole 1.864 and -0.801 e.Å-3  
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Table D.5: Crystal data and structure refinement for [Ni(L2)].  
Identification code 0408ni 












Unit cell dimensions a =25.0542(13) Å α = 90° 
 b = 9.6539(5) Å β = 98.568(5)° 
 c = 27.3083(13) Å γ = 90° 
Volume 6531.4(6) Å3  
Z 8  
Density (calculated) 1.121 Mg/m3  
Absorption coefficient 0.626 mm-1  
F(000) 2304  
Crystal size 0.60 × 0.20 × 0.03 mm3 
Theta range for data collection 2.95 to 26.06°  
Index ranges -30 ≤ h ≤ 29, -11 ≤ k ≤ 10, -33 ≤ l ≤ 33 
Reflections collected 46899  
Independent reflections 12840 [R(int) = 0.053]  
Absorption correction Semi-empirical from equivalents 
Max. and min. Transmission 0.9815 and 0.7050  
Refinement method Full-matrix least-squares on F2 
Data/ restraints/ parameters 12840 / 0 / 693  
Goodness-of-fit on F2 0.794  
Final R indices [I>2sigma(I)] R1 = 0.0603, wR2 = 0.1237 
R indices (all data) R1 = 0.1403, wR2 = 0.1395 
Largest diff. Peak and hole 0.396 and -0.386 e.Å-3  
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Table D.6: Crystal data and structure refinement for [Cu3(L
3)2(H2O)2]Cl2.  
Identification code mo_om_jdp_cu_propyl_data3_0m 












Unit cell dimensions a = 9.1151(4) Å α = 90° 
 b = 25.6003(11) Å β = 100.219(3)° 
 c = 11.5667(6) Å γ = 90° 
Volume 2656.3(2) Å3  
Z 4  
Density (calculated) 1.534 Mg/m3  
Absorption coefficient 1.355 mm-1  
F(000) 1258  
Crystal size 0.20 × 0.07 × 0.01 mm3 
Theta range for data collection 1.59 to 26.37°  
Index ranges -11 ≤ h ≤ 11, -32 ≤ k ≤ 31, -6 ≤ l ≤ 14 
Reflections collected 16963  
Independent reflections 4761 [R(int) = 0.0206]  
Absorption correction Semi-empirical from equivalents 
Max. and min. Transmission 0.9866 and 0.7733  
Refinement method Full-matrix least-squares on F2 
Data/ restraints/ parameters 4761 / 234 / 357  
Goodness-of-fit on F2 1.174  
Final R indices [I>2sigma(I)] R1 = 0.0437, wR2 = 0.0963 
R indices (all data) R1 = 0.0495, wR2 = 0.0986 
Largest diff. Peak and hole 1.155 and -0.418 e.Å-3  
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Table D.7: Crystal data and structure refinement for [Ni(L3)].  
Identification code jdp_2610ni 












Unit cell dimensions a = 24.261(2) Å α = 90° 
 b = 9.0890(8) Å β = 111.1090(10)° 
 c = 26.956(2) Å γ = 90° 
Volume 5545.2(8) Å3  
Z 8  
Density (calculated) 1.340 Mg/m3  
Absorption coefficient 0.744 mm-1  
F(000) 2336  
Crystal size 0.19 × 0.16 × 0.06 mm3 
Theta range for data collection 1.94 to 28.27°  
Index ranges -31 ≤ h ≤ 29, 0 ≤ k ≤ 12, 0 ≤ l ≤ 35 
Reflections collected 6502  
Independent reflections 6502 [R(int) = 0.0000]  
Absorption correction Semi-empirical from equivalents 
Max. and min. Transmission 0.9568 and 0.8656  
Refinement method Full-matrix least-squares on F2 
Data/ restraints/ parameters 6502 / 4 / 361  
Goodness-of-fit on F2 1.056  
Final R indices [I>2sigma(I)] R1 = 0.0377, wR2 = 0.0938 
R indices (all data) R1 = 0.0484, wR2 = 0.0981 
Largest diff. Peak and hole 0.360 and -0.269 e.Å-3  
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Table D.8: Crystal data and structure refinement for [Zn2(L
3)2].  
Identification code jdp_zn2610 












Unit cell dimensions a = 23.1020(3) Å α = 90° 
 b = 18.1100(3) Å β = 90° 
 c = 16.6460(3) Å γ = 90° 
Volume 6964.31(19) Å3  
Z 4  
Density (calculated) 1.011 Mg/m3  
Absorption coefficient 0.733 mm-1  
F(000) 2192  
Crystal size 0.25 × 0.15 × 0.15 mm3 
Theta range for data collection 1.88 to 28.27°  
Index ranges -30 ≤ h ≤ 28, -19 ≤ k ≤ 24, -15 ≤ l ≤ 22 
Reflections collected 35623  
Independent reflections 13618 [R(int) = 0.0533] 
Absorption correction Semi-empirical from equivalents 
Max. and min. Transmission 0.8981 and 0.8380  
Refinement method Full-matrix least-squares on F2 
Data/ restraints/ parameters 13618 / 1 / 654  
Goodness-of-fit on F2 0.838  
Final R indices [I>2sigma(I)] R1 = 0.0484, wR2 = 0.1089 
R indices (all data) R1 = 0.0630, wR2 = 0.1156 
Largest diff. Peak and hole 0.406 and -0.361 e.Å-3  
 
checkCIF/PLATON report (basic structural check) 
No syntax errors found.                               CIF dictionary 
Please wait while processing ....                     Interpreting this report 
Datablock: benz_cu_crystal2_100k 
 
Bond precision: C-C = 0.0067 A Wavelength=0.71073 
Cell: a=9.014(5) b=14.696(5) c=28.716(5) 
 
alpha=90 beta=92.625(5) gamma=90 




Volume 3800(3) 3800(3) 
Space group P 21/n P 1 21/n 1 
Hall group -P 2yn -P 2yn 
Moiety formula C34 H33 Cu2 N3 O8 C34 H33 Cu2 N3 O8 
Sum formula C34 H33 Cu2 N3 O8 C34 H33 Cu2 N3 O8 
Mr 738.73 738.71 
Dx,g cm-3 1.291 1.291 
Z 4 4 
Mu (mm-1) 1.167 1.167 
F000 1520.0 1520.0 
F000' 1523.15 
 
h,k,lmax 12,19,38 12,18,38 
Nref 9830 8506 
Tmin,Tmax 0.633,0.705 0.652,0.721 
Tmin' 0.621 
 
Correction method= MULTI-SCAN 
 
Data completeness= 0.865 Theta(max)= 28.710 
R(reflections)= 0.0505( 5761) 
wR2(reflections)= 0.1513( 
8506) 
S = 0.926 Npar= 429 
 
The following ALERTS were generated. Each ALERT has the format 
       test-name_ALERT_alert-type_alert-level. 
Click on the hyperlinks for more details of the test. 
 
Alert level B 
PLAT220_ALERT_2_B Large Non-Solvent    C     Ueq(max)/Ueq(min) 
...        4.9 Ratio 
PLAT241_ALERT_2_B Check High      Ueq as Compared to Neighbors 
for        C13      
PLAT420_ALERT_2_B D-H Without Acceptor       O4     -   H4     ...          
?       
 
Despite isotropic restraints for one phenyl and one phenoxide 
group of the ligand, thermal motion was high for one half of 
the molecule consistent with positional disorder. The data 
were not of high enough quality to refine the data with two 
contributing conformations to the electron density. Further, 
one DMF and at least one water molecule were disordered in a 
solvent-filled void in the ASU. The electron density for the 
disordered solvent was removed using PLATON’s SQUEEZE 
algorithm. This is why O4-H4 has no H-bond partner. We have 
done the best we can with a fundamentally bad crystal. 
 
Alert level C 
PLAT213_ALERT_2_C Atom C13             has ADP max/min Ratio .....        
3.7 prola 
PLAT213_ALERT_2_C Atom C14             has ADP max/min Ratio .....        
3.4 prola 
PLAT213_ALERT_2_C Atom C24             has ADP max/min Ratio .....        
3.1 prola 
PLAT213_ALERT_2_C Atom C25             has ADP max/min Ratio .....        
3.2 prola 
PLAT213_ALERT_2_C Atom C26             has ADP max/min Ratio .....        
3.4 prola 
PLAT213_ALERT_2_C Atom C27             has ADP max/min Ratio .....        
3.6 prola 
PLAT222_ALERT_3_C Large Non-Solvent    H    Uiso(max)/Uiso(min) 
..        4.6 Ratio 
PLAT241_ALERT_2_C Check High      Ueq as Compared to Neighbors 
for        C14      
PLAT241_ALERT_2_C Check High      Ueq as Compared to Neighbors 
for        C27      
PLAT250_ALERT_2_C Large U3/U1 Ratio for Average U(i,j) Tensor ....        
2.9       
PLAT341_ALERT_3_C Low Bond Precision on  C-C Bonds ...............     
0.0067 Ang   
 
Alert level G 
PLAT003_ALERT_2_G Number of Uiso or Uij Restrained Atom Sites 
....         10       
PLAT005_ALERT_5_G No _iucr_refine_instructions_details  in the CIF          
? 
PLAT007_ALERT_5_G Note: Number of Unrefined D-H Atoms 
............          2       
PLAT128_ALERT_4_G Alternate Setting of Space-group P21/c   .......      
P21/n       
PLAT153_ALERT_1_G The su's on the Cell Axes   are Equal ..........    
0.00500 Ang.  
PLAT232_ALERT_2_G Hirshfeld Test Diff (M-X)  Cu1    --  O8      ..        
5.6 su    
PLAT605_ALERT_4_G Structure Contains Solvent Accessible VOIDS of 
.        414 A**3  
PLAT793_ALERT_4_G The Model has Chirality at C9      (Verify) ....          
R       
PLAT860_ALERT_3_G Note: Number of Least-Squares Restraints 
.......         81       
PLAT869_ALERT_4_G ALERTS Related to the use of SQUEEZE 
Suppressed           ! 
 
   0 ALERT level A = Most likely a serious problem - resolve or 
explain 
   3 ALERT level B = A potentially serious problem, consider 
carefully 
  11 ALERT level C = Check. Ensure it is not caused by an omission 
or oversight 
  10 ALERT level G = General information/check it is not something 
unexpected 
 
   1 ALERT type 1 CIF construction/syntax error, inconsistent or 
missing data 
  14 ALERT type 2 Indicator that the structure model may be wrong 
or deficient 
   3 ALERT type 3 Indicator that the structure quality may be low 
   4 ALERT type 4 Improvement, methodology, query or suggestion 
   2 ALERT type 5 Informative message, check 
 
 
It is advisable to attempt to resolve as many as possible of the alerts in all 
categories. Often the minor alerts point to easily fixed oversights, errors and 
omissions in your CIF or refinement strategy, so attention to these fine 
details can be worthwhile. In order to resolve some of the more serious 
problems it may be necessary to carry out additional measurements or 
structure refinements. However, the purpose of your study may justify the 
reported deviations and the more serious of these should normally be 
commented upon in the discussion or experimental section of a paper or in 
the "special_details" fields of the CIF. checkCIF was carefully designed to 
identify outliers and unusual parameters, but every test has its limitations 
and alerts that are not important in a particular case may appear. 
Conversely, the absence of alerts does not guarantee there are no aspects of 
the results needing attention. It is up to the individual to critically assess 
their own results and, if necessary, seek expert advice. 
Publication of your CIF in IUCr journals 
A basic structural check has been run on your CIF. These basic checks will 
be run on all CIFs submitted for publication in IUCr journals (Acta 
Crystallographica, Journal of Applied Crystallography, Journal of Synchrotron 
Radiation); however, if you intend to submit toActa Crystallographica 
Section C or E, you should make sure that full publication checksare run on 
the final version of your CIF prior to submission. 
Publication of your CIF in other journals 
Please refer to the Notes for Authors of the relevant journal for any special 
instructions relating to CIF submission. 
 
PLATON version of 05/11/2012; check.def file version of 05/11/2012 
Datablock benz_cu_crystal2_100k - ellipsoid plot 
 
 
Download CIF editor (publCIF) from the IUCr  
Download CIF editor (enCIFer) from the CCDC  
Test a new CIF entry 
checkCIF/PLATON report (basic structural check) 
No syntax errors found.                               CIF dictionary 
Please wait while processing ....                     Interpreting this report 
Datablock: 0408cu_t52_sqz 
 
Bond precision: C-C = 0.0061 A Wavelength=0.71073 
Cell: a=10.7378(4) b=15.8005(6) c=22.1628(10) 
 
alpha=87.018(3) beta=79.714(4) gamma=81.185(3) 




Volume 3654.9(3) 3654.9(3) 
Space group P -1 P-1 
Hall group -P 1 ? 
Moiety formula C62 H56 Cl2 Cu3 N4 O8 ? 
Sum formula C62 H56 Cl2 Cu3 N4 O8 
C20.67 H18.67 Cl0.67 Cu N1.33 
O2.67 
Mr 1246.66 415.54 
Dx,g cm-3 1.133 1.133 
Z 2 6 
Mu (mm-1) 0.984 0.984 
F000 1282.0 1282.0 
F000' 1284.93 
 
h,k,lmax 13,19,27 13,19,27 
Nref 14463 14347 
Tmin,Tmax 0.790,0.906 0.757,0.908 
Tmin' 0.744 
 
Correction method= MULTI-SCAN 
 
Data completeness= 0.992 Theta(max)= 26.060 
R(reflections)= 0.0493( 7809) wR2(reflections)= 0.1181( 14347) 
S = 0.822 Npar= 724 
 
The following ALERTS were generated. Each ALERT has the format 
       test-name_ALERT_alert-type_alert-level. 
Click on the hyperlinks for more details of the test. 
 
Alert level B 
PLAT420_ALERT_2_B D-H Without Acceptor       O3A    -   H3A    ...          ?       
PLAT420_ALERT_2_B D-H Without Acceptor       O3B    -   H3B    ...          ?       
PLAT420_ALERT_2_B D-H Without Acceptor       O4A    -   H4A    ...          ?       
PLAT420_ALERT_2_B D-H Without Acceptor       O4B    -   H4B    ...          ?       
 
This alert results from our implementation of PLATON’s SQUEEZE 
algorithm to remove difficult to model solvent from the model. From the 
“disordered” electron density three DMF molecules and 4 or 5 water 
molecules exist in the ASU. The alert may be ignored. 
 
Alert level C 
PLAT094_ALERT_2_C Ratio of Maximum / Minimum Residual Density ....       
2.33       
PLAT220_ALERT_2_C Large Non-Solvent    C     Ueq(max)/Ueq(min) ...        3.1 
Ratio 
PLAT341_ALERT_3_C Low Bond Precision on  C-C Bonds ...............     0.0061 
Ang   
 
Alert level G 
CELLZ01_ALERT_1_G Difference between formula and atom_site contents 
detected. 
CELLZ01_ALERT_1_G ALERT: check formula stoichiometry or atom site 
occupancies. 
           From the CIF: _cell_formula_units_Z    6 
           From the CIF: _chemical_formula_sum  C20.67 H18.67 Cl0.67 Cu N1.33 
O2 
           TEST: Compare cell contents of formula and atom_site data 
 
           atom    Z*formula  cif sites diff 
           C        124.02    124.00    0.02 
           H        112.02    112.00    0.02 
           Cl         4.02      4.00    0.02 
           Cu         6.00      6.00    0.00 
           N          7.98      8.00   -0.02 
           O         16.02     16.00    0.02 
PLAT005_ALERT_5_G No _iucr_refine_instructions_details  in the CIF          ? 
PLAT007_ALERT_5_G Note: Number of Unrefined D-H Atoms ............          4       
PLAT045_ALERT_1_G Calculated and Reported Z Differ by ............       0.33 
Ratio 
PLAT093_ALERT_1_G No su's on H-positions, refinement reported as .      mixed      
PLAT232_ALERT_2_G Hirshfeld Test Diff (M-X)  Cu2    --  N1B     ..        5.4 su    
PLAT606_ALERT_4_G VERY LARGE Solvent Accessible VOID(S) in Structure        
! 
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #         21      
            CU2 -CU1 -CU2 -O2B   -30.00 39.00   2.766   1.555   1.555   1.555   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #         25      
            CU2 -CU1 -CU2 -O1B   121.00 39.00   2.766   1.555   1.555   1.555   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #         30      
            CU2 -CU1 -CU2 -N2B   -57.00 39.00   2.766   1.555   1.555   1.555   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #         35      
            CU2 -CU1 -CU2 -N1B   145.00 39.00   2.766   1.555   1.555   1.555   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #         38      
            O1B -CU1 -O1B -C1B     7.00  0.00   2.766   1.555   1.555   1.555   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #         43      
            O1B -CU1 -O1B -CU2     9.00  0.00   2.766   1.555   1.555   1.555   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #         52      
            O2B -CU1 -O2B -C31B   29.00 23.00   2.766   1.555   1.555   1.555   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #         57      
            O2B -CU1 -O2B -CU2  -167.00 23.00   2.766   1.555   1.555   1.555   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #        172      
            C31A-O2A -CU4 -O2A   120.00 30.00   1.555   1.555   1.555   2.575   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #        173      
            CU3 -O2A -CU4 -O2A   -25.00 30.00   1.555   1.555   1.555   2.575   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #        187      
            CU3 -CU4 -CU3 -O1A  -143.00 11.00   2.575   1.555   1.555   1.555   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #        191      
            CU3 -CU4 -CU3 -O2A     9.00 11.00   2.575   1.555   1.555   1.555   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #        196      
            CU3 -CU4 -CU3 -N1A  -169.00 11.00   2.575   1.555   1.555   1.555   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #        201      
            CU3 -CU4 -CU3 -N2A    32.00 11.00   2.575   1.555   1.555   1.555   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #        202      
            O1A -CU4 -O1A -C1A   -53.90  1.40   2.575   1.555   1.555   1.555   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #        207      
            O1A -CU4 -O1A -CU3   102.10  1.30   2.575   1.555   1.555   1.555   
PLAT720_ALERT_4_G Number of Unusual/Non-Standard Labels ..........          2       
PLAT869_ALERT_4_G ALERTS Related to the use of SQUEEZE Suppressed           
! 
 
   0 ALERT level A = Most likely a serious problem - resolve or explain 
   4 ALERT level B = A potentially serious problem, consider carefully 
   3 ALERT level C = Check. Ensure it is not caused by an omission or oversight 
  26 ALERT level G = General information/check it is not something unexpected 
 
   4 ALERT type 1 CIF construction/syntax error, inconsistent or missing data 
   7 ALERT type 2 Indicator that the structure model may be wrong or deficient 
   1 ALERT type 3 Indicator that the structure quality may be low 
  19 ALERT type 4 Improvement, methodology, query or suggestion 
   2 ALERT type 5 Informative message, check 
 
 
It is advisable to attempt to resolve as many as possible of the alerts in all categories. 
Often the minor alerts point to easily fixed oversights, errors and omissions in your CIF or 
refinement strategy, so attention to these fine details can be worthwhile. In order to 
resolve some of the more serious problems it may be necessary to carry out additional 
measurements or structure refinements. However, the purpose of your study may justify 
the reported deviations and the more serious of these should normally be commented 
upon in the discussion or experimental section of a paper or in the "special_details" fields 
of the CIF. checkCIF was carefully designed to identify outliers and unusual parameters, 
but every test has its limitations and alerts that are not important in a particular case 
may appear. Conversely, the absence of alerts does not guarantee there are no aspects 
of the results needing attention. It is up to the individual to critically assess their own 
results and, if necessary, seek expert advice. 
Publication of your CIF in IUCr journals 
A basic structural check has been run on your CIF. These basic checks will be run on all 
CIFs submitted for publication in IUCr journals (Acta Crystallographica, Journal of Applied 
Crystallography, Journal of Synchrotron Radiation); however, if you intend to submit 
toActa Crystallographica Section C or E, you should make sure that full publication 
checksare run on the final version of your CIF prior to submission. 
Publication of your CIF in other journals 
Please refer to the Notes for Authors of the relevant journal for any special instructions 
relating to CIF submission. 
 
PLATON version of 05/11/2012; check.def file version of 05/11/2012 
Datablock 0408cu_t52_sqz - ellipsoid plot 
 
 
Download CIF editor (publCIF) from the IUCr  
Download CIF editor (enCIFer) from the CCDC  
Test a new CIF entry 
checkCIF/PLATON report (basic structural check) 
No syntax errors found.                               CIF dictionary 
Please wait while processing ....                     Interpreting this report 
Datablock: mo_om_jdp_cu_propyl_data3_0m 
 
Bond precision: C-C = 0.0053 A Wavelength=0.71073 
Cell: a=9.1151(4) b=25.6003(11) c=11.5667(6) 
 
alpha=90 beta=100.219(3) gamma=90 




Volume 2656.3(2) 2656.3(2) 
Space group P 21/c P21/c 
Hall group -P 2ybc ? 
Moiety formula C58 H52 Cu3 N4 O10, 2(Cl) C29 H26 Cl Cu1.50 N2 O5 
Sum formula C58 H52 Cl2 Cu3 N4 O10 C29 H26 Cl Cu1.50 N2 O5 
Mr 1226.59 613.28 
Dx,g cm-3 1.534 1.534 
Z 2 4 
Mu (mm-1) 1.355 1.355 
F000 1258.0 1258.0 
F000' 1260.95 
 
h,k,lmax 11,31,14 11,32,14 
Nref 5440 4761 
Tmin,Tmax 0.892,0.987 0.773,0.987 
Tmin' 0.763 
 
Correction method= MULTI-SCAN 
 
Data completeness= 0.875 Theta(max)= 26.370 
R(reflections)= 0.0437( 4299) 
wR2(reflections)= 0.0986( 
4761) 
S = 1.174 Npar= 357 
 
The following ALERTS were generated. Each ALERT has the format 
       test-name_ALERT_alert-type_alert-level. 
Click on the hyperlinks for more details of the test. 
 
Alert level C 
PLAT094_ALERT_2_C Ratio of Maximum / Minimum Residual Density 
....       2.76       
PLAT220_ALERT_2_C Large Non-Solvent    C     Ueq(max)/Ueq(min) 
...        3.2 Ratio 
 
Alert level G 
PLAT003_ALERT_2_G Number of Uiso or Uij Restrained Atom Sites 
....         39       
PLAT005_ALERT_5_G No _iucr_refine_instructions_details  in the CIF          
? 
PLAT007_ALERT_5_G Note: Number of Unrefined D-H Atoms 
............          2       
PLAT042_ALERT_1_G Calc. and Reported MoietyFormula Strings  
Differ          ? 
PLAT045_ALERT_1_G Calculated and Reported Z Differ by ............       
0.50 Ratio 
PLAT083_ALERT_2_G SHELXL Second Parameter in WGHT Unusually 
Large.       8.56       
PLAT232_ALERT_2_G Hirshfeld Test Diff (M-X)  Cu1    --  O5      ..        
7.3 su    
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... 
#         19      
            O1  -CU1 -CU2 -CU1  -142.00 17.00   1.555   1.555   1.555   
3.667   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... 
#         20      
            O2  -CU1 -CU2 -CU1    72.00 17.00   1.555   1.555   1.555   
3.667   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... 
#         21      
            N1  -CU1 -CU2 -CU1  -116.00 17.00   1.555   1.555   1.555   
3.667   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... 
#         22      
            N2  -CU1 -CU2 -CU1    51.00 17.00   1.555   1.555   1.555   
3.667   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... 
#         23      
            O5  -CU1 -CU2 -CU1   -38.00 17.00   1.555   1.555   1.555   
3.667   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... 
#         24      
            O1  -CU2 -O1  -C1   -162.00 15.00   3.667   1.555   1.555   
1.555   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... 
#         29      
            O1  -CU2 -O1  -CU1    32.00 15.00   3.667   1.555   1.555   
1.555   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... 
#         53      
            O2  -CU2 -O2  -C17    85.00  4.00   3.667   1.555   1.555   
1.555   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... 
#         58      
            O2  -CU2 -O2  -CU1  -124.00  4.00   3.667   1.555   1.555   
1.555   
PLAT860_ALERT_3_G Note: Number of Least-Squares Restraints 
.......        234       
 
   0 ALERT level A = Most likely a serious problem - resolve or 
explain 
   0 ALERT level B = A potentially serious problem, consider 
carefully 
   2 ALERT level C = Check. Ensure it is not caused by an omission 
or oversight 
  17 ALERT level G = General information/check it is not something 
unexpected 
 
   2 ALERT type 1 CIF construction/syntax error, inconsistent or 
missing data 
   5 ALERT type 2 Indicator that the structure model may be wrong or 
deficient 
   1 ALERT type 3 Indicator that the structure quality may be low 
   9 ALERT type 4 Improvement, methodology, query or suggestion 
   2 ALERT type 5 Informative message, check 
 
 
It is advisable to attempt to resolve as many as possible of the alerts in all 
categories. Often the minor alerts point to easily fixed oversights, errors and 
omissions in your CIF or refinement strategy, so attention to these fine 
details can be worthwhile. In order to resolve some of the more serious 
problems it may be necessary to carry out additional measurements or 
structure refinements. However, the purpose of your study may justify the 
reported deviations and the more serious of these should normally be 
commented upon in the discussion or experimental section of a paper or in 
the "special_details" fields of the CIF. checkCIF was carefully designed to 
identify outliers and unusual parameters, but every test has its limitations 
and alerts that are not important in a particular case may appear. 
Conversely, the absence of alerts does not guarantee there are no aspects of 
the results needing attention. It is up to the individual to critically assess 
their own results and, if necessary, seek expert advice. 
Publication of your CIF in IUCr journals 
A basic structural check has been run on your CIF. These basic checks will 
be run on all CIFs submitted for publication in IUCr journals (Acta 
Crystallographica, Journal of Applied Crystallography, Journal of Synchrotron 
Radiation); however, if you intend to submit toActa Crystallographica 
Section C or E, you should make sure that full publication checksare run on 
the final version of your CIF prior to submission. 
Publication of your CIF in other journals 
Please refer to the Notes for Authors of the relevant journal for any special 
instructions relating to CIF submission. 
 
PLATON version of 05/11/2012; check.def file version of 05/11/2012 




Download CIF editor (publCIF) from the IUCr  
Download CIF editor (enCIFer) from the CCDC  
Test a new CIF entry 
checkCIF/PLATON report (basic structural 
check) 
No syntax errors found.                               CIF dictionary 
Please wait while processing ....                     Interpreting this report 
Datablock: jdp_0408ni 
 
Bond precision: C-C = 0.0021 A Wavelength=0.71073 
Cell: a=9.0140(2) b=21.4340(4) c=13.6800(2) 
 
alpha=90 beta=103.228(1) gamma=90 




Volume 2572.93(8) 2572.93(8) 
Space group P 21/c P21/c 
Hall group -P 2ybc -P 2ybc 
Moiety formula C31 H30 N2 O4 C31 H30 N2 O4 
Sum formula C31 H30 N2 O4 C31 H30 N2 O4 
Mr 494.57 494.57 
Dx,g cm-3 1.277 1.277 
Z 4 4 
Mu (mm-1) 0.085 0.085 
F000 1048.0 1048.0 
F000' 1048.47 
 
h,k,lmax 12,28,18 12,28,18 
Nref 6372 6342 
Tmin,Tmax 0.991,0.993 0.982,0.993 
Tmin' 0.982 
 
Correction method= MULTI-SCAN 
 





S = 1.044 Npar= 352 
 
The following ALERTS were generated. Each ALERT has the format 
       test-name_ALERT_alert-type_alert-level. 
Click on the hyperlinks for more details of the test. 
 
Alert level C 
PLAT309_ALERT_2_C Single Bonded Oxygen (C-O .GT. 1.3 Ang) ........         
O1      
PLAT309_ALERT_2_C Single Bonded Oxygen (C-O .GT. 1.3 Ang) ........         
O3      
 
Alert level G 
PLAT005_ALERT_5_G No _iucr_refine_instructions_details  in the CIF          
? 
PLAT180_ALERT_4_G Check Cell Rounding: # of Values Ending with 0 =          
3       
PLAT605_ALERT_4_G Structure Contains Solvent Accessible VOIDS of .         
55 A**3  
PLAT869_ALERT_4_G ALERTS Related to the use of SQUEEZE Suppressed           
! 
 
   0 ALERT level A = Most likely a serious problem - resolve or explain 
   0 ALERT level B = A potentially serious problem, consider carefully 
   2 ALERT level C = Check. Ensure it is not caused by an omission or 
oversight 
   4 ALERT level G = General information/check it is not something 
unexpected 
 
   0 ALERT type 1 CIF construction/syntax error, inconsistent or missing 
data 
   2 ALERT type 2 Indicator that the structure model may be wrong or 
deficient 
   0 ALERT type 3 Indicator that the structure quality may be low 
   3 ALERT type 4 Improvement, methodology, query or suggestion 
   1 ALERT type 5 Informative message, check 
 
 
It is advisable to attempt to resolve as many as possible of the 
alerts in all categories. Often the minor alerts point to easily fixed 
oversights, errors and omissions in your CIF or refinement 
strategy, so attention to these fine details can be worthwhile. In 
order to resolve some of the more serious problems it may be 
necessary to carry out additional measurements or structure 
refinements. However, the purpose of your study may justify the 
reported deviations and the more serious of these should normally 
be commented upon in the discussion or experimental section of a 
paper or in the "special_details" fields of the CIF. checkCIF was 
carefully designed to identify outliers and unusual parameters, but 
every test has its limitations and alerts that are not important in a 
particular case may appear. Conversely, the absence of alerts does 
not guarantee there are no aspects of the results needing 
attention. It is up to the individual to critically assess their own 
results and, if necessary, seek expert advice. 
Publication of your CIF in IUCr journals 
A basic structural check has been run on your CIF. These basic 
checks will be run on all CIFs submitted for publication in IUCr 
journals (Acta Crystallographica, Journal of Applied 
Crystallography, Journal of Synchrotron Radiation); however, if 
you intend to submit toActa Crystallographica Section C or E, you 
should make sure that full publication checksare run on the final 
version of your CIF prior to submission. 
Publication of your CIF in other journals 
Please refer to the Notes for Authors of the relevant journal for any 
special instructions relating to CIF submission. 
 
PLATON version of 05/11/2012; check.def file version of 05/11/2012 
Datablock jdp_0408ni - ellipsoid plot 
 
 
Download CIF editor (publCIF) from the IUCr  
Download CIF editor (enCIFer) from the CCDC  
Test a new CIF entry 
checkCIF/PLATON report (basic structural check) 
No syntax errors found.                               CIF dictionary 
Please wait while processing ....                     Interpreting this report 
Datablock: jdp_oh_bzph 
 
Bond precision: C-C = 0.0031 A Wavelength=0.71073 
Cell: a=12.631(5) b=15.619(5) c=14.201(5) 
 
alpha=90 beta=92.792(5) gamma=90 
Temperature: 296 K 
  
 Calculated Reported 
Volume 2798.3(17) 2798.3(17) 
Space group P 21/n P21/n 
Hall group -P 2yn -P 2yn 
Moiety formula C29 H26 N2 O5, C3 H7 N O C29 H26 N2 O5, C3 H7 N O 
Sum formula C32 H33 N3 O6 C32 H33 N3 O6 
Mr 555.61 555.61 
Dx,g cm-3 1.319 1.319 
Z 4 4 
Mu (mm-1) 0.092 0.092 
F000 1176.0 1176.0 
F000' 1176.56 
 
h,k,lmax 17,21,19 16,19,18 
Nref 7289 6293 
Tmin,Tmax 0.964,0.973 0.964,0.973 
Tmin' 0.964 
 
Correction method= MULTI-SCAN 
 
Data completeness= 0.863 Theta(max)= 28.790 
R(reflections)= 0.0532( 3336) 
wR2(reflections)= 0.1404( 
6293) 
S = 0.879 Npar= 397 
 
The following ALERTS were generated. Each ALERT has the format 
       test-name_ALERT_alert-type_alert-level. 
Click on the hyperlinks for more details of the test. 
 
Alert level B 
PLAT415_ALERT_2_B Short Inter D-H..H-X       H3SA   ..  H5A     ..       1.98 Ang.  
 
NB: this may be ignored as atom H5A belongs to the minor component of the disordered 
hydroxyl group (involving atom O5) on the central carbon of the propyl bridge. The model is 
correct. 
 
Alert level C 
PLAT244_ALERT_4_C Low   'Solvent' Ueq as Compared to Neighbors of         N1S      
PLAT309_ALERT_2_C Single Bonded Oxygen (C-O .GT. 1.3 Ang) ........         O3      
 
Alert level G 
REFLT03_ALERT_1_G ALERT: Expected hkl max differ from CIF values 
           From the CIF: _diffrn_reflns_theta_max           28.79 
           From the CIF: _reflns_number_total               6293 
           From the CIF: _diffrn_reflns_limit_ max hkl   16.   18.   18. 
           From the CIF: _diffrn_reflns_limit_ min hkl  -16.  -19.  -18. 
           TEST1: Expected hkl limits for theta max 
           Calculated maximum hkl   17.   21.   19. 
           Calculated minimum hkl  -17.  -21.  -19. 
PLAT002_ALERT_2_G Number of Distance or Angle Restraints on AtSite          8       
PLAT005_ALERT_5_G No _iucr_refine_instructions_details  in the CIF          ? 
PLAT007_ALERT_5_G Note: Number of Unrefined D-H Atoms ............          2       
PLAT128_ALERT_4_G Alternate Setting of Space-group P21/c   .......      P21/n       
PLAT301_ALERT_3_G Note: Main Residue  Disorder ...................          3 Perc. 
PLAT720_ALERT_4_G Number of Unusual/Non-Standard Labels ..........          6       
PLAT779_ALERT_4_G Suspect or Irrelevant (Bond) Angle in CIF .... #        125      
              O5   -C15  -H15     1.555   1.555   1.555             42.20 Deg.  
PLAT860_ALERT_3_G Note: Number of Least-Squares Restraints .......          4       
PLAT951_ALERT_5_G Reported and Calculated Kmax Values Differ by ..          2       
 
   0 ALERT level A = Most likely a serious problem - resolve or explain 
   1 ALERT level B = A potentially serious problem, consider carefully 
   2 ALERT level C = Check. Ensure it is not caused by an omission or oversight 
  10 ALERT level G = General information/check it is not something unexpected 
 
   1 ALERT type 1 CIF construction/syntax error, inconsistent or missing data 
   3 ALERT type 2 Indicator that the structure model may be wrong or deficient 
   2 ALERT type 3 Indicator that the structure quality may be low 
   4 ALERT type 4 Improvement, methodology, query or suggestion 
   3 ALERT type 5 Informative message, check 
 
 
It is advisable to attempt to resolve as many as possible of the alerts in all 
categories. Often the minor alerts point to easily fixed oversights, errors and 
omissions in your CIF or refinement strategy, so attention to these fine 
details can be worthwhile. In order to resolve some of the more serious 
problems it may be necessary to carry out additional measurements or 
structure refinements. However, the purpose of your study may justify the 
reported deviations and the more serious of these should normally be 
commented upon in the discussion or experimental section of a paper or in 
the "special_details" fields of the CIF. checkCIF was carefully designed to 
identify outliers and unusual parameters, but every test has its limitations 
and alerts that are not important in a particular case may appear. 
Conversely, the absence of alerts does not guarantee there are no aspects of 
the results needing attention. It is up to the individual to critically assess 
their own results and, if necessary, seek expert advice. 
Publication of your CIF in IUCr journals 
A basic structural check has been run on your CIF. These basic checks will 
be run on all CIFs submitted for publication in IUCr journals (Acta 
Crystallographica, Journal of Applied Crystallography, Journal of Synchrotron 
Radiation); however, if you intend to submit toActa Crystallographica 
Section C or E, you should make sure that full publication checksare run on 
the final version of your CIF prior to submission. 
Publication of your CIF in other journals 
Please refer to the Notes for Authors of the relevant journal for any special 
instructions relating to CIF submission. 
 
PLATON version of 05/11/2012; check.def file version of 05/11/2012 
Datablock jdp_oh_bzph - ellipsoid plot 
 
 
Download CIF editor (publCIF) from the IUCr  
Download CIF editor (enCIFer) from the CCDC  
Test a new CIF entry 
checkCIF/PLATON report (basic structural check) 
No syntax errors found.                               CIF dictionary 
Please wait while processing ....                     Interpreting this report 
Datablock: jdp_oh_bzph 
 
Bond precision: C-C = 0.0031 A Wavelength=0.71073 
Cell: a=12.631(5) b=15.619(5) c=14.201(5) 
 
alpha=90 beta=92.792(5) gamma=90 
Temperature: 296 K 
  
 Calculated Reported 
Volume 2798.3(17) 2798.3(17) 
Space group P 21/n P21/n 
Hall group -P 2yn -P 2yn 
Moiety formula C29 H26 N2 O5, C3 H7 N O C29 H26 N2 O5, C3 H7 N O 
Sum formula C32 H33 N3 O6 C32 H33 N3 O6 
Mr 555.61 555.61 
Dx,g cm-3 1.319 1.319 
Z 4 4 
Mu (mm-1) 0.092 0.092 
F000 1176.0 1176.0 
F000' 1176.56 
 
h,k,lmax 17,21,19 16,19,18 
Nref 7289 6293 
Tmin,Tmax 0.964,0.973 0.964,0.973 
Tmin' 0.964 
 
Correction method= MULTI-SCAN 
 
Data completeness= 0.863 Theta(max)= 28.790 
R(reflections)= 0.0532( 3336) 
wR2(reflections)= 0.1404( 
6293) 
S = 0.879 Npar= 397 
 
The following ALERTS were generated. Each ALERT has the format 
       test-name_ALERT_alert-type_alert-level. 
Click on the hyperlinks for more details of the test. 
 
Alert level B 
PLAT415_ALERT_2_B Short Inter D-H..H-X       H3SA   ..  H5A     ..       1.98 Ang.  
 
NB: this may be ignored as atom H5A belongs to the minor component of the disordered 
hydroxyl group (involving atom O5) on the central carbon of the propyl bridge. The model is 
correct. 
 
Alert level C 
PLAT244_ALERT_4_C Low   'Solvent' Ueq as Compared to Neighbors of         N1S      
PLAT309_ALERT_2_C Single Bonded Oxygen (C-O .GT. 1.3 Ang) ........         O3      
 
Alert level G 
REFLT03_ALERT_1_G ALERT: Expected hkl max differ from CIF values 
           From the CIF: _diffrn_reflns_theta_max           28.79 
           From the CIF: _reflns_number_total               6293 
           From the CIF: _diffrn_reflns_limit_ max hkl   16.   18.   18. 
           From the CIF: _diffrn_reflns_limit_ min hkl  -16.  -19.  -18. 
           TEST1: Expected hkl limits for theta max 
           Calculated maximum hkl   17.   21.   19. 
           Calculated minimum hkl  -17.  -21.  -19. 
PLAT002_ALERT_2_G Number of Distance or Angle Restraints on AtSite          8       
PLAT005_ALERT_5_G No _iucr_refine_instructions_details  in the CIF          ? 
PLAT007_ALERT_5_G Note: Number of Unrefined D-H Atoms ............          2       
PLAT128_ALERT_4_G Alternate Setting of Space-group P21/c   .......      P21/n       
PLAT301_ALERT_3_G Note: Main Residue  Disorder ...................          3 Perc. 
PLAT720_ALERT_4_G Number of Unusual/Non-Standard Labels ..........          6       
PLAT779_ALERT_4_G Suspect or Irrelevant (Bond) Angle in CIF .... #        125      
              O5   -C15  -H15     1.555   1.555   1.555             42.20 Deg.  
PLAT860_ALERT_3_G Note: Number of Least-Squares Restraints .......          4       
PLAT951_ALERT_5_G Reported and Calculated Kmax Values Differ by ..          2       
 
   0 ALERT level A = Most likely a serious problem - resolve or explain 
   1 ALERT level B = A potentially serious problem, consider carefully 
   2 ALERT level C = Check. Ensure it is not caused by an omission or oversight 
  10 ALERT level G = General information/check it is not something unexpected 
 
   1 ALERT type 1 CIF construction/syntax error, inconsistent or missing data 
   3 ALERT type 2 Indicator that the structure model may be wrong or deficient 
   2 ALERT type 3 Indicator that the structure quality may be low 
   4 ALERT type 4 Improvement, methodology, query or suggestion 
   3 ALERT type 5 Informative message, check 
 
 
It is advisable to attempt to resolve as many as possible of the alerts in all 
categories. Often the minor alerts point to easily fixed oversights, errors and 
omissions in your CIF or refinement strategy, so attention to these fine 
details can be worthwhile. In order to resolve some of the more serious 
problems it may be necessary to carry out additional measurements or 
structure refinements. However, the purpose of your study may justify the 
reported deviations and the more serious of these should normally be 
commented upon in the discussion or experimental section of a paper or in 
the "special_details" fields of the CIF. checkCIF was carefully designed to 
identify outliers and unusual parameters, but every test has its limitations 
and alerts that are not important in a particular case may appear. 
Conversely, the absence of alerts does not guarantee there are no aspects of 
the results needing attention. It is up to the individual to critically assess 
their own results and, if necessary, seek expert advice. 
Publication of your CIF in IUCr journals 
A basic structural check has been run on your CIF. These basic checks will 
be run on all CIFs submitted for publication in IUCr journals (Acta 
Crystallographica, Journal of Applied Crystallography, Journal of Synchrotron 
Radiation); however, if you intend to submit toActa Crystallographica 
Section C or E, you should make sure that full publication checksare run on 
the final version of your CIF prior to submission. 
Publication of your CIF in other journals 
Please refer to the Notes for Authors of the relevant journal for any special 
instructions relating to CIF submission. 
 
PLATON version of 05/11/2012; check.def file version of 05/11/2012 
Datablock jdp_oh_bzph - ellipsoid plot 
 
 
Download CIF editor (publCIF) from the IUCr  
Download CIF editor (enCIFer) from the CCDC  
Test a new CIF entry 
checkCIF/PLATON report (basic structural check) 
No syntax errors found.                               CIF dictionary 
Please wait while processing ....                     Interpreting this report 
Datablock: 0408ni 
 
Bond precision: C-C = 0.0068 A Wavelength=0.71073 
Cell: a=25.0542(13) b=9.6539(5) c=27.3083(13) 
 
alpha=90 beta=98.568(5) gamma=90 




Volume 6531.4(6) 6531.4(6) 
Space group P 21/c P 1 21/c 1 
Hall group -P 2ybc -P 2ybc 
Moiety formula C31 H28 N2 Ni O4 ? 
Sum formula C31 H28 N2 Ni O4 C31 H28 N2 Ni O4 
Mr 551.24 551.26 
Dx,g cm-3 1.121 1.121 
Z 8 8 
Mu (mm-1) 0.626 0.626 
F000 2304.0 2304.0 
F000' 2307.57 
 
h,k,lmax 30,11,33 30,11,33 
Nref 12895 12840 
Tmin,Tmax 0.861,0.981 0.705,0.982 
Tmin' 0.687 
 
Correction method= MULTI-SCAN 
 
Data completeness= 0.996 Theta(max)= 26.060 
R(reflections)= 0.0603( 5416) 
wR2(reflections)= 0.1395( 
12840) 
S = 0.794 Npar= 693 
 
The following ALERTS were generated. Each ALERT has the format 
       test-name_ALERT_alert-type_alert-level. 
Click on the hyperlinks for more details of the test. 
 
Alert level B 
            Crystal system given = monoclinic 
PLAT420_ALERT_2_B D-H Without Acceptor       O3A    -   H3A    ...          
?       
PLAT420_ALERT_2_B D-H Without Acceptor       O3B    -   H3B    ...          
?       
PLAT420_ALERT_2_B D-H Without Acceptor       O4A    -   H4A    ...          
?       
PLAT420_ALERT_2_B D-H Without Acceptor       O4B    -   H4B    ...          
?       
These may be ignored as the disordered solvent (8 water 
molecules and half a DMF molecule) was removed with 
PLATON’s SQUEEZE algorithm. 
 
Alert level C 
GOODF01_ALERT_2_C  The least squares goodness of fit parameter 
lies 
            outside the range 0.80 <> 2.00 
            Goodness of fit given =      0.794 
RINTA01_ALERT_3_C  The value of Rint is greater than 0.12 
            Rint given   0.123 
PLAT026_ALERT_3_C Ratio Observed / Unique Reflections too Low 
....         42 Perc. 
PLAT220_ALERT_2_C Large Non-Solvent    C     Ueq(max)/Ueq(min) 
...        3.5 Ratio 
PLAT234_ALERT_4_C Large Hirshfeld Difference C15B   --  C16B    ..       
0.17 Ang.  
PLAT241_ALERT_2_C Check High      Ueq as Compared to Neighbors 
for        O1B      
PLAT242_ALERT_2_C Check Low       Ueq as Compared to Neighbors 
for       C15B      
PLAT331_ALERT_2_C Small Average Phenyl   C-C Dist. C20A   -C25A          
1.37 Ang.  
PLAT331_ALERT_2_C Small Average Phenyl   C-C Dist. C20B   -C25B          
1.37 Ang.  
PLAT341_ALERT_3_C Low Bond Precision on  C-C Bonds ...............     
0.0068 Ang   
 
Alert level G 
PLAT005_ALERT_5_G No _iucr_refine_instructions_details  in the CIF          
? 
PLAT007_ALERT_5_G Note: Number of Unrefined D-H Atoms 
............          4       
PLAT093_ALERT_1_G No su's on H-positions, refinement reported as 
.      mixed      
PLAT606_ALERT_4_G VERY LARGE Solvent Accessible VOID(S) in 
Structure        ! 
PLAT720_ALERT_4_G Number of Unusual/Non-Standard Labels 
..........          2       
PLAT869_ALERT_4_G ALERTS Related to the use of SQUEEZE 
Suppressed           ! 
 
   0 ALERT level A = Most likely a serious problem - resolve or 
explain 
   4 ALERT level B = A potentially serious problem, consider 
carefully 
  10 ALERT level C = Check. Ensure it is not caused by an omission 
or oversight 
   6 ALERT level G = General information/check it is not something 
unexpected 
 
   1 ALERT type 1 CIF construction/syntax error, inconsistent or 
missing data 
  10 ALERT type 2 Indicator that the structure model may be wrong 
or deficient 
   3 ALERT type 3 Indicator that the structure quality may be low 
   4 ALERT type 4 Improvement, methodology, query or suggestion 
   2 ALERT type 5 Informative message, check 
 
 
It is advisable to attempt to resolve as many as possible of the alerts in all 
categories. Often the minor alerts point to easily fixed oversights, errors and 
omissions in your CIF or refinement strategy, so attention to these fine 
details can be worthwhile. In order to resolve some of the more serious 
problems it may be necessary to carry out additional measurements or 
structure refinements. However, the purpose of your study may justify the 
reported deviations and the more serious of these should normally be 
commented upon in the discussion or experimental section of a paper or in 
the "special_details" fields of the CIF. checkCIF was carefully designed to 
identify outliers and unusual parameters, but every test has its limitations 
and alerts that are not important in a particular case may appear. 
Conversely, the absence of alerts does not guarantee there are no aspects of 
the results needing attention. It is up to the individual to critically assess 
their own results and, if necessary, seek expert advice. 
Publication of your CIF in IUCr journals 
A basic structural check has been run on your CIF. These basic checks will 
be run on all CIFs submitted for publication in IUCr journals (Acta 
Crystallographica, Journal of Applied Crystallography, Journal of Synchrotron 
Radiation); however, if you intend to submit toActa Crystallographica 
Section C or E, you should make sure that full publication checksare run on 
the final version of your CIF prior to submission. 
Publication of your CIF in other journals 
Please refer to the Notes for Authors of the relevant journal for any special 
instructions relating to CIF submission. 
 
PLATON version of 05/11/2012; check.def file version of 05/11/2012 
Datablock 0408ni - ellipsoid plot 
 
 
Download CIF editor (publCIF) from the IUCr  
Download CIF editor (enCIFer) from the CCDC  
Test a new CIF entry 
checkCIF/PLATON report (basic structural check) 
No syntax errors found.                               CIF dictionary 
Please wait while processing ....                     Interpreting this report 
Datablock: jdp_2610ni 
 
Bond precision: C-C = 0.0029 A Wavelength=0.71073 
Cell: a=24.261(2) b=9.0890(8) c=26.956(2) 
 
alpha=90 beta=111.109(1) gamma=90 




Volume 5545.2(8) 5545.2(8) 
Space group C 2/c C2/c 
Hall group -C 2yc -C 2yc 
Moiety formula C29 H24 N2 Ni O4, 2(H2 O) ? 
Sum formula C29 H28 N2 Ni O6 C29 H28 N2 Ni O6 
Mr 559.22 559.24 
Dx,g cm-3 1.340 1.340 
Z 8 8 
Mu (mm-1) 0.744 0.744 
F000 2336.0 2336.0 
F000' 2339.69 
 
h,k,lmax 32,12,35 31,12,35 
Nref 6879 6502 
Tmin,Tmax 0.868,0.956 0.866,0.957 
Tmin' 0.868 
 
Correction method= MULTI-SCAN 
 
Data completeness= 0.945 Theta(max)= 28.270 
R(reflections)= 0.0377( 5155) 
wR2(reflections)= 0.0981( 
6502) 
S = 1.056 Npar= 361 
 
The following ALERTS were generated. Each ALERT has the format 
       test-name_ALERT_alert-type_alert-level. 
Click on the hyperlinks for more details of the test. 
 
Alert level B 
PLAT420_ALERT_2_B D-H Without Acceptor       O1W    -   H1WA   ...          ?       
PLAT420_ALERT_2_B D-H Without Acceptor       O2W    -   H2WB   ...          ?       
 
This arises because disordered solvent H-bonded to the ordered solvent 
water molecules could not be modeled and had to be removed with 
PLATON’s SQUEEZE algorithm. The alerts may be ignored. 
 
Alert level G 
PLAT002_ALERT_2_G Number of Distance or Angle Restraints on AtSite          6       
PLAT005_ALERT_5_G No _iucr_refine_instructions_details  in the CIF          ? 
PLAT007_ALERT_5_G Note: Number of Unrefined D-H Atoms ............          2       
PLAT605_ALERT_4_G Structure Contains Solvent Accessible VOIDS of .        156 
A**3  
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #          3      
            N2  -NI1 -O1  -C1   -109.40  0.40   1.555   1.555   1.555   1.555   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #          4      
            O1  -NI1 -N2  -C17   -78.80  0.40   1.555   1.555   1.555   1.555   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #          7      
            O1  -NI1 -N2  -C16   100.10  0.40   1.555   1.555   1.555   1.555   
PLAT720_ALERT_4_G Number of Unusual/Non-Standard Labels ..........          4       
PLAT860_ALERT_3_G Note: Number of Least-Squares Restraints .......          4       
PLAT869_ALERT_4_G ALERTS Related to the use of SQUEEZE Suppressed           ! 
 
   0 ALERT level A = Most likely a serious problem - resolve or explain 
   2 ALERT level B = A potentially serious problem, consider carefully 
   0 ALERT level C = Check. Ensure it is not caused by an omission or oversight 
  10 ALERT level G = General information/check it is not something unexpected 
 
   0 ALERT type 1 CIF construction/syntax error, inconsistent or missing data 
   3 ALERT type 2 Indicator that the structure model may be wrong or deficient 
   1 ALERT type 3 Indicator that the structure quality may be low 
   6 ALERT type 4 Improvement, methodology, query or suggestion 
   2 ALERT type 5 Informative message, check 
 
 
It is advisable to attempt to resolve as many as possible of the alerts in all 
categories. Often the minor alerts point to easily fixed oversights, errors and 
omissions in your CIF or refinement strategy, so attention to these fine 
details can be worthwhile. In order to resolve some of the more serious 
problems it may be necessary to carry out additional measurements or 
structure refinements. However, the purpose of your study may justify the 
reported deviations and the more serious of these should normally be 
commented upon in the discussion or experimental section of a paper or in 
the "special_details" fields of the CIF. checkCIF was carefully designed to 
identify outliers and unusual parameters, but every test has its limitations 
and alerts that are not important in a particular case may appear. 
Conversely, the absence of alerts does not guarantee there are no aspects of 
the results needing attention. It is up to the individual to critically assess 
their own results and, if necessary, seek expert advice. 
Publication of your CIF in IUCr journals 
A basic structural check has been run on your CIF. These basic checks will 
be run on all CIFs submitted for publication in IUCr journals (Acta 
Crystallographica, Journal of Applied Crystallography, Journal of Synchrotron 
Radiation); however, if you intend to submit toActa Crystallographica 
Section C or E, you should make sure that full publication checksare run on 
the final version of your CIF prior to submission. 
Publication of your CIF in other journals 
Please refer to the Notes for Authors of the relevant journal for any special 
instructions relating to CIF submission. 
 
PLATON version of 05/11/2012; check.def file version of 05/11/2012 
Datablock jdp_2610ni - ellipsoid plot 
a  
 
Download CIF editor (publCIF) from the IUCr  
Download CIF editor (enCIFer) from the CCDC  
Test a new CIF entry 
checkCIF/PLATON report (basic structural 
check) 
No syntax errors found.                               CIF dictionary 
Please wait while processing ....                     Interpreting this report 
Datablock: jdp_zn2610 
 
Bond precision: C-C = 0.0060 A Wavelength=0.71073 
Cell: a=23.1020(3) b=18.1100(3) c=16.6460(3) 
 
alpha=90 beta=90 gamma=90 




Volume 6964.31(19) 6964.31(19) 
Space group P n a 21 P n a 21 
Hall group P 2c -2n P 2c -2n 
Moiety formula C58 H48 N4 O8 Zn2 C58 H48 N4 O8 Zn2 
Sum formula C58 H48 N4 O8 Zn2 C58 H48 N4 O8 Zn2 
Mr 1059.79 1059.74 
Dx,g cm-3 1.011 1.011 
Z 4 4 
Mu (mm-1) 0.733 0.733 
F000 2192.0 2192.0 
F000' 2195.09 
 
h,k,lmax 30,24,22 30,24,22 
Nref 8918[ 17251] 13618 
Tmin,Tmax 0.876,0.896 0.838,0.898 
Tmin' 0.833 
 









S = 0.838 Npar= 654 
 
  
The following ALERTS were generated. Each ALERT has the format 
       test-name_ALERT_alert-type_alert-level. 
Click on the hyperlinks for more details of the test. 
 
Alert level B 
PLAT111_ALERT_2_B ADDSYM Detects (Pseudo) Centre of Symmetry .....         
90 PerFi 
 
This can be ignored: the crystal is a racemic twin and the 
structure has been refined with the appropriate twin law. 
 
PLAT420_ALERT_2_B D-H Without Acceptor       O2     -   H2     ...          
?       
PLAT420_ALERT_2_B D-H Without Acceptor       O4     -   H4     ...          
?       
PLAT420_ALERT_2_B D-H Without Acceptor       O6     -   H6     ...          
?       
PLAT420_ALERT_2_B D-H Without Acceptor       O8     -   H8     ...          
?       
 
These flags may be ignored: the solvent (5 DMF molecules) was 
disordered and the electron density due to the disordered solvent 
region has been removed using PLATON’s SQUEEZE algorithm The 
ligand OH groups were H-bonded to disordered solvent 
molecules; removal of the solvent molecules thus creates OH 
groups that are not H-bonded in the structure. 
 
Alert level C 
STRVA01_ALERT_4_C           Flack test results are meaningless. 
           From the CIF: _refine_ls_abs_structure_Flack    0.000 
           From the CIF: _refine_ls_abs_structure_Flack_su    1.700 
PLAT220_ALERT_2_C Large Non-Solvent    O     Ueq(max)/Ueq(min) ...        
3.6 Ratio 
PLAT230_ALERT_2_C Hirshfeld Test Diff for    C49    --  C50     ..        5.7 
su    
 
Alert level G 
PLAT005_ALERT_5_G No _iucr_refine_instructions_details  in the CIF          
? 
PLAT007_ALERT_5_G Note: Number of Unrefined D-H Atoms ............          
4       
PLAT032_ALERT_4_G Std. Uncertainty on Flack Parameter Value High .      
1.700       
PLAT083_ALERT_2_G SHELXL Second Parameter in WGHT Unusually 
Large.       8.91       
PLAT093_ALERT_1_G No su's on H-positions, refinement reported as .      
mixed      
PLAT113_ALERT_2_G ADDSYM Suggests Possible Pseudo/New Space-
group.       Pbcn      
PLAT180_ALERT_4_G Check Cell Rounding: # of Values Ending with 0 =          
3       
PLAT606_ALERT_4_G VERY LARGE Solvent Accessible VOID(S) in 
Structure        ! 
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #         
15      
            N1  -ZN1 -O3  -C29  -131.50  1.10   1.555   1.555   1.555   
1.555   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #         
19      
            N1  -ZN1 -O3  -ZN2    25.60  1.20   1.555   1.555   1.555   
1.555   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #         
36      
            N3  -ZN2 -O7  -C58  -119.40  1.10   1.555   1.555   1.555   
1.555   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #         
40      
            N3  -ZN2 -O7  -ZN1    36.20  1.10   1.555   1.555   1.555   
1.555   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #         
44      
            O3  -ZN1 -N1  -C7   -135.60  1.10   1.555   1.555   1.555   
1.555   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #         
48      
            O3  -ZN1 -N1  -C14    40.40  1.30   1.555   1.555   1.555   
1.555   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #         
60      
            O7  -ZN2 -N3  -C36  -154.10  0.90   1.555   1.555   1.555   
1.555   
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... #         
64      
            O7  -ZN2 -N3  -C43    23.30  1.20   1.555   1.555   1.555   
1.555   
PLAT850_ALERT_4_G Check Flack Parameter Exact Value 0.00 and su ..       
1.70       
PLAT869_ALERT_4_G ALERTS Related to the use of SQUEEZE Suppressed           
! 
 
   0 ALERT level A = Most likely a serious problem - resolve or explain 
   5 ALERT level B = A potentially serious problem, consider carefully 
   3 ALERT level C = Check. Ensure it is not caused by an omission or 
oversight 
  18 ALERT level G = General information/check it is not something 
unexpected 
 
   1 ALERT type 1 CIF construction/syntax error, inconsistent or missing 
data 
   9 ALERT type 2 Indicator that the structure model may be wrong or 
deficient 
   0 ALERT type 3 Indicator that the structure quality may be low 
  14 ALERT type 4 Improvement, methodology, query or suggestion 
   2 ALERT type 5 Informative message, check 
 
 
It is advisable to attempt to resolve as many as possible of the 
alerts in all categories. Often the minor alerts point to easily fixed 
oversights, errors and omissions in your CIF or refinement 
strategy, so attention to these fine details can be worthwhile. In 
order to resolve some of the more serious problems it may be 
necessary to carry out additional measurements or structure 
refinements. However, the purpose of your study may justify the 
reported deviations and the more serious of these should normally 
be commented upon in the discussion or experimental section of a 
paper or in the "special_details" fields of the CIF. checkCIF was 
carefully designed to identify outliers and unusual parameters, but 
every test has its limitations and alerts that are not important in a 
particular case may appear. Conversely, the absence of alerts does 
not guarantee there are no aspects of the results needing 
attention. It is up to the individual to critically assess their own 
results and, if necessary, seek expert advice. 
Publication of your CIF in IUCr journals 
A basic structural check has been run on your CIF. These basic 
checks will be run on all CIFs submitted for publication in IUCr 
journals (Acta Crystallographica, Journal of Applied 
Crystallography, Journal of Synchrotron Radiation); however, if 
you intend to submit toActa Crystallographica Section C or E, you 
should make sure that full publication checksare run on the final 
version of your CIF prior to submission. 
Publication of your CIF in other journals 
Please refer to the Notes for Authors of the relevant journal for any 
special instructions relating to CIF submission. 
 
PLATON version of 05/11/2012; check.def file version of 05/11/2012 
Datablock jdp_zn2610 - ellipsoid plot 
 
 
Download CIF editor (publCIF) from the IUCr  
Download CIF editor (enCIFer) from the CCDC  
Test a new CIF entry 
